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Current challenges towards 
malaria elimination; 
Heterogeneity of malaria
Section I

1Progress in malaria control 
and current challenges on the 
road to malaria elimination
Chapter 1
Illustration on page 10 by Dr. Judith Sitters, figures 1 and 2 designed by Dr. Sarah Merkling
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Malaria – A historic perspective 
“A possible fatal periodic 
fever associated with the 
foul air surrounding swamps 
and biting mosquitos”.[1]
According to ancient scriptures malaria has plagued humanity for many millennia 
[2]. Phylogenetic analysis indicates that Plasmodium parasites have been present 
for millions of years in our hominid ancestors [3, 4]. The antiquity of this parasite is 
emphasized by the fact that over two hundred species of Plasmodium are found in a 
wide range of vertebrates [5] such as birds [6], rodents [7], reptiles [8] and monkeys 
[9]. The long presence of Plasmodium in its vertebrate hosts has given the parasite 
ample time to almost perfectly adapt to life in humans, where it has caused infections 
for ten thousands of years [10]. The evolution of mankind has been influenced by 
selective pressure exerted by the malaria parasite, as illustrated by the presence 
of human genetic traits associated with degrees of protection against malaria in 
populations (historically) exposed to malaria [11, 12]. Over time, the malaria parasite 
has become endemic in many parts of the world, following the epidemiology of its 
mosquito vector, agricultural transitions and human population density [13]. 
In the early 17th century, came the discovery of the indigenous Peruvian Cinchona 
bark or Jesuit powder, which offered a relief for people suffering from intermittent 
fevers. Later the active ingredient would become known as quinine which was 
widely used as a first line anti-malarial therapy up to the 1940s [14]. In the 18th 
century, the disease associated with marshy areas received its Italian name ‘mala 
aria’, literally meaning ‘bad air’, which formed the basis for its current name. It would 
not be until 1880 that the causal organism was discovered by a French army surgeon 
called Charles Laveran who observed the parasites in human red blood cells while 
on mission in Algeria [15]. The mechanism of transmission was discovered in India 
by a British medical doctor, Ronald Ross, who found pigmented cysts in the body of 
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a female mosquito that had previously fed on the blood of a Plasmodium infected 
patient in 1898 [16]. Together with the findings of the Italian scientist Giovanni 
Battista Grassi, this led to the elucidation of the complex life cycle and transmission 
of the malaria parasites and paved the way for early control efforts [17]. These early 
control measures had a strong focus on mosquito vector management, initially 
concentrating on their larval stages, by using for instance the application of oil 
on water surfaces of breeding sites [18]. With the development of insecticides like 
dichlorodiphenyltrichloroethane (DDT), which was widely used during and post- 
World War Two [19], the focus of vector control shifted towards the adult stages of the 
mosquito. With the availability of DDT and potent drugs like chloroquine, the World 
Health Organization (WHO) launched the Global Malaria Eradication Programme 
in 1955 [17]. This campaign aimed for the interruption of malaria transmission in 
endemic countries, including some African colonies. However, the Global Malaria 
Eradication Programme excluded the majority of tropical Africa, realising the 
complexity of malaria control in these regions with high infection rates and a general 
lack of sufficient health infrastructure to allow elimination campaigns [20]. In 1969 
the goal of malaria eradication was abandoned due to spreading resistance against 
chloroquine and the banned use of DDT in the same period [19, 21]. Recently some 
countries started utilizing DDT once again for controlled indoor use [22]. It was not 
until the late 1990s when the ambitious goals for malaria control in sub Saharan 
Africa were again defined in the Roll Back Malaria campaign. At that moment, the 
global malaria prevalence was once again on the rise [23]. The WHO in accordance 
with other leading organizations in public health, the World Bank, G8 countries and 
the organization of African Unity, hoped to strengthen health systems in developing 
countries and aimed to make effective treatment and prevention more universally 
accessible [24]. In 2000 this ambition was fortified with the targets described in the 
Millennium Development Goals (MDG) that explicitly described the aim of reducing 
malaria-attributed mortality and prevalence of malaria infection. Between 2000 and 
2015, eight countries managed to eliminate malaria [25, 26]. In 2015, WHO and her 
partners established a comprehensive framework titled “Global Strategy for Malaria 
2016-2030” [27], closely following the timeline of the Sustainable Development 
Goals (SDG). The vision advocated in this strategy aimed to eliminate malaria from 
an additional ten countries by 2020, and a total of 35 countries by 2030, bringing 
the world closer to global eradication of malaria[27]. These specific goals have also 
been specific in more detail within the Global Technical Strategy (GTS) for Malaria 
2016-2030 [27].
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The complex lifecycle of the malaria parasite
There are five known species of Plasmodium which are commonly found to infect 
humans, namely P. falciparum, P. vivax, P ovale (two sub-species P. o. curtisi and P. o. 
wallikeri [28]), P. malariae and P. knowlesi [29], the latter emerging as a clinically and 
epidemiologically relevant threat in recent years [29, 30]. At present Plasmodium 
falciparum causes the largest burden of infection, the most severe symptoms and 
highest mortality [31]. The life cycle of the P. falciparum parasite is depicted in 
figure 1. The cycle starts with an infected female Anopheline mosquito taking a 
blood meal on a human host. Sporozoites are released from her salivary glands. 
A proportion of these sporozoites manage to migrate through the dermal layers 
where they enter the central blood circulation, and, within a short period of time, 
they proceed to enter the liver. There they invade hepatocytes, taking around 6-8 
days to mature, and undergo an asexual multiplication to produce merozoites. After 
bursting out of the hepatocytes, the merozoites enter subsequently the cardio-
vascular system. Each merozoite invades an erythrocyte and then matures to form 
a schizont in which 16 to 32 new merozoites are formed [32, 33]. This replication in 
the blood is the common denominator for all the clinical symptoms associated with 
malaria. Asexual parasitaemia can cause cerebral malaria and profound anaemia, 
which are two common clinical manifestations of severe malaria disease. A small 
proportion of asexual parasites commits to become sexual stage gametocytes which 
are not pathogenic [34] and mature in the bone marrow for 10-12 days [35, 36]. 
These gametocytes remain in a state of arrested cell development until ingested by a 
female Anopheline mosquito [37]. Once ingested the parasites reside in the mosquito 
midgut, where male gametocytes transform and divide to form up to eight motile 
flagellated microgametes which fuse with the female macrogamete. The resulting 
zygote then matures to form the motile ookinete, which invades and traverses the 
midgut epithelium to form an oocyst under the basal lamina. After around ten days 
of maturation the oocyst ruptures and releases hundreds to thousands of sporozoites 
[38] which proceed to migrate to the mosquito salivary glands, completing the life 
cycle of the parasite and rendering the insect infectious to humans [37, 39, 40]. 
During its life cycle the parasite differs in its biological characteristics and presents 
life-stage specific antigenic epitopes, resulting in differences in its susceptibility to 
antimalarials and recognition by the immune-system [41, 42]. These characteristics, 
combined with its complex life-cycle that takes place in two host-organisms, make 
malaria a challenging disease to combat. 
17
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Figure 1: The life cycle of the malaria parasite
The life cycle of the malaria parasite takes place in two hosts. While taking a blood meal, an infected 
female Anopheles mosquito inoculates sporozoites into a human host (A). A proportion of sporozoites 
reaches the liver, where they invade hepatocytes (B), where they mature in schizonts which rupture 
and release merozoites into the cardio-vascular system (C). Merozoites invade erythrocytes where 
they mature in schizonts and undergo asexual replication which forms between 16-32 new merozoites 
(D). This replication in the blood is the cause of all clinical symptoms associated with malaria. A small 
proportion of infected red blood cells will produce sexual stage gametocytes (E), which in their 
turn can be ingested by a female Anopheline mosquito (F). Once ingested the parasites reside in the 
mosquito midgut, where motile flagellated microgametes fuse with the female macrogamete and 
mature into a motile ookinete (G), which invades and traverses the midgut epithelium to form an 
oocyst (H). After maturation the oocyst ruptures and releases hundreds to thousands of sporozoites 
(I) which migrate to the salivary glands, rendering the mosquito infectious to humans.
Global epidemiology: malaria still forms a significant threat 
Between 2000 and 2015, global mortality rates due to malaria have approximately 
halved [29].These impressive, and widely observed, declines in global mortality 
and morbidity are not attributable to a single intervention strategy, but rather 
to a combination of efforts originating from different disciplines of science [43] 
and economic development and potentially augmented by poorly understood 
developments in vector populations [44]. 
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For some countries that previously experienced low, stable or moderately high 
malaria transmission, this has resulted in the elimination of malaria [29]. Some 
key control measures played a large role in this, the most noticeable being the 
development and increased availability of affordable artemisinin-combination 
therapy (ACT), an anti-malarial drug which is cures current infection as well as to 
reduce the transmission potential [45-47]. In more recent years, the implementation 
of Intermittent Preventive Treatment (IPT) campaigns, aimed to reach high risk 
groups like pregnant women (IPTp) [29] and infants (IPTi) [48], might have also 
contributed to a reduction in clinical malaria and malaria associated mortality. On the 
front of vector control, the distribution of long lasting insecticide treated bed nets 
(LLINs) and the interventions at household level by indoor residual spraying with 
insecticides (IRS) have contributed to declining malaria rates by reducing mosquito 
numbers and effective contacts between humans and mosquitoes [29, 49]. 
Despite the significant recent advances made in disease and vector control, malaria 
is still responsible for at least 216 million cases worldwide (95% C.I.: 196-3263 million 
cases), and an estimated 445,000 deaths (95% C.I.: 235,000-639,000) in 2016. The 
majority of deaths (92%) occur in Africa region as defined by WHO(-AFRO), and 70% 
of the global deaths occur in children below the age of five years [29]. Especially in 
developing countries located in sub-Saharan Africa, malaria morbidity and mortality 
cause an extra burden for the already fragile economic infrastructure and in so doing 
impair the general development of these regions [50]. Malaria endemic countries do 
show a considerable overlap with patterns of poverty (figure 2), and at a household 
level the risk of actually becoming infected is highest in the poorest communities 
[51]. This is largely explained by the limited access to services committed to treatment 
and prevention [29, 52]. It has been estimated that the Gross Domestic Product 
(GDP) growth rate of malaria endemic countries are 1.3% lower on an annual basis in 
comparison to countries which are malaria free. In such countries, this has resulted 
in a 33% lower GDP per capita on average compared to countries absent of endemic 
malaria, even after correcting for confounding historical, cultural and geographical 
factors [53]. Malaria and poverty are thereby undeniably related in a vicious cycle; 
malaria is a true poverty related disease that contributes to ongoing poverty and 
most severely affects poor communities [54]. 
Current challenges for malaria elimination 
With the set trend of global declining malaria prevalence, the calls for malaria 
elimination from international public health and philanthropic institutions to 
actively pursue elimination and ultimately eradication, have increased in recent 
years [55-58]. In some settings, these ambitions are hindered by everyday logistical 
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challenges, and on a more structural fundamental level, there are obstacles 
hampering the pursuit towards elimination. Part of these challenges lay in the 
technical aspects of identifying all malaria infected individuals which is becoming 
increasingly evident in areas of declining transmission, where there is an increased 
number of asymptomatic cases.
Figure 2; Hotspots of malaria transmission in the dry and wet season. Mosquito exposure and 
parasite carriage are highly focal in the dry season (A). People living in hotspots are exposed to 
higher mosquito densities and, because individuals in households belonging to hotspots are more 
likely to be infected and infectious, mosquitoes are more likely to acquire a malaria infection in these 
households. In the wet season, as mosquito density and geographic distribution increase, infectious 
mosquitoes drive infection out into the rest of the village (B). Adapted and reprinted with permission 
from Bousema, PLoS Medicine 2012 [145]
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Figure 3; R0 constitution and driving factors: The basic reproductive number, R0, is derived by 
computing the expected number of vertebrate hosts or vectors that would be infected through one 
complete generation of the parasite by a single infected mosquito or a single infected human. The 
underlying mathematical model, by Ross [157] and Macdonald [64] and with a slight modification by 
Smith and McKenzie [158], is a quantitative description of the idealized life cycle. This diagram follows 
one by Macdonald et al. [159]. The parameters are described below. Reprinted from Smith et al. [65] with 
permission of PloSOne.
Measuring and targeting malaria transmission in a changing climate
Different metrics can be utilized to assess changes in transmission intensity, and 
depending on the context some metrics may be more informative than others 
[61]. One universal metric to express the transmission potential of an infectious 
disease is the basic reproductive number (R0) [62-64]. R0 reflects how many new 
cases arise from a single infected case. For many diseases, and especially for malaria, 
this number varies and is very context specific [65]. When R0  > 1, the infection is 
spreading in a population, when R0 < 1, the infection prevalence will decrease 
over time. Because of the dual host dependency and the large array of factors 
contributing to exposure, R0 varies greatly in case of malaria, and values below one 
to as high as several thousands have been reported in a study looking at 121 African 
populations [65]. R0 is determined by several components, as shown in figure 3. One 
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of these is the Entomological Inoculation Rate (EIR) [61]. The EIR is defined as the 
number of infectious bites per person per time unit. Variation in mosquito exposure 
plays a substantial role in transmission heterogeneity [66] and much of the variation 
in mosquito exposure can be explained by differences in ecological parameters. 
However, socio-economic status [67] and human genetic factors [12, 68] associated 
with malaria may also contribute to the observed patterns in malaria risk [69, 70]. 
Obtaining information about the changing epidemiological trends in countries on 
the road to malaria elimination is key to developing new and more context specific 
intervention programmes [71]. Before these interventions can contribute to further 
shrinking the global malaria burden [72], several challenges need to be addressed. 
Asymptomatic and sub-microscopic infections, a true challenge in low 
endemic settings
In 2012 the WHO launched its ‘Test, Treat and Track initiative’ (T3), “supporting 
malaria endemic countries in their effort to achieve universal coverage with diagnostic 
testing and antimalarial treatment as well as in strengthening their malaria surveillance 
systems”[59]. In the WHO defined Africa region, 38% of recorded suspected malaria 
cases still lack basic laboratory confirmation, and over 20% of malaria negative cases 
receive ACTs at public health facilities [29]. The T3 initiative offers key priorities 
in malaria control and elimination efforts, but mainly underlines the necessity of 
increasing availability and accessibility of more sensitive diagnostic tests, like RDTs, 
for routine clinical use [59]. In line with declining prices of RDTs, this effort is well 
underway, and for the first time in 2013, the number of diagnostic tests performed 
exceeded the number of distributed ACTs in the WHO defined Africa region. Today 86 
of the 99 countries with ongoing malaria transmission offer free malaria diagnosis in 
the public sector [29]. Although there are operational challenges to be considered, 
the scale up, development and effective implementation of the T3 pillars could 
significantly strengthen malaria control, evaluation and elimination efforts [60]. 
However, whilst moving towards malaria elimination, there is a need to consider all 
malaria-infected individuals, rather than focus only on symptomatic malaria cases. 
Typical clinical malaria symptoms include fever, sweats, chills, vomiting, headache, 
diarrhoea, anaemia, jaundice and splenomegaly [73]. Most studies define 
symptomatic malaria as the presence of fever (auxiliary temperature ≥37.5°C) or 
reported fever while having measurable parasitemia, sometimes above a certain 
threshold density that is considered to be causally related to fever [74-76]. It is 
increasingly well acknowledged that symptomatic malaria cases only comprise 
a small fraction of the total infected population [77]. Several community surveys 
reveal that ≥75% of the malaria infected individuals may carry their infections 
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without obvious concurrent symptoms [78, 79]. In these asymptomatic cases 
parasite densities can be either microscopically or sub-microscopic (subpatent) 
detectable [74, 80]. Individuals with asymptomatic infections can carry both, asexual 
parasites and gametocytes, and can actively contribute to onward transmission [81]. 
Asymptomatic infections may progress to a later symptomatic state, but this is not 
the case for a substantial proportion of infections [76, 82]. It has been reasoned that 
asymptomatic malaria is a result of exposure related immunity in which parasite 
densities are controlled by the immune system [83, 84]. However, asymptomatic 
malaria is also observed in areas of low transmission rates where repeated exposure 
is less common, and where exposure-related immunity might be generated as 
a consequence of a lower genetic variability between malaria parasites. This may 
allow individuals with limited previous exposure to control their parasitemia [76], 
and, due to the lack of symptoms, these asymptomatically infected individuals do 
not actively seek healthcare [85, 86]. Untreated asymptomatic infections have been 
reported to persist for up to 18 months in some individuals and commonly span the 
period between two transmission seasons in settings of seasonal malaria [87, 88]. 
The relative contribution of asymptomatic infections, and in particular subpatent 
infections, to malaria transmission is a topic of much debate [77],[89]. In a study from 
the Amazonian region, febrile and therefore symptomatic cases seemed to be more 
infective to mosquito hosts when compared to asymptomatic cases [90]. In contrast, 
the vast majority of malaria infections in an area of intense malaria transmission, 
like Burkina Faso, was asymptomatic, and, although individuals presenting clinical 
symptoms had the highest gametocyte and total parasite densities, more than 90% 
of all mosquito infections were due to asymptomatic infections, of which >50% 
would very likely not be detectable by microscopy or RDTs [91]. The relationships 
between parasite densities, gametocyte densities and transmission to mosquitos are 
non-linear[92]. Although a female Anopheline mosquito ingests small quantities of 
blood (on average 2-3 µL) during a blood meal [78], a successful infection can be still 
observed at blood gametocyte densities as low as 1 gametocyte/µL of blood [92].
One specific setting where asymptomatic infections may be of particular relevance 
is in low endemic settings or in areas where malaria burden is very low but the 
presence of permissive mosquito vectors allows the introduction of malaria by 
malaria-infected individuals migrating from areas with ongoing transmission [93]. 
Because of the plausible contribution of asymptomatic patent and subpatent 
infections to onward malaria transmission [78], the detection and treatment of all 
malaria infections is a priority in malaria elimination settings [94, 95] and areas 
where re-introduction of malaria is a concern. 
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At present, there are two community-wide intervention strategies advocated to include 
asymptomatic and sub-microscopic infections in malaria control campaigns. One of 
these approaches is Mass Drug Administration (MDA), based on the administration 
of curative doses of antimalarial drugs regardless of parasite carriage [96]. Another 
more targeted approach is Mass Screen and Treat (MSAT), which involves a form of 
diagnostic screening before curative drugs are administered to parasite positive 
individuals [97]. Both strategies have had limited success in the past. Covering and 
treating the whole infected population is a challenge for both approaches [96, 98, 99]. 
MDA interventions invariably lead to unnecessary drug exposure in areas with low 
parasite prevalence. In such areas MDA might accelerate the process of drug resistance 
development or spread [100, 101]. While MSAT approaches avoid the treatment of 
uninfected individuals, current diagnostic approaches lack the sensitivity to detect all 
infections because of the above mentioned fraction of infections which is present at 
densities below the detection limit of microscopy or RDT [78, 102]. Molecular methods 
can offer a solution in these contexts, especially if they can be fitted to point of care 
diagnostic utilities [103, 104]. 
Current tools for malaria diagnosis, measuring transmission and 
monitoring malaria control efforts 
Molecular diagnostics have a much greater sensitivity than current microscopy and 
RDT diagnostics. The sensitivity of molecular methods depends on the volume of 
blood examined[105], the target selection (with multiple gene copies leading to 
higher sensitivity), extraction efficiency and assay performance [78]. 
Diagnostic sensitivities ≤1 parasite per µL of blood are within reach for PCR-based 
diagnostics or, theoretically, one target copy per reaction [106]. This is in contrast 
to microscopy and RDTs for which the detection limit lays several orders higher 
(range: ~100 parasites per µL in routine, non-research settings) [29, 107, 108]. The 
qualifications and skills of individual microscopists also play determining roles in 
the sensitivity and reliability of individual microscopy readings [109, 110], making 
it difficult to ensure consistency between surveys or study areas. In a meta-analysis 
covering 106 surveys, microscopy managed to detect 54.1% of all PCR-detected 
infections. Restricted to low endemic settings, this estimate decreased to below 20% 
[80]. In these low endemic settings, molecular tools or other diagnostics to capture a 
larger fraction of all infections are needed. Serological markers of malaria exposure, 
measuring antibodies directed to asexual stage antigenic epitopes of the parasite 
[111, 112], do not exclusively measure the current presence of infections but detect 
recent exposure to malaria. This results in a higher sensitivity to capture malaria-
exposed individuals in communities, and malaria antibody prevalence is generally 
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higher than parasite prevalence [113]. Antibody responses to malaria antigens show 
strong correlation with classical entomological measures of transmission intensity 
and exposure [61, 112]. Antibody responses can be utilized to detect spatial 
variation and temporal stability in transmission intensity, especially in areas of low 
endemicity [114, 115]. In addition they can be used to evaluate the impact and 
efficacy of interventions [116]. The acquisition of antibodies is based on cumulative 
responses to specific antigens, and antibodies produced are detectable for long 
periods after infection, making them very suitable for detecting transmission and 
spatial heterogeneity in transmission within areas of low malaria endemicity [70]. 
Despite the longevity of antibody circulation, age-specific sero-conversion rates can 
be utilized to assess the short-term impact of interventions over time [70, 116]. 
Table 1; Overview of different types of tests can be utilized for diagnoses and exposure 
assessment, serology measures different outcomes in comparison to LMS, RDTs and molecular 
tools. (Based on; [107])
Light Microscopy Rapid Diagnostic 
Tests
Serology Molecular tests
Utility Diagnoses Diagnoses Control/Elimination/
Exposure
Diagnoses/Control/
Elimination
Target Visualization of parasites in whole 
blood sample
Antigen Antibodies DNA/RNA
Information yield Current infection Current and past 
infection*
past infection, relative 
exposure
current infection
sensitivity Up to 50 parasites/µL, depends on 
slide reader
>100 parasites/µL not directly applicable 0.5-5 parasites/µL
Quantitative Quantitative for parasitemia no Semi- quantitative for 
exposure rate
Quantitative for 
parasitemia 
*RDT’s that utilize the detection of histidine-rich protein-2 have the drawback that HRP-2 can 
accumulate in the blood up to 4 weeks post-treatment and parasite clearance.[156] 
All these tools have their different uses when it comes to their diagnostic utility, 
measuring current transmission and changes in transmission intensity [61]. A 
summarized overview of currently available tests and their possible utility is shown 
in table 1. Whilst there are many decades of experience with microscopy as diagnostic 
tool, serology and molecular diagnostics impose new challenges, in particular their 
need for proper cold-storage and specialized laboratory equipment. Molecular 
techniques depend on the detection of nucleic acid derived from blood material, 
but the collection and storage of venous blood samples is not always possible. As 
an alternative approach, filter papers are being used to collect drops of blood which 
can be easily obtained by finger prick [117]. This way of sampling allows for easy 
collection and storage and can yield significant reductions in operational costs. 
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However, there are some concerns as well. Often these samples are sub-optimally 
stored and this can impact their quality. Operational approaches to incorporate 
more sensitive, often molecular or serological diagnostics , depend on high quality 
blood material [118]. An operationally attractive approach to improve sampling and 
storage is highly needed to support public health interventions in the era of malaria 
elimination when areas of low endemicity constitute the primary arena of activities.
Vector control with changing vector dynamics
Three main mosquito species are predominantly responsible for transmission of 
malaria parasites in Sub-Saharan Africa: Anopheles gambiae s.s., An. funestus and An. 
Arabiensis [29, 36, 119-121]. Vector–based interventions for malaria aim to reduce 
mosquito populations or human exposure against mosquito bites. The use of LLINs 
and IRS led to a decline in malaria parasite prevalence in the human population [29, 
122, 123], and they are still considered to be the main strategies in integrated vector 
control [120]. In some studies the combination of these two interventions yielded 
an additional protective effect, while in other settings with high LLIN coverage, 
there was no added benefit of IRS [124, 125]. Both LLINs and IRS may provide a 
community protective effect by affecting the total vector population in an area 
[123], especially for households that are in close proximity to those using LLINs or 
IRS [126, 127]. In recent years, the shortcomings of indoor vector interventions are 
becoming increasingly apparent. The wide-scale implementation of IRS and LLINs 
may have led to changes in mosquito populations and mosquito feeding behaviour 
[128]. In Western Kenya there is a recent evidence of increasing proportions of 
An. funestus within the population of caught Anophelines. This occurred after a 
period of steep decline of malaria transmitting mosquitos due to the early wide-
scale implementation of LLINs and IRS.[121]. Outdoor biting of mosquitoes also 
seems to become more prevalent in areas where ITNs and IRS have been widely 
used [129-131]. Targeting outdoor biting vectors poses a considerable challenge 
for malaria control [132]. Novel interventions, like the use of mosquitocidal drug 
ivermectin [133], may be needed and they may currently be hampered by its short 
active half-life [134], or like the target of the mosquito larval stages, for example 
by larval source management, a strategy used with the earliest attempts of malaria 
control[18]. Larval source management strategies target the aquatic larval stages of 
the mosquito and do yield success in some scenarios [120]. One of these promising 
larval control strategies makes use of the microbial larvicide Bacillus thuringiensis 
israelensis (Bti) which is applied in potential mosquito breeding sites and specifically 
targets the larvae of the malaria vectors while remaining safe for the ecological 
habitat [135]. This approach achieved a two-fold decrease in new malaria infections 
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compared to the use of only ITNs in western-Kenya [136], and has yielded promising 
results in other settings [137-139]. 
Changing geographical epidemiology of malaria 
With the decline in malaria transmission, spatial variation in disease risk is becoming 
more apparent. Heterogeneity in malaria incidence and exposure to malaria-
infected mosquitoes is present at all levels of malaria transmission intensity. 
Infectious diseases often follow a so-called ‘20/80 rule’ distribution, meaning that 
20% of the population harbours 80% of the infection burden. Malaria is no exception 
and typically follows these patterns [66]. Several factors have been associated with 
geographical clustering of malaria transmission including distance to breeding 
sites [140], presence of eaves and quality of household building [141]; those 
have an influence on exposure to mosquitos and malaria prevalence on a micro-
epidemiological scale [142-144]. Within a larger focus of malaria transmission 
(defined as an independent area that can sustain malaria transmission), smaller 
hotspots of intense malaria exposure may exist. A hotspot of malaria transmission is 
defined as a geographical part of a focus where malaria transmission and R0 exceed 
the average level of transmission in the area [145]. A more detailed definition of 
hotspots, factors driving heterogeneity and their implications for malaria control are 
presented in chapter 2.
In high endemic areas the burden of disease may be more widely distributed and 
clustering of cases might not be particularly apparent [72]. Now that more countries 
and regions are transitioning into a more low-endemic state of malaria transmission 
[29] spatial heterogeneity in disease distribution is becoming clearer. Given that 
individuals who are most often bitten are also most likely to infect mosquitos [65], 
the question arises whether these individuals may amplify transmission [114] and 
whether this could hold the key to effective malaria control. If geographical areas of 
intense transmission can be reliably detected, this could prove an effective means to 
deploy more accurately targeted interventions [114, 145]. These maintained hotspots 
of malaria infections could be persistent and particularly focal in the low-transmission 
season, typically outside the rainy seasons [70, 145]. However, during the rainy season 
when the vector population peaks, these sustained reservoirs of persistent hotspots 
are hypothesized to fuel malaria transmission to surrounding areas (figure 4), and 
amplify local transmission, leading to an increase in the R0 [65, 145]. 
In addition to the theoretical benefit of hotspot targeted interventions (i.e. individuals 
living in these areas are most affected and most important for transmission), there 
is a more practical reason why it is relevant to consider targeted interventions. 
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The WHO estimates that in 2013 there was still a funding gap for malaria control 
of roughly 2.5 billion US dollars annually [29]. This severe gap in funding limits the 
likelihood of achieving universal coverage of integrated vector control approaches 
like IRS and LLINs, and reduces the local availability of curative drugs and intermittent 
preventive screening operations. Making use of the observation that cases of malaria 
are often clustered within geographically confined areas [143, 146, 147], and that 
stable hotspots are detectable in periods of low transmission intensity, deploying 
hotspot targeted interventions could yield a significant reduction in operational 
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Figure 4: Overlap between the poorest countries which suffer the highest malaria burden
Malaria lays the heaviest burden on the poorest and vulnerable communities. It primarily affects low- 
and lower-middle income countries. Within endemic countries, the poorest and most marginalized 
communities are the most severely affected, having the highest risks associated with malaria, and 
the least access to effective services for prevention, diagnosis and treatment. Thus, malaria control 
and ultimately its elimination is inextricably linked with health system strengthening infrastructure 
development and poverty reduction. Reprinted with from the WHO world malaria report 2015.[29]
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efforts and costs [70, 145]. Resources could be more effectively allocated and more 
‘ground’ could be covered. Not only could the available budget be reallocated to 
deploy interventions with more impact, but also progress toward elimination could 
move faster and more sustainably. Recent reports of spreading resistance against 
artemisinin derivatives [148, 149] and a multitude of insecticides, [150-152] like the 
pyrethroid  class of insecticides [153-155], support the notion that interventions 
need to be deployed as judiciously and efficiently as possible [118, 149]. 
Aims
The two main aims of this thesis are:
i) To optimise tools and methodologies to reliably detect hotspots of malaria 
transmission in an area of widespread and heterogeneous malaria transmission in 
the Western Kenyan Highlands;
ii) To ascertain the impact of hotspot targeted interventions on malaria transmission 
in the wider community. 
Thesis outline
The chapters in this thesis are grouped into three sections. Together these sections 
form a comprehensive overview of heterogeneity in malaria transmission and the 
current potential of hotspot targeted interventions in areas of widespread but 
heterogeneous malaria transmission.
Section I: Current challenges towards malaria elimination; 
Heterogeneity of malaria
The first section of this thesis reviews evidence of heterogeneity in malaria 
transmission and related factors. Chapter 2 describes ecological, human and vector 
variables associated to malaria heterogeneity, defines what hotspots are, how can 
they be detected and describes the theoretical considerations underlying hotspot-
targeted interventions. 
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Section II: Operational considerations for detecting hotspots of 
malaria transmission in field setting
The second section deals with molecular and serological tools that support the 
monitoring of malaria transmission intensity and practical elements related to 
sample collection, storage and processing in low transmission/pre-elimination 
settings. In chapter 3 the effects of dried blood spot storage in terms of duration 
and cold storage on the quality of P. falciparum DNA are evaluated; in chapter 4 a 
dual extraction assay is presented which allows the simultaneous extraction of DNA 
and elution of antibodies from dried blood spots. 
Section III: The implementation and evaluation of hotspot-targeted 
interventions
This section presents findings of the main research objectives of this thesis: 
the impact of hotspot targeted interventions on transmission. In chapter 5 the 
complete, detailed study protocol is presented for both detecting hotspots as well as 
the deployment and evaluation a cluster-randomized hotspot targeted intervention 
study. Chapter 6 explores in detail what community and environmental aspects 
contribute to the formation of hotspots and which risk factors are associated with 
hotspots. Chapter 7 discusses an active case detection strategy where we utilise 
the clustering of malaria cases in households to identify pockets of asymptomatic 
sub microscopic infections and thus classify households that are eligible for focal 
mass drug administration. We determine which sentinel population best identifies 
the majority of malaria infections. In Chapter 8, we present the results of the large 
baseline study which was conducted in order to determine if hotspots of intense 
malaria transmission can be detected. Subsequently we describe the results of a 
cluster randomized trial in which we evaluate the impact of hotspot targeted 
interventions in a selection of hotspots.
In chapter 9 all findings of the preceding sections are discussed and placed into 
context for current and future malaria elimination efforts. 
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Spatial variation in malaria incidence
The occurrence of clinical malaria attacks is not equally distributed in space in 
time. In many endemic regions, malaria incidence shows striking spatio-temporal 
variation. The temporal variation in malaria exposure is well described for areas of 
seasonal malaria transmission. The extent of seasonality differs between regions 
and can be quantified as the proportion of all malaria episodes occurring in the 
peak transmission season. Marked seasonality can be defined as a transmission 
pattern in which more than 75% of malaria episodes occur in 6 or fewer months 
[1]; in some areas ~90% of all malaria episodes may occur in a period as short as 3 
months [2]. Malaria transmission is practically absent in months when drought and/
or temperatures are less suitable for mosquito propagation or the development of 
malaria parasites inside their mosquito vectors [3-5].
In addition to this variation in time, geographical variation can be very pronounced. 
Spatial variation in malaria exposure exists between neighbouring villages [6-8] or 
sub-villages [9, 10] and even between households in the same village [8, 10-12]. 
In longitudinal studies where the incidence of clinical malaria attacks is quantified 
at an individual level, it is commonly observed that some individuals can remain 
malaria-free for more than one year while others experience multiple malaria attacks 
during the same period [10, 13, 14]. In an area of 16km2 exposed to low and unstable 
malaria transmission in the highlands of Kenya, small geographical areas were 
identified where malaria risk was up to 40-fold higher than elsewhere [15]. In studies 
conducted in areas of low to moderate endemicity in Uganda and Tanzania, 47-
69% of children remained malaria free during a period of >20 months while others 
experienced up to 9-14 malaria attacks [10, 13]. 
It has long been assumed that this heterogeneity is absent or at least far less evident 
in areas of higher endemicity [16]. It is, however, likely that even in highly endemic 
regions considerable variation in the exposure to malaria infected mosquitoes exists 
[7, 16, 17]. This heterogeneity in exposure may not lead to easily detectable variation 
in malaria incidence in these regions, because many infections in high endemic 
regions do not cause clinical symptoms [18, 19] and even the individuals with the 
lowest relative exposure may experience at least one malaria episode in a year [17]. 
As a consequence, variation in malaria exposure within these regions may remain 
undetected. Despite this, micro-epidemiological variations in disease risk can be 
detected in areas with an entomological inoculation rate (EIR) of >100 infected bites 
per person per year (ibpy). if studies prospectively quantify malaria incidence, or the 
incidence of malaria infections regardless of symptoms [11, 20], and link incidence 
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to individual geo-located households. In a region of intense malaria transmission 
in Ghana (EIR ~400 ibpy),  some children experienced malaria attacks at a rate that 
was five-fold higher than the village average while one-third of children remained 
malaria-free over a period of 21 months [7]. Our current understanding is that spatial 
variation in malaria exposure is present across all levels of transmission intensity but 
is more easily recognised at lower endemicity.
Defining hotspots of malaria transmission
Global trends of reducing malaria transmission intensity [21-25], have changed the 
epidemiology of malaria. These changes have uncovered heterogeneity in disease 
transmission in areas that were previously exposed to intense and apparently 
homogeneous malaria transmission. In these areas, small localities of intense 
transmission intensity can exist (or persist) in regions with a lower average level 
of malaria exposure [8, 10]. These findings have fuelled the academic and public 
health interest in defining hotspots of malaria transmission intensity [26]. For this, it 
is essential to define what is meant by hotspots of malaria transmission. The current 
literature is inconsistent; entire countries or islands are sometimes classified as 
malaria hotspots [27, 28], while some studies reserve the term hotspots of malaria 
transmission for small geographical areas that form part of a larger endemic region[8, 
10, 29]. Two related but distinct geographical elements in malaria transmission 
should be separated:
1. The World Health Organization definition of a focus of malaria transmission 
is a defined and circumscribed locality situated in a currently or 
former malarious area and containing the continuous or intermittent 
epidemiological factors necessary for malaria transmission. Foci of malaria 
transmission can be classified as residual active, residual non-active, 
cleared up, new potential, new active, endemic or pseudo foci [30]. In more 
academic terms, an active focus of malaria transmission is a geographical 
area that supports malaria transmission, where the local Anopheles 
population sustains R0, the average number of secondary cases arising in a 
susceptible population as a result of a single human case over the course of 
their malaria infection, to a level >1 [10, 16]. A mosquito breeding site forms 
the centre of a focus of malaria transmission. The size of the focus of malaria 
transmission depends on the maximum effective dispersal range of vector 
mosquitoes; the border is the location furthest away from the breeding site 
where malaria is still supported by this breeding site. 
44 |   Chapter 2
2. A hotspot of malaria transmission is defined as a geographical part of a 
focus of malaria transmission where malaria transmission exceeds the 
average level. Micro-epidemiological conditions for malaria transmission 
are favourable in a hotspot of malaria transmission, resulting in R0 estimates 
that exceed the average for the focus of malaria transmission. The size of 
a hotspot of malaria transmission is smaller than the maximum dispersal 
range of vector mosquitoes; its borders are defined by the distance from the 
centre of the hotspot where transmission intensity is no longer (statistically 
significantly) higher than the average for the focus of malaria transmission 
[8, 10].
Human factors and heterogeneity in malaria 
transmission
The occurrence of clinical malaria and, to a lesser extent, asymptomatic infection 
is influenced by innate and acquired protective responses. Several human 
genetic polymorphisms have been identified that have been associated with 
protection against (severe) clinical malaria An additional aspect of human genetic 
polymorphisms that is receiving increasing attention is their potential impact 
on gametocyte carriage and the transmission of malaria to mosquitoes [31, 32]. 
This results in a double interest in human genetic polymorphisms in the context 
of heterogeneity in malaria transmission: they may explain part of the variation 
in malaria incidence and may also result in differences in malaria transmission 
potential in the human population. Their impact on malaria incidence may influence 
the accuracy of detecting hotspots of malaria transmission (see paragraph on 
operational approaches to detecting hotspots of malaria transmission), their impact 
on transmission potential may contribute to the formation of hotspots of malaria 
transmission.
Genetic factors related to human susceptibility to malaria infection and 
clinical malaria
The malaria parasite depends on human red blood cells (RBC) for shelter and the 
provision of nutrients for the duration of its infection in humans. It is therefore 
logical that it is sensitive to variations in RBCs. Over one hundred RBC-related 
genetic polymorphisms have been described, several of which have well described 
effects on the erythrocyte phenotype [33]. For haemoglobin alterations affecting 
the β-chains (e.g. HbS, HbC and HbE) or conditions in which the balance between 
α and β chains is altered (e.g. α and β- thalassaemia), there is sufficient evidence 
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for a role in protection against (severe) malaria. The same is true for alterations 
in levels of a key enzyme in red blood cells, glucose-6-phosphate deficiency, and 
structural alterations leading to physical structural changes on the RBC membrane 
like the Duffy blood group [34]. With the exception of the Duffy blood group, none 
of these polymorphisms seem to protect against initial infection with malaria but 
rather convey ways to keep the infection controlled and prevent progression to high 
density infections or severe disease.  Although these genetic polymorphisms have 
direct beneficial effects for the human host, their epidemiological consequences for 
malaria transmission may not necessarily be equally beneficial. 
Haemoglobinopathies: Haemoglobin variants S , C and  E
Haemoglobin (Hb) is a tetrameric molecule which comprises one of the main 
structural and functional elements of erythrocytes. It consists of two α-chains and 
two β-chains. In an altered form of haemoglobin, which is described as haemoglobin 
S (HbS) a mutation occurs which leads to the modification of one or both β-chains. 
Heterozygote carriers (HbAS) have one normal and one altered β-chain. Their red 
blood cells function relatively normal. This contrasts with RBCs of homozygous 
individuals (HbSS) in whom both β-chains are abnormal;  HbSS cells assume a typical 
sickle shape under low oxygen conditions which leads to increased cell lysis and 
obstruction in the micro-vascular system. In countries where advanced medical care 
lacks HbSS homozygote individuals often die during early childhood. HbAS does 
not have this detrimental effect but protects against severe clinical consequences of 
malaria infection, but not against infection itself [35]. HbAS individuals may have a 
90% lower risk of severe and lethal malaria compared to normal (HbAA) individuals 
[36, 37]. Infected HbAS cells, sickle at a higher frequency compared to uninfected 
cells; sickle cells are known to be cleared in the spleen at higher frequencies. This 
results in a direct reduction of parasite densities and may also confer enhanced 
antigen presentation in the spleen, resulting in an improved acquisition of immune 
responses [38]. This immune component is supported by findings that the extent of 
the protective effect conferred by HbAS increases with age [38]. Sickle haemoglobin 
is also described to have a negative effect on the cytoadherence of RBCs infected 
with P. falciparum. This seems to correlate with an altered display of P. falciparum 
erythrocyte membrane protein-1 (Pf-EMP-1), a protein of great significance in terms 
of virulence and the adherence of infected RBC’s to micro vascular veins [39].
Haemoglobin C and E are both alternations in the β-globin chain but affect the 
erythrocytes in different ways. HbC is mainly found in West Africa and in higher 
frequencies in specific parts of West Africa like Ghana and Burkina Faso. The 
protective effect of HbC can especially be observed in HbCC homozygotes [35] and 
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may be related to a reduced ability of P. falciparum parasites to grow and multiply 
in these variant RBCs [35, 40, 41]; in HbAC cells parasite growth may be at the same 
level as normal cells [42]. An alternative mechanism for the protective effect of HbC 
may be a reduced expression of Pf-EMP-1, resulting in reduced cytoadherence of 
infected cells and a lower risk of severe (but not of uncomplicated) malaria [35, 40, 
41]. 
Haemoglobin E is also associated with a reduced risk of severe malaria [35]. There 
is some evidence of reduced parasite growth in cells in both HbAE and HbEE 
individuals; both cell types also seem to be phagocytosed at higher frequencies 
when infected [43]. Similar to HbCC, HbEE is relatively benign and it is possible that 
selection favours both homo- and heterozygotes [35].  
Haemoglobinopathies: thalassaemias
Thalassaemias are polymorphisms resulting in an imbalance in the synthesis of α 
and β-globin chains of the haemoglobin molecules. α-thalassaemia is commonly 
found in regions of sub-Saharan Africa and Asia where malaria is or has been 
endemic. α-thalassaemia results from a deletion of one or more α-globulin genes. 
The clinical consequences depend on how many genes are still operational and how 
severe the imbalance between α and β globulin is. Absence of all 4 genes results in 
stillborns and is therefore not observed in malaria-endemic populations. Deletion of 
one or two of the genes may result in lower haemoglobin levels [44]. α-thalassaemia 
is associated with protection against severe anaemia during asymptomatic malaria 
infections [44], protection against severe disease but not against asymptomatic 
infection [35] and probably not against uncomplicated disease [45]. There seems 
to be a strong correlation with age dependant factors determining to what degree 
α-thalassaemia offers protection against malaria. [46, 47]. 
β-thalassaemia is associated with a lower parasite density but not prevalence [48]
and is more prevalent in the Mediterranean and Middle East than in sub-Saharan 
Africa. When infected with malaria parasites, β-thalassaemic cells show a reduced 
parasite growth in-vitro when exposed to oxidant stress. Individuals with a single 
a-thalassaemic gene deletion seem to support parasite growth at normal rates; 
there is some evidence that infected thalassaemic cells to show enhanced antigen 
presentation [49], suggesting an immune component in thalassaemia-associated 
protection. 
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RBC enzymes: Glucose-6-phosphate dehydrogenase deficiency
Since erythrocytes lack nuclei and active translation machinery they are greatly 
dependent on some key long lived enzymes to create and maintain an appropriate 
environment for the cell to exhibit its function. Glucose-6-phosphate dehydrogenase 
(G6PD) is one of these enzymes; it metabolizes glucose through the pentose 
phosphate pathway and plays a key role in synthesizing NADPH. The gene coding for 
this enzyme is located on the X-chromosome and therefore autosomal; explaining 
why the more severe forms G6PD are mostly found in males in whom a mutation 
in a single gene results in a less efficient or completely deficient enzyme. Different 
mutations are responsible for varying degrees of G6PD deficiency across the globe 
[50], the most common African variant resulting in less severe G6PD deficiency than 
the Mediterranean variant [51].
The protection against malaria conferred by G6PD deficiency involves the early 
phagocytosis of infected RBCs. G6PD-deficient infected RBCs are phagocytized more 
efficiently than infected normal cells through a mechanism that may involve human 
immune components and the fact that they are more prone to oxidative stress. [52] 
This results in a similar risk of infection while the time to reach densities that cause 
symptomatic or severe malaria would be longer for G6PD deficient individuals [53].
 Membrane proteins: Ovalocytosis
Ovalocytosis is a disorder which affects the cytoskeleton of the erythrocyte. The 
typical round shape of RBCs is changed to a more oval shape. This condition is 
predominantly found in South East Asia; and although the condition is rare in most 
regions, it can be found in up to 15% of the population of some Asian countries. 
Ovalocytosis is associated with a more rigid RBC and an increased RBC adherence 
to endothelium receptors that are not present in the vascular endothelium of the 
brain [54].  Ovalocytosis has also been associated with resistance against invasion 
by some, but not all, parasite lines in vitro [55]. Ovalocytosis is associated with a 
reduced risk to the development of severe (cerebral) malaria [54, 56] but not against 
asymptomatic infection [35, 57]. 
Membrane proteins: Duffy blood group negativity
Lack of the Duffy antigen or Duffy blood group negativity, is associated with 
protection against P. vivax. This parasite is largely absent in much of sub-Saharan 
African countries while prevalent in Asia and South America. This geographical 
pattern has largely been attributed to a single nucleotide polymorphism  leading to 
the absence of the Duffy binding protein from RBCs in most African populations. This 
Duffy binding protein was long thought to be absolutely essential for the binding 
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and entering of P. vivax merozoites of RBCs. In more recent years, transmission of P. 
vivax has been reported in Duffy negative individuals. [58, 59] This would indicate 
that the parasite has found an alternative pathway to invade red blood cells within 
individuals negative for the Duffy antigen[60]. Nevertheless, the Duffy antigen 
is a striking illustration of how human genetic polymorphisms can shape the 
geographical map of malaria transmission.
Other genetic related factors
The correlation between genetically defined RBC polymorphisms and malaria 
has fuelled ideas around the burden of disease and selective pressure. Host gene 
polymorphisms in relation with malaria may not be restricted to those affecting 
RBCs. Cohort studies in Kenya indicated that  the genetic contribution to variability 
of malaria incidence is well beyond that explained by the anticipated effects of 
the haemoglobinopathies alone; genetic and unidentified household factors may 
each account for around one quarter of the total variability in malaria incidence 
[61]. Associations with severe malaria and high parasitaemia have also been found 
with human leukocyte antigens (HLA), a highly polymorphic family of molecules 
that play a crucial role in immune responses. [62] Also other specific chromosomal 
regions contributing to the hosts immune response have been identified. [63, 64]. 
Differences have been found in populations of same ancestral origin but living at 
higher altitudes where malaria was not endemic [65]. Genome wide linkage and 
association studies have shown several associations with genetic immune-related 
traits and host responses to malaria infections[66]. All these combined findings 
prove that malaria parasites have imposed a strong selective pressure on the human 
genome in former and current malaria endemic regions. The list of genetic factors 
associated with (severe) clinical malaria is becoming longer and as more results 
from genome wide linkage and association studies become available, the complex 
pathophysiology of malaria is likely to be progressively revealed  [65]. 
Human genetic factors related to human infectiousness to mosquitoes
There are several ways in which human genetic polymorphisms may influence 
transmission potential. Reductions in the risk of infection with malaria parasites or 
the density of malaria parasites will plausibly result in a reduction in transmission 
potential [67] while a longer duration of infections will in turn increase transmission 
potential. These conflicting possible outcomes warn against strong conclusions 
based on cross-sectional data that largely miss effects that become apparent with 
time. 
49Heterogeneity in malaria transmission   |
2
There is little evidence for a reduced risk of malaria infection associated with any of 
the above described polymorphisms (with the exception of Duffy antigen); instead 
they may lower parasite density or slow parasite growth which may translate in a 
longer duration of asymptomatic infections. This will increase the development and 
duration of gametocyte carriage, which seems to be supported by the suggestion 
that there is a significant human genetic contribution to gametocyte carriage in 
asymptomatic but not in symptomatic infections [68].
There are several indications that human genetic factors may influence gametocyte 
carriage and malaria transmission. Differences in gametocyte carriage were observed 
between tribes in West Africa that could not be explained by innate differences in 
immunity against asexual parasites [69]. Most detailed studies on human genetic 
polymorphisms in relation to malaria transmission potential have focused on HbC 
and HbS.  HbAS was associated with increased gametocyte carriage and increased 
density of gametocytes [68] and with an increased transmission of malaria to 
mosquitoes [31]. In line with this, Gouagna and colleagues observed an association 
between the protective HbC and HbS genotypes and increased transmission 
to mosquitoes, an effect estimated as up to twofold in in vivo and fourfold in ex 
vivo studies [32]. It was hypothesized that HbS and HbC might promote sexual 
differentiation, reduce human transmission blocking immune responses or increase 
gametocyte carriage as a result of the longer duration of parasite carriage in these 
individuals [32]. 
One longitudinal study that tried to determine a direct link between α-thalassaemia 
and gametocyte carriage or density failed to show a significant impact [68]. 
Gametocyte rates were reported to be lower in children carrying the β-thalassaemia 
trait although the cause for this association remains to be established [48]In summary, 
data are very limited but for HbC and S there is some evidence that the individual 
protection conferred by these haemoglobinopathies comes at the epidemiological 
cost of a higher transmission potential to the wider community.
Human genetic factors and hotspots of malaria transmission
Genetic factors that render individuals more or less susceptible to malaria infection or 
clinical malaria attacks can strongly influence intra-individual differences in malaria 
incidence. If human genetic factors cluster geographically, i.e. in compounds or 
villages, this clustering may be epidemiologically relevant for malaria transmission. 
Using the terminology of foci and hotspots of malaria transmission: neighbouring 
villages may differ in genetic background [70] and hence their risk of malaria (i.e. 
contribute to the intensity of transmission in a focus of malaria transmission). In 
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some exceptional areas,individuals who are genetically more prone to produce 
gametocytes during their infection may cluster geographically in such a way that 
they infect mosquitoes which subsequently spread the infection to populations with 
a different genetic make-up. Human genetic components could therefore contribute 
to the formation of a hotspot of malaria transmission. This has been suggested for 
areas in Burkina Faso where the susceptibility for malaria, and potentially a different 
infectiousness of different tribes to mosquitoes, has been described [69, 70]. This 
scenario may prove to be less exceptional once genetic elements determining the 
human transmission potential are identified at household or family level and if local 
‘super spreaders’, people who are disproportionally infectious to mosquitoes  [67, 
68], can be identified. In this respect, the authors believe there will be an important 
role for human genetic factors that determine their attractiveness to mosquitoes; 
these factors may explain heterogeneity in malaria exposure in villages where all 
known risk factors for malaria are apparently homogeneously distributed. Until 
these factors are revealed, most studies on heterogeneity in malaria transmission 
justifiably focus on factors related to spatial variation in mosquito exposure.
Heterogeneity in mosquito exposure
Factors determining spatial heterogeneity in mosquito exposure
Given the nature of malaria transmission, it is unsurprising that heterogeneity in 
malaria incidence has long been associated with the vicinity of mosquito breeding 
sites. Observations from ancient Egypt and Greece already noted the association 
between fevers and wet ground and anti-malaria regulations in Italy in the early 
nineteenth century required that irrigated land had to be at least 500 meters away 
from general housing and at least 8 kilometres from the capital of a kingdom 
[16, 71]. More recent studies described an association between malaria incidence 
and the distance to the forest [7], river [72, 73], water body [10, 12] or confirmed 
Anopheles breeding site [10, 74]. The strength of these associations will depend 
on the productivity of breeding sites and the effective mosquito dispersal range. 
The productivity of mosquito breeding sites is variable and is influenced by factors 
including the type [75-79], size [79] and stability of habitats [76], temperature [77, 
80], rainfall [81], vegetation [75, 78, 79], salinity [78], presence of larvae of other 
mosquito species [79] and other micro-environmental characteristics. The presence 
of water in a potential focus of malaria transmission therefore does not automatically 
translate in an epidemiologically important source of malaria vectors. Similarly, 
the apparent absence of evident water bodies does not exclude the presence of a 
source of mosquito emergence. This was recently illustrated by the association of 
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hotspots of malaria transmission with soil moisture content [8] despite an apparent 
homogeneous ecology [8, 26]. Obviously, findings of higher mosquito abundance 
in endemic areas do not equal increased malaria transmission intensity; in northern 
Tanzania a highly significant cluster of higher mosquito exposure was not associated 
with a higher malaria incidence [10]. 
The effective mosquito dispersal range from breeding sites will depend on their 
localisation in relation to potential blood meal sources. If humans are the primary 
source of blood meals for mosquitoes, the dispersal of mosquitoes from their 
breeding sites will strongly depend on the human population density in the area 
surrounding this breeding site. The Anopheles dispersal range may generally be 
less than 1km in densely populated areas [16, 82-84] but low population densities 
motivate mosquitoes to extend their flying range in search of a blood meal, potentially 
leading to ranges of ≥2 kilometres [16, 85, 86]. In densely populated areas, there 
can be a strong gradient in relative mosquito exposure and distance to a (potential) 
breeding site. In an urban area in Senegal, mosquito exposure approximately halved 
with every 200m increase in distance from a known mosquito breeding site [83]. In 
a Malian village with one permanent breeding site and dense human inhabitation 
at 50-1000m from this breeding site, there were evident hotspots of mosquito 
exposure in the dry season close to the main breeding site but mosquitoes were 
more dispersed during the wet season (figure 1)
Figure 1. Mosquito catches in an area of moderate and seasonal malaria transmission in Mali. 
Mosquitoes were sampled in every household on a monthly basis. The size of the circles represents 
the average number of mosquitoes caught per households. Mosquito exposure was low and 
clustered near the main permanent breeding site in the dry season (left) but was higher and more 
widely dispersed during the wet season (right) (Bousema, unpublished observations).
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The pattern described in figure 1 is typical for areas of seasonal malaria transmission, 
where mosquito exposure is commonly most clustered in the dry season when few 
permanent breeding sites exist [83, 86]. After seasonal rains the permanent breeding 
sites become more productive but  alternative breeding sites also arise that are 
more widely distributed across the transmission focus, leading to a wider dispersal 
of mosquitoes. Seasonal mosquito dispersal patterns may also change under the 
influence of seasonal variations in wind patterns [86]. 
In areas where the human population is on average located further away from 
the breeding site, more sparsely distributed or where mosquitoes feed on human 
and non-human hosts, geographical patterns may be less distinct. In a rural area 
in Tanzania where households were located 800-2000 m from a permanent river, 
where large numbers of cattle were present and Anopheles arabiensis was the main 
vector, there was no clear association between mosquito exposure and distance to 
the river [73].
Factors determining the contact rate between man and mosquito
In addition to the distance to mosquito breeding sites, elements that influence 
the contact rate between humans and mosquitoes have an obvious effect on the 
exposure to (infected) mosquitoes. The incidence of malaria and/or the exposure 
to mosquitoes has been associated with poorer housing conditions, especially 
incomplete housing [87], mud walls [10, 87, 88], uneven wall structure [10], thatched 
roofs and ceiling [10, 86, 87, 89], window screening [73], window size [73], presence 
of eaves [86, 88, 90], presence of animals [88, 91] and the use of smoke or local 
incense to repel mosquitoes [86, 88, 91]. Improvements in the house conditions, 
notably mosquito screening and closure of eaves, therefore lead to substantial 
reductions in mosquito exposure and can contribute to a reduction in anaemia 
in human inhabitants [92]. Other household protective measures such as indoor 
residual spraying (IRS) and insecticide treated nets (ITNs) have also been associated 
with reductions in malaria incidence [10, 93-95]. In addition to a direct protective 
effect, reducing the risk of malaria in people sleeping under an ITN, there is evidence 
for a community effect of ITNs. In an area of intense malaria transmission in Western 
Kenya, it was described that ITNs exert a protective effect in compounds lacking ITNs 
that are located within 300m of compounds with ITNs [93]. This indirect beneficial 
effect of ITNs is evident for child mortality, moderate anaemia and high-density 
parasitaemia [93]. 
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Regardless of the usage of protective measures, the attractiveness of humans also 
differs. Intra-individual mosquito attractiveness is related to variability in carbon 
dioxide (CO2) release, ammonia, lactic acid, and other aliphatic carboxylic acids 
[96]. Pregnancy may increase attractiveness to mosquitoes by a factor 1.7-4.5 [97], 
possibly as a result of differences in body surface, related to CO2 release, temperature 
and odour. Non-pregnant individuals also differ in their attractiveness to mosquitoes 
and in their response to being bitten, resulting in differences in the number of bites 
experienced by individuals [98]. The intrinsic variation in attractiveness is probably 
largely mediated by sweat-associated human volatiles [99, 100]. This human odour 
profile has a genetic background [101], explaining the genetic component that 
was previously associated with differential attractiveness [102]. Human leukocyte 
antigen (HLA) genes in particular may be involved in determining the intrinsic 
differential attractiveness of humans to mosquitoes [103] through their influence 
on the human body odour profile. The role of olfaction in vector-borne diseases is 
described in detail in a previous book in this series [104].
Stability of hotspots of malaria transmission over time
To be of public health relevance, the geographical location of hotspots should 
be identifiable and show a certain consistency over time. If hotspots of malaria 
transmission change between seasons or years, it will become costly and logistically 
challenging to identify and target hotspots to have a beneficial impact on the burden 
of disease. The temporal stability and logistical identifiability are therefore crucial 
for utilizing hotspots of malaria transmission for effective malaria control.  Some 
studies have reported that clusters of higher malaria incidence may change with 
time [8, 105] while others indicated that they are remarkably stable over months 
or even years [8, 10, 11, 15, 105-107]. Unstable clusters of malaria incidence may 
reflect a problem in using malaria incidence for detecting hotspots, something that 
is explained in more detail below in the section on approaches to identify hotspots 
of malaria transmission. In areas of unstable malaria transmission, an unpredictable 
influx of malaria-infected individuals into an area with a suitable climate for malaria 
may also lead to different hotspots of malaria transmission over time [105]. Contrary 
to these important but relatively uncommon observations, most published reports 
indicate that hotspots of malaria transmission or mosquito exposure are stable over 
time. The most convincing evidence for this temporal stability of geographically 
defined hotspots comes from areas where transmission intensity decreased over 
time as a consequence of climatic changes or untargeted interventions but where 
hotspots of intense malaria transmission persisted [11, 15, 106, 107].
54 |   Chapter 2
The most readily available data to describe the temporal consistency of hotspots 
of malaria transmission comes from entomological studies. Although we argued 
that the presence of mosquitoes does not automatically equal elevated malaria 
transmission intensity, field studies that sampled mosquitoes in the same households 
over several months provide valuable information on the consistency in exposure 
to malaria vectors. In table 1, the findings from some of these studies from West 
and East Africa are summarised. Although the average number of mosquitoes differs 
tremendously between the wet and dry season, the same households are exposed 
to the highest relative number of mosquitoes. One could argue that this (statistically 
significant) consistency is unsurprising in relatively large geographical areas where 
environmental differences make certain sub-villages consistently more exposed to 
malaria than others (e.g. Korogwe and Ifakara in the table below).  However, the 
findings from households in a single village in Mali indicate that also at micro-
epidemiological level, relative exposure to anophelines may be highly consistent 
over time despite temporal fluctuations in mosquito abundance.
Table 1.Consistency in mosquito exposure in three African settings
Ifakara,
Tanzania[9, 108]
Korogwe,
Tanzania[10]
Sotuba,
Mali 
Location Latitude 8° 8’ S 
Longitude 36° 41’ E
Latitude 5° 9’ S 
Longitude 38° 29’ E
Latitude 12° 40’ N 
Longitude 7° 55’ W
Parasite prevalence 2-9 year old children 55.1 (53.3-56.9 28.6 (23.3-33.7) 6.1% (3.4-10.4)
Households sampled 32 185 254
Area sampled 4*5km 5*6km 0.8*0.7km
Average anopheles mosquito count wet 
season (range)
137.8 (4-1266) 5.8 (0-129) 16.0 (0-184)
Average anopheles mosquito count early 
dry season/cool season (range)
1.4 (0-10.7) 1.3 (0-24) 7.9 (0-142)
Average anopheles mosquito count end 
dry season/hot season (range)
0.4 (0-5.2) 0.50 (0-30) 1.2 (0-13)
Correlation household catches wet – 
early dry (p-value)
0.54 (0.0015)** 0.30
(<0.001)**
0.41 (<0.001)**
Correlation household catches wet – end 
dry (p-value)
0.45 (0.01)* 0.15 (0.05) 0.38 (<0.001)**
Correlation household catches early – 
end dry (p-value)
0.72 (<0.001)** 0.32 (<0.001)** 0.42 (<0.001)**
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Using hotspots for targeted malaria control
Do hotspots fuel wider malaria transmission?
There are several reasons to assume that hotspots form important reservoirs for 
further malaria transmission. In areas of very low and unstable malaria transmission, 
hotspots can be present throughout the seasons and form the only likely source of 
parasites for seasonal or epidemic increases in malaria transmission in the wider 
community [15, 107]. Mathematical models also consistently show that the overall 
level of transmission intensity is increased by heterogeneity in malaria transmission, 
suggesting a fuelling effect of hotspots of malaria transmission. In a seminal study 
by Woolhouse and colleagues, R0 was 2-4 fold increased when heterogeneity in 
mosquito exposure was included in malaria transmission models [109]. It was 
later demonstrated that the impact of heterogeneity in mosquito exposure on 
transmission efficiency may differ between different settings [110]: heterogeneity 
in mosquito exposure may augment malaria transmission in low endemic settings 
by allowing mosquitoes to source their infections efficiently from hotspots; in areas 
of very high transmission intensity heterogeneity in mosquito exposure may result 
in segregation of populations where the clustering of mosquito exposure hinders 
instead of stimulates the spread of malaria. In more general terms, mosquitoes 
have to preferentially source their parasites from hotspots and subsequently spread 
their infection geographically to form a source of malaria transmission to a wider 
community. For this, the entire population of a focus of malaria transmission should 
be exposed to the same mosquito population while individuals living in hotspots 
should have more encounters with an otherwise randomly mixing mosquito 
population. 
A study in Tanzania where mosquitoes were captured, marked with fluorescent 
powder, released and recaptured observed that 68% of mosquitoes returned to the 
same household as where they were initially captured [111] but these findings were 
not confirmed in follow-up experiments. In Papua New Guinea mosquitoes appeared 
to have a ‘memorized’ home range and limited dispersal range in the focus of 
malaria transmission they are accustomed to [112]. These indications that mosquito 
populations may not mix randomly in villages need confirmation but would have 
important epidemiological consequences [113]. In an extreme and highly unlikely 
scenario, no dispersal of mosquito populations from hotspots could result in intense 
transmission intensity inside hotspots of malaria transmission without consequences 
for the rest of the focus of malaria transmission that are exposed to a different 
mosquito population. A more likely scenario would be that there is a certain level of 
site fidelity and mosquitoes acquiring infections in hotspots transmit this infection 
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to humans living outside hotspots but at a lower rate than is currently assumed by 
mathematical simulation models. 
Will targeted interventions reduce malaria transmission?
Untargeted control efforts are relatively inefficient if heterogeneous transmission 
is assumed and high-risk households are missed [16, 113]. A disproportionate 
exclusion of hotspots of malaria transmission from malaria control measures is not 
a hypothetical scenario since several of the factors that have been associated with 
increased mosquito exposure are related to a lower socio-economic status which is 
in turn an important predictor of low participation in control methods. Population 
averaged coverage levels may therefore not accurately reflect the ‘effective coverage’ 
with malaria control measures. 
There are several reasons why interventions targeted to hotspots of malaria 
transmission will be more efficient in reducing the burden of malaria than untargeted 
approaches. The most obvious is to protect individuals living in areas where the risk 
of (severe) malaria is highest. The largest, and most cost-efficient, impact on (severe) 
disease can be expected if those individuals who are most at risk preferentially 
receive protective measures. However, this does not reflect the full potential of 
hotspot targeted interventions. The additional and perhaps most attractive benefit 
of targeting hotspots of malaria transmission is that it can result in community-wide 
beneficial effects. By reducing or interrupting transmission in those households that 
contribute most to malaria transmission, community-wide malaria control may be 
improved in a cost-efficient manner.  For this, a paradigm shift in thinking about 
malaria control is needed that focuses on epidemiologically relevant malaria cases 
instead of clinically vulnerable individuals [114]. If the main objective of targeted 
interventions would be to protect individuals at risk of severe disease, an approach 
may be chosen where the known risk groups of (severe) disease are preferentially 
included in interventions. Although this will reduce morbidity and mortality in 
clinically relevant risk groups, the public health impact may be limited because other 
parts of the population can be equally important for disease transmission [67, 115]. 
Asymptomatic individuals of all age groups play an important role in maintaining 
malaria transmission [116, 117] and are particularly common in hotspots of malaria 
transmission [8, 15, 118]. To maximize the impact of targeted interventions, these 
interventions should therefore aim to eliminate malaria transmission in and from the 
hotspot. For this, a comprehensive approach is needed where conventional vector 
control methods such as ITNs and IRS can be combined with more laborious but 
efficacious vector control tools such as larviciding [119] and interventions that aim to 
reduce the human infectious reservoir of malaria. Interventions that aim to clear the 
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human infectious reservoir of malaria may include tools that are currently deemed 
less suitable for community-wide coverage such as mass drug administration with 
antimalarial drugs [120], focal screening of asymptomatic individuals followed 
by antimalarial treatment [118, 120] and employment of (transmission-blocking) 
malaria vaccines in all age groups [121, 122].
Mathematical simulations suggest that perfectly targeted malaria control efforts can 
have an impact that is up to 4-fold higher than that of untargeted control efforts 
[16, 110]. As discussed in the previous paragraph, these estimates are influenced by 
epidemiological characteristics of the transmission setting (notably spatial patterns 
in population density and mixing patterns in mosquito populations [110, 113]) and 
may need to be adjusted in the context of mosquito site fidelity. Nevertheless, all 
current evidence suggests a beneficial effect of targeted control efforts if i) hotspots 
of malaria transmission can be operationally identified; ii) this information allows 
logistically feasible targeting; iii) the benefit of a higher efficiency of interventions 
financially outweighs the costs of detecting hotspots of malaria transmission [16]. 
The first hurdle to take is to define an operational approach for detecting hotspots 
of malaria transmission. 
Operational approaches to detecting hotspots of 
malaria transmission
Hotspots of malaria transmission have been detected based on variations in the 
human and in the vector components of malaria transmission. Micro-epidemiological 
elevations in malaria incidence are often used as evidence for malaria hotspots [8, 
10, 13, 29, 123]. In addition, elevations in (asymptomatic) parasite prevalence [8, 
124, 125], serological responses to malaria-specific antigens [10, 124, 126], mosquito 
abundance [10] and exposure to infected mosquitoes [10] have been utilized in 
attempts to quantify micro-epidemiological variations in malaria risk. 
Entomological indicators
The most direct evidence of a hotspot of malaria transmission would be an increased 
exposure to infected mosquito bites. This gold standard measure for defining 
transmission intensity is difficult to assess at micro-epidemiological level: it depends 
on intensive sampling of mosquitoes over time and space and the detection of 
parasite stages in the mosquito salivary glands by microscopical examination or 
enzyme-linked immunosorbent assay (ELISA) [127]. This makes entomological 
evaluations very laborious, especially in areas with low vector densities where 
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currently available mosquito sampling tools lose sensitivity [73, 128]. An additional 
problem is the current uncertainty about the best mosquito sampling tool. Repeated 
sampling over time and at multiple locations require simple and affordable tools 
such as miniature light traps, odour baited traps or pyrethrum spray catches. 
Water storage clay pot traps were piloted as low-cost affordable approach that 
can be used for large-scale sampling [129] but have serious limitations in reliably 
sampling mosquitoes in field settings [130]. Importantly, sampling strategies for 
outdoor biting and resting mosquitoes are poorly standardized. This creates a risk 
of ignoring important vector populations that have a preference for outdoor biting 
and resting [131]. These limitations make it operationally unattractive to depend 
on entomological assessments of malaria exposure to define hotspots of malaria 
transmission in most endemic settings. 
Human indicators
More indirect but more easily accessible evidence for hotspots of malaria transmission 
may come from detecting (the consequences of ) malaria infections in humans. The 
overarching advantage of relying on infections in humans is that this circumvents 
any problems in low densities or indoor/outdoor biting mosquitoes. Heterogeneity 
in malaria incidence is a frequently used indicator of increased exposure but its 
validity is affected by the differential acquisition of immunity inside and outside 
hotspots and treatment seeking behaviour. In areas that are consistently exposed 
to higher levels of malaria transmission, immunity may be acquired at a faster rate 
and as a consequence fewer infections result in clinical malaria. Clinical malaria 
and high density parasitaemia may therefore be lowest in areas exposed to higher 
levels of transmission intensity where people have acquired protective immunity 
more rapidly [74, 132]. Clinical incidence may therefore give inaccurate estimates if 
measured in age-groups where residence in a hotspot of malaria transmission has 
resulted in an effective immune response. 
This confounding effect of immunity may be less prominent for asymptomatic 
parasite carriage. Asymptomatic parasite carriage may last several months [133] 
making estimates more robust in settings where the clinical infrastructure allows 
rapid treatment of symptomatic infections. Most importantly, immune responses 
that prevent infection are acquired later in life compared to clinical immunity [134]; 
low density infections in hyper immune adults suggest that immunity effectively 
preventing malaria infection may actually be very rare [19, 135]. This suggests 
that clustering of asexual parasite carriage may form a more stable indicator of 
transmission intensity than clinical malaria episodes [8].
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A third option to utilize malaria infections in humans as indirect indicator of higher 
malaria exposure is formed by serological markers of malaria exposure. Antibody 
responses to malaria specific antigens are acquired in response to (cumulative) 
exposure and can be used to define small-scale variations in malaria exposure [10, 
126, 136]. Because antibody responses are relatively long-lived, serological markers 
of malaria exposure are likely to be most suitable for detecting stable hotspots 
of malaria transmission [10] and most sensitive in areas of low endemicity [137]. 
The strong age-dependency of antibody responses necessitates an analysis of an 
age-dependent conversion rate from sero-negative to sero-positive [10, 136] or 
an age-adjusted antibody density [126, 138]. Human genetic polymorphisms that 
modulate the risk of clinical and asymptomatic parasite carriage (see above) may 
also influence malaria specific antibody responses [139]. The importance of this 
immune modulating effect remains to be established but could alter the sensitivity 
of serological markers of exposure in identifying hotspots of malaria transmission in 
areas where human genetic polymorphisms show spatial heterogeneity.
Spatial analysis on entomological or human indicators
The level of statistical significance is a relevant factor in determining whether 
a certain geographical area forms a plausible hotspot of malaria transmission. 
A powerful statistical tool that is frequently used to analyse spatial and spatio-
temporal patterns is SaTScan [140]. The SaTScan software is freely available online 
and uses a Kulldorf spatial scan statistic [105] to detect clusters in space and (if 
requested) time. A scanning window is used that moves across space and counts the 
observed and expected number of cases or attributes of cases for each location and 
size of the window. For the sake of simplicity, the remainder of the text will assume 
a case-control approach (Bernouilli model) although SaTScan also allows scans on 
continuous or categorical variables and allows the detection of hotspots (higher 
count than expected) as well as coldspots (lower count than expected). In the case-
control approach, the window with the greatest ratio of observed to expected cases 
is noted. The statistical significance of this hotspot or coldspot is then evaluated 
taking into account the multiple tests for the many potential cluster locations and 
sizes evaluated The output of the SaTScan analysis gives the location, size and level 
of statistical significance of the most likely clusters. 
One important characteristic of the SaTScan approach is that it calculates the 
number of expected cases by considering an even distribution of cases across 
the population and is very susceptible to the restrictions given by the user (e.g. 
maximum window size, allowance of overlapping clusters). This means that a spatial 
scan on a large geographical area will only pick up the most extreme hotspots. An 
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additional complication with spatial scans on patterns in the occurrence of malaria 
is formed by the strong seasonal fluctuations in malaria incidence.  Spatial scans on 
variables that are less susceptible to these seasonal fluctuations such as cumulative 
malaria incidence over several seasons [8, 10], cumulative parasite prevalence [8] 
or long-lived antibodies to malaria antigens [8, 10, 126, 141] are likely to produce 
most robust results. The scans can be performed separately for individual villages 
to increase the likelihood of detecting hotspots that are of local relevance but that 
would not have been detected in an area-wide scan. 
Environmental models
Environmental factors have long been associated with individual malaria risk. 
The simplest environmental models for detecting spatial variation in malaria risk 
incorporate distance to plausible mosquito breeding sites. These models have some 
value in predicting malaria risk [7, 13, 16, 73] but failed to explain hotspots of malaria 
transmission in two recent studies [8, 10]. In reality, the prediction of hotspots of 
malaria transmission is relatively straightforward in foci of malaria transmission with 
a single or very limited number of plausible sources of mosquito emergence are 
present. In other settings the correlation between malaria risk and distance to water 
may be weak [10] and additional factors have to be incorporated in models to reach 
a sensitivity that justifies rationally targeting malaria control. In these circumstances 
site-specific models may have to be prepared to encapsulate all locally relevant 
predictors of malaria risk. This makes environmental models less attractive from a 
public health perspective. 
A more sophisticated form of environmental modelling that may partly overcome 
the necessity for on-site data-collection to define local malaria risk factors is an 
approach that utilizes remote sensing data to determine factors such as elevation, 
daytime and night-time temperature, humidity, vegetation, soil moisture content, 
etc. The Malaria Atlas Project incorporates epidemiological data on parasite 
prevalence, environmental covariates and human settlement data and has resulted 
in malaria risk maps for different endemic regions [142-144]. A current limitation for 
utilizing environmental data for detection hotspots of malaria transmission is that is 
routinely available remote sensing data has limited spatial resolution, typically 8km2 
or 1km2 per pixel [8, 145]. Some data is available at a higher resolution but have been 
validated lass widely and currently do not benefit from processing by a temporal 
algorithm (Fourier), an approach that normalizes readings while preserving the 
seasonal variation in measures [145].  As a consequence, environmental models are 
currently not validated for detecting hotspots of malaria transmission with malaria 
transmission foci. 
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Operational approaches to target hotspots of 
malaria transmission
Once hotspots of malaria transmission are detected, they can be targeted with 
conventional and less conventional malaria control tools. Hotspot-targeted 
interventions are likely to be beneficial for people living inside and people living 
outside the targeted hotspots (see section “Will targeted interventions reduce 
malaria transmission?”). The most straightforward approach of targeting hotspots 
is formed by the local up-scaling of efficacious conventional vector control tools 
such as ITNs and IRS. However, this approach will only target indoor biting and/or 
resting vectors while there is accumulating evidence that outdoor biting vectors 
are becoming increasingly important for malaria transmission [146, 147]. The 
very essence of hotspot targeted interventions, focal interventions to protect the 
community at large, allows more laborious interventions that become operationally 
attractive because these require implementation in a fraction of the malaria endemic 
area only. Vector control tools that form attractive components of intensive hotspot-
targeted interventions include larviciding of mosquito breeding sites [148] and the 
use of entomopathogenic fungi [149] for the control of adult mosquitoes. Both tools 
require frequent re-application that makes them less attractive for community-
wide interventions but this shortcoming does not necessarily hinder targeted 
implementations. Similarly, the use of odour-baited mosquito traps [150, 151] as 
part of community-wide interventions is currently unattractive but a targeted push-
pull approach where mosquitoes are deterred from households in hotspots with a 
repellent and lured into traps with synthetic human odours may hold promise. 
Intensive vector control in hotspots can be supported by interventions that aim 
to reduce the transmission potential of the human host. The human infectious 
reservoir can be reduced by improving malaria case management in hotspots, 
thereby reducing the duration of parasite and gametocyte carriage in clinical 
malaria cases [152]. Because a large proportion of parasite carriers in hotspots 
may harbour their parasites without experiencing symptoms [118], and therefore 
without actively seeking treatment, a more aggressive approach to clear the human 
infectious reservoir will be beneficial to reduce malaria transmission. The most 
inclusive approach is formed by mass treatment campaigns where all individuals, 
regardless of symptoms, receive a full therapeutic dose of antimalarials [153]. Apart 
from ethical issues with mass drug administration, an operational drawback is that 
it may require several rounds to be efficacious [120]. This makes deployment of 
mass treatment campaigns most attractive in the form of targeted interventions. 
Mass drug administrations are laborious and ethically challenging in asymptomatic 
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individuals who do not experience a personal benefit from treatment. In targeted 
interventions, the additional efforts to clear the human infectious reservoir 
are justified by the increased importance of the targeted parasite carriers for overall 
malaria transmission. 
A last operational element that is important in identifying and targeting hotspots of 
malaria transmission concerns human movement patterns. Parasitaemic individuals 
may contribute to hotspots of malaria transmission in low endemic settings, as was 
suggested for the Kenyan highlands [15]. In addition, the effect of interventions 
targeted to the human population (e.g. treatment campaigns) may be diminished 
by the migration of parasitaemic and untargeted individuals. A comprehensive 
approach where parasites are targeted in humans and mosquitoes is likely to be less 
affected by human movement patterns. 
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Conclusions
i. Spatial variation in malaria incidence and exposure to malaria-infected 
mosquitoes is present at all levels of transmission intensity
ii. Hotspots of malaria transmission are geographical parts of foci of malaria 
transmission that are characterised by an increased level of transmission 
intensity compared to the average value of the focus.
iii. Human genetic factors contribute considerably to individual variation in 
malaria risk but with exception of areas where genetic traits cluster at micro-
epidemiological level, do not explain hotspots of malaria transmission. 
iv. There is some evidence that human genetic factors contribute specifically to 
transmission stages of malaria parasites and their infectivity to mosquitoes. 
These findings require confirmation in future studies but could be of 
epidemiological relevance in explaining malaria transmission patterns and 
planning malaria control efforts.
v. Spatial variation in mosquito exposure is remarkably consistent despite 
large seasonal fluctuations in mosquito densities. Within regions and 
individual villages, the same households can be exposed to consistently 
higher mosquito numbers.
vi. The spread of malaria infections from hotspots to the wider community 
is biologically plausible but needs prospective confirmation and 
quantification to support the planning of hotspot-targeted interventions.
vii. Hotspot-targeted interventions should aim at reducing or preventing 
malaria transmission in and from the hotspot, not at protecting vulnerable 
individuals living in a hotspot of malaria transmission.
viii. Hotspots of malaria transmission can be identified by entomological and 
human parameters. Malaria incidence is an unreliable indicator of hotspots 
of malaria transmission unless restricted to age-groups that have limited 
clinical immunity; malaria parasite carriage or the presence or density of 
serological markers of malaria exposure may be more robust indicators of 
heterogeneity in malaria exposure.
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Abstract
Extraction and amplification of DNA from dried blood spots (DBS) collected in field 
studies is commonly used for detection of Plasmodium falciparum. However, there 
have been few systematic efforts to determine the effects of storage and extraction 
methods on the sensitivity of DNA amplification. We investigated the effects of 
storage conditions, length of storage, and DNA extraction methods on amplification 
via three PCR-based assays using field samples and laboratory controls. Samples 
stored as DBS for 2 or more years at ambient temperature showed a significant 
loss of sensitivity that increased with time; after 10 years only 10% of samples with 
parasite densities greater than 1,000 parasites/µl were detectable by nested PCR. 
Conversely, DBS and extracted DNA stored at -20˚C showed no loss of sensitivity 
with time. Samples with low parasite densities amplified more successfully with 
saponin/Chelex compared to spin-column based extraction, though the latter 
method performed better on samples with higher parasite densities stored for 2 
years at ambient temperature. DNA extracted via both methods was stable after 
20 freeze-thaw cycles. Our results suggest that DBS should be stored at -20˚C or 
extracted immediately, especially if anticipating 2 or more years of storage.
Address correspondence to Alanna Schwartz, Department of Infectious Diseases, 
University of California, San Francisco, 1001 Potrero Avenue Building 3 Room 523, 
San Francisco, California 94110. E-mail: Alanna.schwartz@ucsf.edu
79Effects of dbs storage and extraction on amplification
3
Introduction
Dried blood spots (DBS) offer a routine means of storing field-collected blood 
samples for subsequent analysis of plasmodial nucleic acids.1,2 While it is appreciated 
that DNA degrades over time, there have been few systematic efforts to quantify this 
degradation, and there is a lack of agreed upon standards for storage, extraction, 
and amplification of plasmodial DNA from DBS. Studies have shown that humidity 
negatively effects DNA quality and shown that Whatman 3MM and 903 filter paper 
are ideal for long term storage.3 However, it is unclear which other factors influence 
the sensitivity of subsequent DNA amplification.4 To systematically characterize 
factors affecting the sensitivity of amplification of P. falciparum DNA stored as 
DBS, we analyzed field samples spanning over a decade and well-characterized 
laboratory controls to measure the effects of storage conditions, length of storage, 
and DNA extraction methods on successful amplification of plasmodial DNA. Our 
results allow discrimination between DNA degradation before and after extraction, 
provide guidance on how to interpret the validity of existing results, and offer best 
practices for sample storage and extraction. 
Materials and Methods
Samples: For the determination of the sensitivity of nested PCR, the effect of storage 
of DBS at ambient temperature and -20˚C, and the effect of multiple freeze thaws 
on extracted DNA, we used control DBS containing P. falciparum strain W2 parasites 
at known parasite densities. Parasites were cultured and synchronized at the ring 
stage using standard methods.5 Parasitemias were determined from Giemsa-stained 
thin smears. Positive controls were prepared by mixing infected red blood cells with 
uninfected whole blood to create parasite densities ranging from 0.1 to 100,000 
parasites/µl. To simulate collection of dried blood spots, blood was spotted in 20µl 
aliquots onto Whatman 3MM filter paper (with the exception of the DBS stored 
at two different temperatures, which were spotted on Whatman 903 filter paper), 
air-dried overnight, and stored at -20˚C for up to 1 year in plastic bags sealed with 
desiccant. Clinical samples came from 3 longitudinal antimalarial drug efficacy trials 
performed between 2000 and 2011 in Kampala and Tororo, Uganda, and stored 
at ambient temperature in San Francisco. The details of these studies have been 
previously published.6–8 These samples were selected randomly for our study after 
stratifying based on parasite density, which was determined by thick smear.
 
80 |   Chapter 3
Laboratory methods: DBS were cut into 6 mm diameter circles using a single hole 
punch, and DNA was extracted by the saponin/Chelex method,9 yielding a final 
DNA volume of ~125µL, or using the QiaAmp DNA mini extraction spin column, 
yielding a final DNA volume of 100µL, following the manufacturer’s instructions 
(Qiagen) with 5µg of carrier RNA. Extracted DNA was stored at -20˚C until use. 
Nested PCR for cytochrome B mitochondrial DNA using 5 µL of template DNA 
followed previously published methods,10 except that for round 1 of amplification 
primers were CB1ab (5’- TTTAGCAAGTCGATATACACCAGA-3’) and CB2ab (5’- 
CTTTAACTTGCCAACTCCCTATCA-3’); and temperature cycling conditions were: 5 min 
at 94˚C, 40 cycles of 94˚C for 30 seconds, 62.5˚C for 90 seconds, 68˚C for 90 seconds, 
and a final elongation at 68˚C for 10 minutes, yielding an amplicon length of 1241 
base pairs. Single round PCR of microsatellites was performed for two previously 
published loci (TA40 and PfG377) using 1uL of template DNA in a 5uL reaction 
volume.11 All amplifications were performed on a Bio-Rad Thermocycler C1000 or 
S1000 (Bio-Rad Laboratories). Amplification products were detected by agarose gel 
electrophoresis for nested PCR and via capillary electrophoresis for microsatellites. 
Microsatellite results were deemed positive if peak height was above 250 relative 
fluorescent units. 
Statistical Analysis: All data were analyzed using 2011 Microsoft Excel and R version 
2.15.3. To compare sensitivity of PCR between various groups of samples, the Chi 
Squared test was used. To estimate the effect of length of storage time on the 
sensitivity of PCR to detect DNA in samples of various parasite densities, a binomial 
generalized additive model (R package “mgcv”) was used, including storage time 
and parasite density in the same tensor product smoothing function.
Results
Sensitivity of nested PCR targeting cytochrome B mitochondrial DNA
To evaluate the sensitivity of nested PCR for amplifying this DNA target, we 
performed PCR on DBS spotted with 20µl of blood containing a range of parasite 
densities (0.1 - 100,000 parasites/µl), stored as DBS at -20˚C, and extracted within 
2 months of preparation. The cytochrome B PCR methods had 100% sensitivity for 
detecting P. falciparum in samples containing ≥10 parasites/µl, with 90% and 30% 
sensitivity for 1p/µL and 0.1p/µL respectively.
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Storage of DBS vs. extracted DNA from clinical samples of various 
ages
To determine whether storing samples as DBS or extracted DNA better maintained 
the sensitivity of nested PCR, we evaluated a series of clinical samples collected 
over a 10 year time period. Duplicate DBS samples were either stored at ambient 
temperature since the time of collection and saponin/Chelex extracted for this study 
or saponin/Chelex extracted near the time of collection and stored at -20˚C until 
this study. For samples stored for only 2 years, sensitivity was similar between newly 
and previously extracted DNA (Table 1). For samples stored for 5 years, however, 
sensitivity was lower for newly vs. previously extracted DNA at the lowest parasite 
density range (p=0.04). For samples stored for 10 years, there was a dramatic decrease 
in sensitivity for newly extracted samples, even at the highest parasite density range 
(p<0.001). To evaluate whether an alternative extraction method would improve 
sensitivity for these older samples, a third DBS for 8 out of 10 of these samples was 
extracted using a spin-column based extraction method. This method did not offer 
improvement in sensitivity (data not shown). Previously extracted samples did not 
show a significant decrease in sensitivity with age, though there was a trend towards 
lower sensitivity at the lowest parasite densities tested. These results indicate that 
long-term storage as extracted DNA at -20˚C better maintains sensitivity for PCR 
compared to storage as DBS at ambient temperature.
Storage of DBS at ambient temperature vs. -20˚C
To evaluate the effects of the temperature at which DBS are stored on the 
sensitivity of subsequent PCR amplification, we stored a series of duplicate control 
DBS containing known densities of parasites, including those below the limit of 
detection by microscopy, at ambient temperature and at -20˚C for 2.5 years. These 
samples were then extracted using saponin/Chelex and spin-column methods, 
and amplified via nested PCR for cytochrome B. Less sensitive single-round PCR 
targeting two microsatellite loci were used as an alternative amplification method 
for comparison. Sensitivity of nested PCR was 100% for all samples containing ≥100 
parasites/µL, but lower parasite densities showed a significantly higher positivity 
rate for samples stored at -20˚C vs. ambient temperature (p<0.001) and extracted 
via saponin/Chelex vs. spin-column methods (p=0.04, Table 2). Single-round 
microsatellite amplifications were less sensitive overall, but as with nested PCR, 
microsatellite PCR had higher success rates when the DBS was stored at -20˚C before 
saponin/Chelex extraction (p<0.001). Spin-column extraction performed no worse 
than saponin/Chelex when samples were stored at -20˚C (p=0.3), and significantly 
better when DBS samples were stored at ambient temperature (p<0.001), although 
this relationship did not hold for low parasite densities. These results indicate that 
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DBS stored for more than 2 years should ideally be kept at -20˚C and suggest that 
saponin/Chelex extraction may provide better PCR sensitivity for samples with low 
parasite density (<100 parasites/µL), whereas spin-column extraction may provide 
better sensitivity for samples with higher parasite densities stored for more than 2 
years at ambient temperature.
Table 1: Effect of Time of Storage on Success of PCR Amplification from Field Samples Stored as 
Extracted DNA or DBS 
Age of Sample 
(years)
1,000-100,000 p/µL 
n=10
100-1,000 p/µL 
n=15
10-100 p/µL 
n=20
2
Newly Extracted 100% 80% 60%
Previously Extracted 100% 80% 70%
5
Newly Extracted 100% 73% 30%
Previously Extracted 100% 73% 65%
10
Newly Extracted 10% NA NA
Previously Extracted 100% 73% 50%a
aOnly 6 blood spots could be located with correlating previously extracted DNA at this parasite 
density range; p/µL, parasites/µL; percentages represent the percent of samples that tested positive 
by PCR; NA: not done due to poor sensitivity at higher density samples. 
Table 2: Effect of Storage Temperature and Extraction Method on PCR Sensitivity
Chelex Qiagen
Assay (n=10) Storage Temperature of DBS 1,000p/µL 100p/µL 10p/µL 1p/µL 1,000p/µL 100p/µL 10p/µL 1p/µL
Cytochrome B
-20˚C 100% 100% 100% 100% 100% 100% 100% 70%
Ambient 100% 100% 90% 0% 100% 100% 30% 0%
TA40 
-20˚C 100% 100% 20% 0% 90% 80% 20% 0%
Ambient 0% 0% 0% 0% 100% 90% 30% 0%
PfG377
-20˚C 100% 100% 0% 0% 100% 90% 0% 0%
Ambient 20% 10% 0% 0% 100% 90% 0% 0%
TA40 and PfG377 are microsatellite loci; p/µL, parasites/µL; percentages represent the percent of 
samples that tested positive by PCR
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Quantitative analysis of PCR detectability with DBS storage time
As described above, we found that the sensitivity of detecting parasites via PCR from 
DBS stored at ambient temperature decreased with storage time for clinical samples 
and laboratory controls. To estimate the degree of this effect, we statistically 
modeled the detectability of parasites extracted via saponin/Chelex and amplified 
via cytochrome B PCR using data from all such samples included in tables 2, 3 and 4 
(Figure 1). As expected, sensitivity for very low parasite densities dropped off rapidly, 
but was maintained longer for higher parasite densities.
Figure 1: Statistically modeled probability of detection by cytochrome B PCR by storage time for DBS 
stored at ambient temperature and extracted with saponin/Chelex. Labels on each curve represent 
parasite densities (parasites/µL).
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Multiple freeze thaws of extracted DNA
To determine whether multiple freeze thaw cycles affected PCR sensitivity, we 
amplified known parasite density controls after extracting with saponin/Chelex or 
spin-column methods and freeze thawing duplicate sets of samples 1 vs. 20 times 
over 2 months. There was no significant effect of freeze thawing DNA extracted 
via either method, as measured with cytochrome B or microsatellite PCR (data not 
shown). 
Discussion
We showed that the choice of storage, extraction, and amplification methods all 
had a significant effect on the ability to detect P. falciparum DNA by PCR from 
DBS samples. Samples stored as DBS for 2 or more years at ambient temperature 
showed a loss of sensitivity that increased with time, whereas DBS and extracted 
DNA stored at -20˚C did not. Experiments on laboratory controls demonstrated that 
multiple freeze-thaw cycles of extracted DNA did not significantly affect sensitivity, 
indicating that DNA within the supernatant of saponin/Chelex extraction does not 
degrade with repeated freeze thawing. DNA extraction via the saponin/Chelex 
method tended to outperform spin columns for low-density infections, whereas 
spin-column extraction had an advantage in extracting older samples with higher 
parasite densities. 
Storage of DBS at ambient temperature compromised sensitivity, with amplification 
of samples with submicroscopic parasitemia noticeably diminished at 2 years and 
sensitivity for higher parasite densities compromised in samples stored for longer 
periods. Indeed, we were unable to detect even relatively high parasite densities 
(≥1,000 parasites/µL) by PCR in samples stored at ambient temperature for 10 years. 
Figure 1 provides an estimate of the loss of sensitivity over time, though results from 
other sites may vary based on storage conditions, DNA extraction methods, and PCR 
amplification assays. Our findings are in agreement with two prior studies, which 
showed decreased PCR sensitivity for microscopically detectable infections after 4 
and 7 years of storage.12,13 Thus, studies attempting to determine the prevalence 
of parasitemia by PCR, especially from subjects who are likely to have low parasite 
densities (e.g. asymptomatic subjects or those who are negative by microscopy or 
rapid diagnostic test), should be interpreted cautiously if DBS samples have been 
stored at ambient temperature for more than 2 years. Based on our results, if DBS 
samples are not analyzed promptly, they should be stored at -20˚C or DNA should 
be extracted before storage. 
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It should be noted that while we stored all DBS samples with desiccant, in many 
cases samples stored at ambient temperature were noted to contain saturated 
desiccant. While ideally desiccant would be changed frequently and DBS stored in 
completely airtight containers, in practice this is infrequently achieved.14 The benefit 
of DBS storage at -20˚C may be from decreased humidity and/or colder temperatures 
inhibiting enzymatic activity that leads to DNA fragmentation and growth of molds. 
Of note, we have developed a protocol for inexpensive, compact storage of DBS cards, 
which facilitates storage of large numbers in freezers (supplementary material).
Regarding DNA extraction, we found significantly increased sensitivity for low 
parasite densities using the inexpensive saponin/Chelex method vs. spin column 
extraction, consistent with our prior findings.10 A likely explanation is that some DNA 
is lost during binding and elution to the spin column. A caveat to this finding is 
that we only evaluated 3 PCR assays; assays more sensitive to inhibitors may benefit 
from use of highly purified DNA obtained from the spin column technique. On the 
other hand, spin-column extraction using protocols from Qiagen, which involves 
lysis with Proteinase K instead of saponin, may have an advantage in obtaining DNA 
from older samples, which are difficult to lyse, especially when parasite densities are 
high such that inefficiencies of the column are relatively unimportant. Anecdotally, 
we have also found that spin-column extraction appears to work better than the 
saponin/Chelex method for DBS samples obtained from placentas,15 perhaps for the 
same reason. A positive finding in our study is that saponin/Chelex extracted DNA 
was remarkably stable during long term storage at -20°C, and that the detectability 
of parasite DNA was not affected by repeated freeze-thaws. Thus, if DNA can be 
extracted soon after DBS collection, stored DNA can be expected to remain stable.
A strength of this study was the use of laboratory controls, enabling us to test 
effects of storage, extraction, and amplification on DBS samples of known parasite 
densities that include submicroscopic densities, as well as the use of clinical samples 
of various ages. Clinical and laboratory samples each have limitations. For clinical 
samples, parasite densities were measured via microscopy, which may have limited 
accuracy especially for low parasite densities. This may explain why our sensitivity for 
detecting low density infections was lower than expected. For laboratory controls, 
collection and storage may not reflect all sources of variation in field samples. 
In conclusion, we have shown that sensitivity for detecting DNA from DBS stored at 
ambient temperature decreases with length of storage time, with decreases seen as 
soon as 2 years after collection. Studies using stored samples should take this into 
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account, and when possible future studies should store DBS at -20°C or extract DNA 
soon after collection. 
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Abstract
Background
Informing and evaluating malaria control efforts relies on knowledge of local transmission 
dynamics. Serological and molecular tools have demonstrated great sensitivity to 
quantify transmission intensity in low endemic settings where the sensitivity of 
traditional methods is limited. Filter paper blood spots are commonly used a source of 
both DNA and antibodies. To enhance the operational practicability of malaria surveys, a 
method is presented for combined DNA extraction and antibody elution. 
Methods
Filter paper blood spots were collected as part of a large cross-sectional survey 
in the Kenyan highlands. DNA was extracted using a saponin/chelex method. The 
eluate of the first wash during the DNA extraction process was used for antibody 
detection and compared with previously validated antibody elution procedures. 
Antibody elution efficiency was assessed by total IgG ELISA for malaria antigens 
apical membrane antigen-1 (AMA-1) and merozoite-surface protein-1 (MSP-142). 
The sensitivity of nested 18S rRNA and cytochrome b PCR assays and the impact of 
doubling filter paper material for PCR sensitivity were determined. The distribution 
of cell material and antibodies throughout filter paper blood spots were examined 
using luminescent and fluorescent reporter assays.
Results
Antibody levels measured after the combined antibody/DNA extraction technique 
were strongly correlated to those measured after standard antibody elution 
(p <0.0001). Antibody levels for both AMA-1 and MSP-142 were generally slightly lower 
(11.3-21.4 %) but age-seroprevalence patterns were indistinguishable. The proportion 
of parasite positive samples ranged from 12.9 % to 19.2 % in the different PCR assays. 
Despite strong agreement between outcomes of different PCR assays, none of the 
assays detected all parasite-positive individuals. For all assays doubling filter paper 
material for DNA extraction increased sensitivity. The concentration of cell and 
antibody material was not homogenously distributed throughout blood spots.
Conclusion
Combined DNA extraction and antibody elution is an operationally attractive 
approach for high throughput assessment of cumulative malaria exposure and 
current infection prevalence in endemic settings. Estimates of antibody prevalence 
are unaffected by the combined extraction and elution procedure. The choice of 
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target gene and the amount and source of filter paper material for DNA extraction 
can have a marked impact on PCR sensitivity. 
Keywords
Plasmodium, malaria, antibodies, IgG, DNA, submicroscopic, extraction, transmission, 
PCR, ELISA
Background
To effectively implement and evaluate malaria control efforts a detailed knowledge 
is required of Plasmodium carriage and transmission within target populations. 
Transmission intensity is traditionally assessed using mosquito trapping techniques 
to determine exposure to infected Anopheles mosquitoes. In low endemic areas, 
where vector populations may be sparsely infected, small or heterogeneously 
distributed, trapping becomes operationally and technically unattractive [1-3]. 
A frequently used alternative is the prevalence of malaria infection in human 
populations, which is typically assessed by light microscopy. However, the limited 
detection limit and operational constraints of microscopical surveillance present 
a major barrier to its application in low endemic areas [4-8]. With patterns of 
reducing malaria transmission intensity in many African settings [9-14], it will 
become increasingly important to have sensitive alternatives for population level 
surveillance in areas approaching a phase of elimination [7, 15]. 
Serological and molecular tools have been proposed to be particularly useful for 
monitoring transmission intensity and determining parasitaemia among populations 
in areas of low endemicity. Antibody responses to recombinant asexual malaria 
antigens are strongly associated with entomological measures of transmission 
intensity and microscopical parasite prevalence [16], but at low endemicity have 
a greater discriminative power [3]. Low level transmission may be detectable in 
the absence of microscopically detectable infection [17] and serological markers 
can detect spatial variation in transmission intensity [18] and the efficacy of 
interventions [19].While serology can be used to detect spatial and temporal 
patterns in transmission intensity [20], antibody responses are long-lived and, 
unless sampling is restricted to very young age groups, additional tools are required 
to quantify on-going transmission. The polymerase chain reaction (PCR) is a highly 
sensitive method for detecting Plasmodium infection at all levels of endemicity 
[21-23]. In a meta-analysis comprising 106 surveys, microscopy detected 54.1 % of 
all PCR-detected infections; a figure that decreased to below 20 % in low endemic 
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settings [24]. Sub-microscopic parasite carriage has been shown to contribute 
significantly to the malaria infectious reservoir [25, 26] and is therefore of relevance 
for inclusion in control programmes. Actively identifying infected individuals using 
PCR may, therefore, be critically important when attempting to interrupt malaria 
transmission [7, 27, 28]. While PCR is commonly used as gold standard for detecting 
all parasitaemic individuals, there is variation between different PCR approaches [29, 
30] and DNA extraction from filter papers may vary in efficiency [30, 31]. 
In the context of malaria elimination, there is a need to optimize molecular and 
serological assays for rapid and simultaneous assessment of the significant numbers 
of samples that will be generated by large scale, long term surveillance [32]. At 
present, DNA extraction and antibody elution are the most time consuming and 
laborious aspects of serological and molecular assessments. It would be operationally 
attractive to source DNA and antibodies from the same blood spots, as this would 
allow serology and PCR to be conducted in unison, increasing throughput while 
decreasing costs. 
Here, a simple method for concurrently extracting antibodies and DNA from filter 
paper blood spots is presented. Antibody responses to malaria antigens are assessed 
to compare the efficacy of antibody elution. PCR assays using two different target 
genes are compared, andtwo sources of variation in PCR outcome are explored: 
the distribution of parasite material on filter papers and the amount of filter paper 
material that is used for DNA extraction. 
Methods
Study area and subjects
Blood spot samples were collected in 2011 as part of a cross-sectional study in the 
Western Kenyan Highlands (latitude -0.470431°, longitude 34.842628°), an area of 
seasonal malaria transmission in which P. falciparum dominates. The objectives of 
the original study and details of the study area are detailed elsewhere [33]. Ethical 
approval was granted by the Scientific Steering Committee (SSC), the Ethical Review 
Committee (ERC) of the Kenya Medical Research Institute (KEMRI) Nairobi (proposal 
numbers SSC 2163, 2181 and 1589), the London School of Hygiene & Tropical 
Medicine ethics committee (#6111), and from Centers for Disease Control and 
Prevention (with exempt status) [33]. Blood derived from a finger prick was blotted 
onto Whatman no. 3 filter paper (Whatman, Maidstone, UK) and was dried overnight 
before storage with silica gel at -20 °C. Each filter paper contained three individual 
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blood spots of indeterminate volume. Filter papers were wetted through by blood 
spots completely, as described by Corran et al [34]. A subset of 240 randomly 
selected blood spots was selected for both PCR and enzyme-linked immunosorbent 
assay (ELISA). 
Standard antibody elution 
The full protocol of the elution and extraction steps is provided in the supporting 
documentation (Additional file 1, 3 and 4). Three filter paper discs of 2.5  mm in 
diameter were punched from the centre of each dried blood spot. Filter paper discs 
were immediately placed into the wells of replicate 2.0 ml 96 deep well plates (Axygen 
Biosciences, CA, USA), one containing individual discs, the other pairs of discs. Each 
plate contained 80 samples so that the sample number in each corresponded to 
that of 2 ELISA plates, leaving wells free for controls. For standard elution single filter 
papers were incubated in 1120 µl of a 0.5 % sodium azide/ PBS solution [34]. Plates 
were sealed and placed onto a plate shaker on their side, allowing the cut filter paper 
discs to move freely along the length of their wells. After overnight incubation, the 
eluate was stored at -80 °C. The final serum dilution of the eluate based on estimates 
of the volume of whole blood in a 2.5 mm filter paper disc was 1:400 [34]. 
Combined antibody elution and DNA extraction
Filter paper discs were prepared and stored in deep well plates as for standard 
antibody elution. For combined DNA extraction and antibody elution (henceforth 
combined elution), 1120 µl of a 0.5 % saponin/PBS solution was added to each well 
and plates were incubated overnight as for standard elution. 200  µl of the eluate, 
which contained all soluble elements including antibodies, was transferred to a new 
plate and stored at -80 °C until use in ELISA. To continue with DNA extraction, the 
remaining saponin solution was aspirated and 1 ml of PBS washing solution was 
added to each well at 4 °C. Plates were horizontally incubated on a shaker for one 
hour as above, before PBS was aspirated and discarded. 150  µl of a 6  % Chelex in 
DNase/  RNase free water solution was added to each sample. Plates were sealed 
using adhesive foil mats (Axygen Biosciences, CA, USA) and incubated in a water 
bath for 3*10 minutes at 97 °C. Between 10 minute incubations plates were briefly 
centrifuged in order to relieve pressure and ensure optimal DNA elution. After the 
last incubation plates were spun down at maximum speed for 5 minutes to allow the 
Chelex to settle. 120 µl of the DNA containing solution was taken and aliquoted into 
new plates. Samples were stored at -80 °C until further analyses. To exclude the risk 
of cross-contamination during extraction materials were extensively tested using 
positive and negative controls (2.5 % Plasmodium DNA and blank wells respectively). 
No cross-contamination was observed during extraction (Additional file 5)
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AMA-1 and MSP-142 ELISA
IgG antibody responses against AMA-1 (BPRC, 0.3  µg/ml coating concentration) 
and MSP-142 (FVO, 0.2  µg/ml coating concentration) were detected as previously 
described [16, 35]. Test sera were analysed in duplicate at 1:1000 (MSP-142) or 1:2000 
(AMA-1) in PBST/Marvel milk powder (Cadbury, UK). Blank wells and a serial dilution 
of pooled hyper-immune sera were included in duplicate on each plate to correct for 
non-specific antibody reactivity and standardise responses for inter-plate variation. 
Seroprevalence of IgG antibodies to both antigens was determined using a mixture 
model as described previously [16, 34]. The model was used on each population of 
samples, giving four separate positivity thresholds (one each for AMA-1 standard 
elution, AMA-1 combined elution, MSP-142 standard elution, and MSP-142 combined 
elution). 
Parasite detection by PCR
Three nested PCR assays were evaluated; an 18S PCR targeting the small ribosomal 
subunit of Plasmodium falciparum developed by Snounou et al [22] and two variations 
of a more recent assay which targets the mitochondrial cytochrome b as described 
by Steenkeste et al. [36, 37]. Because of inconsistent amplification of amplicons 
generated by the nest 1 (N1) primers described by Steenkeste et al primers of the 
N1 reaction were redesigned. The 18S PCR was performed according to the original 
protocol except that the quantity of template used in the N1 reaction was increased 
from 1 µl to 5 µl. In every set of PCR conditions 5 µL template was used in the N1 
reaction and 1.5 µl of product in the N2 reaction. For a more detailed overview of 
primer sequences, product sized and PCR cycling conditions see Additional file 1 
Pooled DNA extracts from P. falciparum NF54 cultured in Nijmegen, the Netherlands 
were run on every PCR plate as a positive control, alongside a negative water 
control. Positive control was diluted to the extent that both N1 and N2 fragments 
were sufficiently amplified so that both amplicons could be visualized on gel. N1 
and N2 products were mixed and 10  µl was visualized on a 0.8  % agarose gel by 
electrophoresis in 0.5 x Tris-acetate-EDTA buffer (0.04 M Tris-acetate and 1 mM EDTA, 
pH  8.0). Each assay was assessed using single and double filter papers, creating a 
total of 6 PCR conditions for comparison.
Distribution of parasite material on filter papers
To visualize cell material in filter paper blood spots two C57BL/6 mice were infected 
as previously described with a transgenic Plasmodium berghei strain (PbGFP-Luccon) 
expressing a fusion protein of GFP and Luciferase from the eef1a promoter [38, 39]. 
The original studies that were used as a source of blood material were performed 
according to the regulations of the Dutch “Animal On Experimentation act” and 
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the European guidelines 86/609/EEG; approval was obtained from the Radboud 
University Experimental Animal Ethical Committee (RUDEC 2009-019). 100  µl of 
blood from the infected mice was collected in heparinised tubes and mixed with 
3.2 µl of highly concentrated (67 mg/ml) D-luciferin (Xenogen, CA, USA) dissolved in 
PBS [38]. 30 µl of this mixture was pipetted onto Whatman no. 3 paper (Whatman, 
Maidstone, UK) in a manner closely approximating that of blood spot collection 
in the field. Drops were first formed on the pipette tip before contact with the 
paper was made, and filter papers were wetted through completely. Blood spots 
were left to dry for 15 minutes before luminescent imaging was performed using a 
Lumina Caliper (PerkinElmer, MA, USA) (5 cm FOV, medium binning factor, 1 second 
exposure). This process was repeated for two blood spots. A blood spot without the 
addition of D-luciferin was used as a negative control. 
Distribution of antibody material on filter papers
Batches of 100 µl whole human blood were mixed with fluorescent labeled anti- APC-
Cy7-anti-CD4 (Biolegend, CA, USA) and/or anti-human APC-IL-2. (eBioscience, CA, 
USA).  Blood spot preparation and imaging was performed as in the cell distribution 
experiments.
Data analysis
Statistical analysis was conducted using STATA 12 (StataCorp., TX, USA) and 
GraphPad Prism 5.0 (GraphPad Software Inc., CA, USA). IgG responses between 
groups of paired data were compared by Wilcoxon signed rank test. Seroprevalence 
comparisons were made using Chi-square test, with a test for trend in proportions. 
Associations between IgG responses expressed as antibody titre were quantified 
by Spearman correlation coefficients, and differences between elution approaches 
tested by linear regression presenting 95% confidence intervals (CI).  The level of 
agreement, kappa value and sensitivity were assessed by comparing individual PCR 
conditions with ‘true positivity’ that was defined as positivity in any one of the PCR 
assay variants. The difference in the proportion of positive samples between PCR 
conditions was tested by McNemar’s chi-square for paired data. To minimize the 
influence of possible false positive PCR results on sensitivity estimates, calculations 
were repeated after ‘true positivity’ was defined as a positive PCR in at least two of the 
PCR conditions.  For the cell/antibody distribution experiments Living image 3.2 was 
used (PerkinElmer, MA, USA). To map the relative fluorescence/intensity in different 
areas of the blood spot they were overlaid with grids containing cells of 2.5 mm2. 
Grids extended to the spots edges, and cells were excluded from analysis if their area 
was not entirely filled with dried blood. For comparison between cells, fluorescence 
and luminescence values were calculated as a proportion of the highest cell value.
96 |   Chapter 4
Results
Antibody responses
Antibodies were eluted from 236 filter papers by both the standard elution 
procedure and the combined elution procedure. For both AMA-1 and MSP-142, a 
strong positive correlation was observed between the IgG responses of filter paper 
blood samples eluted by standard and combined methods (Figure 1). While strongly 
correlated, there was a tendency toward higher antibody responses when samples 
were eluted using the standard methodology for both antigens (p=<0.0001). 
For antibody level (optical density), responses were on average 11.3% higher for 
AMA-1, and 21.4% higher for MSP-142 when using standard rather than combined 
elution. Linear regression analysis showed that for AMA-1 an increase of titre 1 using 
combined elution was associated with an increase of titre  1.773 (95  % CI 1.712-
1.834; p<0.0001) using standard elution. For MSP-142 an increase of titre 1 using 
combined elution was associated with an increase of titre 1.811 (95 % CI 1.647-1.975, 
p<0.0001) using standard elution. For use as marker of exposure, antibody responses 
against AMA-1 and MSP-142 are commonly combined to give a prevalence of any 
anti-P. falciparum antibodies [17, 18, 20]. Between standard and combined elution 
methods seroprevalence of antibody responses to AMA-1 and MSP-142 did not 
differ significantly (p >0.8), and for both methods showed a strong age-dependent 
increase (Figure 2; p <0.0001). Within age-groups, antibody seroprevalence did not 
differ significantly between elution methods (p >0.5).
Parasite prevalence by PCR
Parasite prevalence by PCR differed between different methodologies and ranged 
from 12.9 % (31/240) when the 18s rRNA-based PCR was used with single filter paper 
discs to 19.2 % (46/240) when the original cytochrome b based PCR was used with 
two filter paper discs (Table 1). The level of agreement between these two estimates, 
representing the two extremes of parasite prevalence, was high (90.4 %, kappa 0.65) 
but the cytochrome b PCR with two filter paper discs resulted in significantly more 
positive results compared to the 18s rRNA based PCR with single filter paper discs 
(p=0.002).  When true positivity was defined as a sample being positive in any one of 
the assays, the standard cytochrome b assay using DNA from two filter paper discs 
showed the highest sensitivity (83.6 % C.I. 71.2-92.2 %). Defining true positivity as 
a positive signal in at least two of the PCR assays did not change the estimates of 
sensitivity and kappa considerably (see Additional file 2). 
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Figure 1. Antibody level from standard and dual filter paper blood spot elution methods for 
AMA-1 and MSP-142. A. Scatter plot showing anti-AMA-1 IgG level detected in 236 individuals by 
standard (x-axis) and combined (y-axis) elution of filter paper blood spots. R2 (linear regression) = 0.93 
( p=<0.0001). B. Scatter plot showing anti-MSP-142 IgG level detected in 236 individuals using 
standard (x-axis) and combined (y-axis) elution of filter paper blood spots. R2 (linear regression)  0.671 
(p=<0.0001).
Figure 2. Seroprevalence of anti-AMA-1 or MSP-142 IgG responses by filter paper elution method 
and age. Error bars indicate 95 % confidence intervals (CI). Sample sizes for the age groups were 53 (< 
5 years), 38 (6-10 years), 43 (11-15 years), 36 (16-25 years), and 67 (>25 years).
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Doubling filter paper material for DNA extraction increased the sensitivity of PCR 
assays by 5.4-16.3  %.  When pairs of results from the same PCR assay but using 
DNA template from single or double filters were compared (n=720 pairs), the latter 
resulted in significantly more parasite positive results (p=0.013). 130 of the PCRs 
performed on DNA from double filter paper punches were PCR positive, compared 
to 111 of the PCRs performed on DNA from single filter paper punches. Surprisingly, 
18.0 % (20/111) of the samples that were positive in a PCR using template from a 
single filter punch were negative in the PCR performed when two punches were 
taken from the same filter paper.
Doubling filter paper material also appeared to increase the consistency of PCR 
outcomes on the same DNA material, albeit not statistically significant. When the 18s 
rRNA-based PCR and both cytochrome b based PCRs were performed on material 
from the same extraction, inconsistent results (i.e. one or two but not all three PCR 
assays giving amplification) were observed for 8.3% (20/240) of the samples when 
material from single filter paper punches was used compared to 5.9% (14/240) of 
samples when filter paper material was doubled (Table 2, p=0.36).
Distribution of parasite material on blood spots 
Luminescence produced by GFP expression in Pb-GFPluccon infected blood samples 
was previously shown to correlate strongly with parasitaemia [40]. Here, the 
distribution of DNA on filter paper was assessed by measuring the luminescent 
intensity in dried blood spots from mice infected with Pb-GFPluccon [41]. Cell by cell 
luminescence analysis of the grid overlaying the blood spot was used to describe 
heterogeneity in parasite material in different parts of the blood spot. Both blood 
spots tested showed a considerable degree of heterogeneity in the distribution of 
parasite material (Figure 3). In the two separate experiments, 25 % and 64 % of the 
grid cells contained less than 85 % of the parasite material of the grid cell with the 
highest quantity. Parasite material seemed less concentrated towards the extreme 
edges of the blood spot; the grid cell with the lowest parasite quantity contained 
70% of the maximum value (Figure 3).
Distribution of antibody material on blood spots 
The distribution of antibodies on filter paper was evaluated by the adding two marker 
molecules which have approximately the same molecular weight of human IgG and 
have no detectable interaction with other components in human blood. Analysis 
of fluorescence intensity based on the overlaying grid showed that also antibodies 
were heterogeneously distributed throughout the blood spot (Figure 3). In the two 
separate experiments, 65 % of the grid cells contained less than 85 % of the parasite 
99Combined DNA extraction and antibody elution from filter papers
4
Figure 3: DNA/Cell and antibody distribution on filter paper. A. Photograph of one of the two 
blood spots analysed for cell material distribution, in which luminescence intensity is proportional 
to the density of cell material. Luminescence intensity values in the cells of the overlying grid are 
calculated as a proportion of the highest cell value, and are presented in the adjacent grid schema. 
B. Photograph of one of the two blood spots analysed for antibody material distribution, in which 
fluorescence intensity is proportional to the density of antibodies. Fluorescence intensity values are 
calculated and presented as in Figure 3A.
Table 1. Agreement between 18s, modified cytochrome b and original cytochrome PCR assays. 
PCR Assay Filter paper number Positivity,
 % (n/N)
Agreement, % Kappa Sensitivity, 
% (95% CI)
18S rRNA
Single 12.9 (31/240) 90.0 0.666 56.4 (42.3 - 69.7)
Double 16.7 (40/240) 93.8 0.804 72.7 (59.0 - 83.9)
Modified Cytochrome B
Single 15.4 (37/240) 92.5 0.760 67.3 (53.3 - 79.3)
Double 18.3 (44/240) 95.4 0.861 80.0 (67.0 - 89.6)
Original Cytochrome B
Single 17.9 (43/240) 95.0 0.847 78.2 (65.0 - 88.2)
Double 19.2 (46/240) 96.3 0.887 83.6 (71.2 - 92.2)
The Agreement, kappa value and sensitivity were calculated by comparing individual PCR conditions 
with ‘true positivity’ that was defined as positivity in any one of the PCR assay variants. The abbreviation 
n/N indicates PCR positive individuals (n) as a proportion of the total sample size (N). 
Table 2. Consistency of outcomes in different PCR assays in relation to the amount of filter 
paper material used for extraction. The proportion (n/N) of positive PCR assays when aliquots of 
the same extracted material was used in three different PCR assays. 
Filter paper 
number
Never positive (%) Positive in 1/3 PCR 
assays (%)
Positive in 2/3 PCR 
assays (%)
Positive in 3/3 PCR assays 
(%)
Single 80.8 (194/240) 2.9 (7/240) 5.4 (13/240) 10.8 (26/240)
Double 79.6 (191/240) 1.3 (3/240) 4.6 (11/240) 14.6 (35/240)
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material of the grid cell with the highest quantity. Contrary to the observations on 
parasite material, there was no evident pattern in antibody concentration on the 
blood spot and concentrations of antibodies did not appear to be higher in the 
middle of the spot (Figure 3). The grid cell with the lowest antibody concentration 
contained 67% of the maximum value. 
Discussion
The methodology described in this report offers a cost-efficient high-throughput 
approach to preparing large numbers of filter paper samples for the assessment 
of cumulative malaria exposure and current infection status. Used in concert, 
serological and molecular assays can provide detailed insight into the transmission 
dynamics of Plasmodium. 
The utility of serological assessments in malaria surveillance has been evidenced by 
numerous studies of the antibody responses of endemic populations to recombinant 
Plasmodium [42] and Anopheles [43-45] antigens. Recently the importance of molecular 
tools in malaria surveillance has been emphasised, as it has become apparent that 
the extent and relevance of sub-microscopic malaria infections in low endemic areas 
may be much greater than previously assumed [6, 24]. As the number of areas making 
efforts to reduce or interrupt native malaria transmission grows so will the importance 
of sensitively detecting malaria exposure [7, 32, 46]. As such, the development of 
strategies to ease sample collection and processing during wide-scale population level 
surveillance is both timely and apposite to the wider malaria eradication agenda. The 
use of filter papers for blood collection and their subsequent storage and processing 
for sero-epidemiological analyses was discussed in depth by Corran et al. [34].  Since 
this time many studies have benefitted from the use of filter paper blood spots as a 
source of serum antibodies to reveal age-dependent [20], spatial [17-19] and temporal 
[47] patterns in cumulative malaria exposure. In the current study antibody levels (OD) 
from the standard elution methodology and the combined elution methodology 
(in which a portion of the filter paper eluate undergoes onward processing for DNA 
extraction) show a strong and highly significant correlation. Though the relationship 
between absolute antibody titre in paired measures was strongly related, higher 
antibody levels were generally observed when blood spots underwent standard 
elution procedures. The reason for this is unknown and may reflect differences in the 
relative concentration of detergent. The lower antibody yield in the combined method 
warns against using the two approaches simultaneously; quantitative outcomes of 
individual samples cannot be directly compared when different elution methods 
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have been used. In epidemiological studies it is more common to analyse variation 
in malaria exposure using measures of (age-dependent) antibody seroprevalence 
[19, 20, 48]. In the current study, seroprevalence did not differ significantly between 
the two elution methods, and both methods showed the same age-dependent 
acquisition of antibody responses. This indicates that combining antibody elution 
with DNA extraction is an operationally attractive alternative to the standard method 
of antibody elution that can reliably be used to compare antibody responses between 
populations of blood donors.  
The elution of antibodies during the process of DNA extraction adds an advantage 
to the chelex/saponin extraction method, which is probably the most widely used 
extraction method in epidemiological malaria studies. This extraction method has 
repeatedly been shown to give comparable results when compared to commercial 
extraction kits [49, 50]; although in case of older or incorrectly dried and stored filter 
papers commercial kits may be recommended [31]. Because of its evident superior 
sensitivity compared to microscopy [6, 24], PCR may be considered to be the gold 
standard for the detection of malaria infections in epidemiological studies. The current 
study highlights three relevant caveats to this assumption. Firstly, different PCRs differ 
in their sensitivity to detect malaria parasite. Although a recent meta-analysis found 
no differences in sensitivity compared to microscopy for different nested PCR assays 
[24], the current study presents evidence for a higher sensitivity of PCR based on the 
cytochrome b target gene compared to the most widely used 18s rRNA target gene 
[31, 51]. This may be due to better conservation of mitochondrial material [52]. The 
current study shows no advantage of the newly designed primers for the cytochrome 
b gene in overcoming the anecdotal problems of inconsistency of PCR results with 
the original protocol.  The shorter N1 primers amplify the same area , may give more 
consistent results (data not shown) and may increase primer stability during freeze/
thawing cycles but did not lead to improved sensitivity for the 240 samples tested in 
the current study. 
Secondly, the current study presents evidence that increasing the amount of filter 
paper material for DNA extraction results in an increased sensitivity. Although this 
finding is intuitively correct, its actual relevance for determining parasite prevalence 
in field studies has not been described in detail before. One could argue that a single 
copy of template material may result in successful amplification and therefore only 
infections with densities close to the threshold density for detection by PCR would 
give discordant PCR results. The current findings suggest that this is frequently the 
case and that doubling filter paper material can lead to parasite prevalence estimates 
that are up to 3.8 % higher. 
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Thirdly, the results illustrate the stochastic nature of PCR. Although the agreement 
between PCR outcomes was very high, agreement was never perfect. Discordant PCR 
results were common, especially if single filter paper punches were used. Importantly, 
some PCRs performed on single filter paper punches detected parasites while the 
same PCR on double filter paper punches did not. This serves as a word of warning 
against assuming 100 % sensitivity of PCR. It has been previously acknowledged that 
PCR assays may fail to detect all circulating parasite clones [53, 54], the current study 
indicates that this imperfection of PCR assays may also affect parasite prevalence 
estimates. The exploratory experiments described in this study on the distribution 
of parasite material on filter papers may be relevant in this respect: the amount of 
parasite material can differ by more than 15% between different punches from the 
same bloodspot despite the blood completely wetting the paper. 
Conclusion
When the combined DNA extraction-serum elution methodology is used, robust 
PCR and ELISA results can be obtained. The combined approach can significantly 
reduce the workload in large-scale epidemiological studies and allow efficient use 
of blood spot material for molecular and immunological assays. The efficient use of 
blood spot material may allow researchers to increase the amount of filter paper 
material that is used for this combined extraction. This will increase PCR sensitivity 
and may increase robustness of parasite prevalence estimates. 
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Supplement 1: Combined DNA extraction and antibody elution from filter papers for the 
assessment of transmission intensity in epidemiological studies
Primer sequences and product sizes
PCR assay/Nest Primer 
name
Sequences 5’ - 3’ Length 
(bp)
Amplicon size 
(bp)
18S Snounou
Nest 1
rPLU6 TTAAAATTGTTGCAGTTAAAACG 23
1200
rPLU5 CYTGTTGTTGCCTTAAACTTC 19
Nest 2
rFAL1 TTAAACTGGTTTGGGAAAACCAAATATATT 30
205
rFAL2 ACACAATAGACTCAATCATGACTACCCGTC 30
Cytochrome B original
Nest 1
GCDW2 CGGTCGCGTCCGGTAGCGTCTAATGCCTAGACGTATTCCTGATTATCCAG 50
1253
GCDW4 CGCATCACCTCTGGGCCGCGTGTTTGCTTGGGAGCTGTAATCATAATGTG 50
Cytochrome B modified
CytB_1 TTTAGCAAGTCGATATACACCAGA 24
1241
CytB_2 CTTTAACTTGCCAACTCCCTATCA 24
Cytochrome B both
Nest 2
PLAS 1 GAGAATTATGGAGTGGATGGTG 22
815
PLAS 2 TGGTAATTGACATCCAATCC 20
Supplement 1: PCR Mastermix compositions and PCR thermal cycler programme
Snounou N1 &N2 N1&N2 cycler programme
PCR Buffer 1x 95°C 5 min
MgCl2 2.5mM 94°C 60 sec
35x dNTPs 0.2mM 60°C 60 sec
Primer 0.25mM 72°C 90 sec
Polymerase 2U 72°C 10 min
Cytochrome B Original N1 Cytochrome B Original N2 N1&N2 cycler programme
PCR Buffer 1x PCR Buffer 1x 95°C 15 min
MgCl2 3mM MgCl2 2mM 94°C 5 min
dNTPs 0.2mM dNTPs 0.2mM 94°C 90 sec
40xPrimer 1µM Primer 1µM 60°C 90 sec
Polymerase 2U Polymerase 2U 72°C 90 sec
72°C 10 min
Cytochrome B new N1 & N2 N1 cycler programme N2 cycler programme
PCR Buffer 1x 95°C 5 min 95°C 5 min
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MgCl2 2.5mM 94°C 90 sec
40x
94°C 90 sec
40xdNTPs 0.2mM 62.5°C 90 sec 60°C 90 sec
Primer 1µM 68°C 90 sec 72°C 90 sec
Polymerase 2U 72°C 10 min 72°C 10 min
Supplement 1: Reagent and material list
Combined extraction
Item Supplier Article code#
2 mL plate Axygen P-DW-20-C
0.5mL plate Corning 3957
Axygen platemax aliminium sealing film  (boiling) Axygen #PCR-AS-200
Lids for 2mL plates Axygen AM-2ML-RD
Lids for 0.5mL plates Thermo Scientific AB-0674
Ethanol (molecular grade) - -
Saponin Sigma Aldrich S4521-25G
Chelex 100 Resin Bio-Rad 143-2832
PBS tablets Sigma Aldrich P4417-100TAB
H2O DNA’ase/RNA’ase free Sigma-Aldrich W4502-1L
ELISA
Immunolon plates HBX4 Thermo Scientific 3855
Anti-Human IgG (H+L), HRP Conjugate Promega W4031
SigmaFast OPD Sigma-Aldrich P9187-50SET
Skimmed Milk powder Sigma-Aldrich 70166-500G
TWEEN® 20 Sigma-Aldrich P1379-100mL
NaH2PO4 Sodium phosphate monobasic monohydrate Sigma-Aldrich S3522-1KG
Na2HPO4  Sodium phosphate dibasic dihydrate Sigma-Aldrich 30412-5KG
NaCL Sigma-Aldrich S7653-5KG
H2SO4 Sulphuric acid concentrate Sigma-Aldrich 32044-1EA
PCR
TAQ Polymerase (flexi) Promega M8308
dNTP Promega U1410
H2O DNA’ase/RNA’ase free Sigma-Aldrich W4502-1L
Primers Sigma-Aldrich -
Biorad flexible plates Biorad MLP-9601
Biorad sealing film B Biorad MSB-1001
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Additional File 2:  Agreement between 18s, modified cytochrome b and original cytochrome 
b PCR assays when a single sample is considered a true positive when positive in at least two 
PCR assays. 
PCR Assay Filter paper number Positivity, % (n/N) Agreement, % Kappa Sensitivity, % (95% CI)
18S rRNA
Single 12.9 (31/240) 91.3 0.6981 59.6 (45.1 - 73.0)
Double 16.7 (40/240) 94.2 0.8125 75.0 (61.1 - 86.0)
Modified Cytochrome B
Single 15.4 (37/240) 92.9 0.767 69.2 (54.9 - 81.3)
Double 18.3 (44/240) 96.7 0.896 84.6 (71.9 - 93.1)
Original Cytochrome B
Single 17.9 (43/240) 96.3 0.8821 82.7 (69.7 - 91.8)
Double 19.2 (46/240) 96.7 0.8975 86.5 (74.2 - 94.4)
For sensitivity assessments, true positivity was determined as a sample being positive in at least two 
of the PCR assay variants. The abbreviation n/N indicates PCR positive individuals (n) as a proportion 
of the total sample size (N). 
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Standard Operating Procedure
Title:  Combined High Troughput Saponin/ Chelex Extraction of DNA 
and Antibodies from Blood Spotted What No. 3 Filterpaper
Version: 3 | Last revision: 12/02/13
Purpose / introduction
This SOP describes the detailed process of extracting and  DNA and Antibodies 
from blood spotted Whatman No.3 filter using Saponin for lyses of cell material and 
elution of Antibodies and Chelex for binding and removal of oxidative elements. 
These filter paper samples were previously collected on filter paper and stored in 
the freezer at least at -20°C. The protocol is optimized to extract material from two 
2.5 millimeter discs, yielding higher amounts of DNA and Antibodies which then 
can be used in downstream PCR and ELISA based applications for the detection of 
both human and parasite DNA and parasite directed Antibodies. This protocol is 
fast but more prone to contamination because of the 96-well format. Therefore we 
recommend using the same consumables as we did. 
Short summary of procedure
Two filter paper discs of 2,5mm in diameter are taken from the center of a single dried 
bloodspot and added into a deep well plate incubated in 1120µL (you can use 1mL 
is you are only doing PCR on these samples, always use at least 1mL, adjust based 
on desired antibody dilution) of a 0.5% Saponin solution at RT. Occupied plates are 
shaken overnight. Cells will lyse and the lysate will be released into the supernatant. 
DNA will remain attached to a now near to clear white filterpaper disc. The saponin 
solution will contain serum components including antibodies. 200uL of the saponin 
solution is then stored in a new plate for ELISA. After a single washing step with PBS 
the disc(s) will be incubated in a 6% Chelex solution and finally heated at 95°C for up 
to 30 minutes, while intermediately being spanned down. Chelex will bind positively 
charged oxidative elements leaving DNA in solution after denaturation at 95°C. After 
incubation a final high speed centrifuge step follows after which the supernatant 
(now containing the eluted DNA) is stored in a new tube/plate with preferably no 
Chelex contamination. 
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Equipment & consumables
• 2 x Tweezers (per person)
• 2x Holepunchers ( per person, 2,5 millimeter in diameter) 
• Bunsen Burner
• 70% Ethanol 
• Small bucket to hold Ethanol (with lid)
• Dry heat block or waterbath at 95°C
• Racks for 10mL & 50mL tubes
• 0-200 multichannel pipette 
• 200-1mL multichannel pipette
• 200uL and 1mL pipette tips
• 96 well plates (wells of 2mL+ volume) and according lids (axygen, see additional 
file 1)
• 96 well plates 1.2mL + lids
• Axygen sealing lids (for boiling)
• 1L/500mL Bottles
Reagents
• 100% ethanol (small bucket 50 mL for sterilization) 
• 0,5% high grade saponin in PBS prepared fresh or stored at 4°C or  -20°C (Sigma-
Aldrich, Product Number S4521), best to have Saponin solution is at RT before 
use. (100mL per plate, for 1L mix add 5 grams of Saponin)
• 1X Phosphate Buffered Saline (PBS) Calcium and Magnesium free pH 7.4, stored 
at 4°C (100mL per plate)
• 6% Chelex-100 (Bio-rad) in DNA’ase/RNA’ase free water stored at room 
temperature (15mL per plate)
• Distilled water DNA/RNA’ase free
7.0 Detailed methodology
1. Organizing the plate
2. This protocol has been designed for general DNA isolation and detection of 
specific antibodies AMA/MSP, always check that your final saponin dilution 
works with your ELISA protocol.
3. For initial use, sterilize the hole puncher and forceps by flaming them in a bunsen 
generated flame. Dip them in the absolute ethanol and flame them off. During 
every sterilization step it’s essential that there is no residue alcohol on the tools, 
this will fixate the blood and greatly reduce DNA yield.
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4. Due to the nature of our ELISA assays and the inclusion of controls you can only 
add 80 samples per 96-well plate leaving the last two columns reserved for 
controls. 
5. Use the hole puncher to punch 2 X 2,5mm holes from well covered areas of the 
blood spot; ideally one from the center and one away from the center. Add the 
discs in the designated well by making use of forceps. Make sure the filter paper 
discs have room to move freely in the well.  
6. Sterilize the hole puncher and  forceps 
7. Continue with the next sample in B1, fill up the plate with 80 samples
8. Leave wells in column 11 and 12 empty (control wells)
9. Extraction
10. With a multichannel pipette, add 1120uL (this will elute your serum into 1/400, 
check if this is correct for your own antigen) of a 0.5% Saponin solution to every 
well. 
11. Seal every plate with a rubber sealing pad, make sure it is tightly sealed
12. Put plate on a shaker, use and intermediate shaking speed, make sure all the 
discs are freely moving in the plate and that the plate is properly stabilized. 
Leave it shaking overnight.
13. Centrifuge plate for 1 minute at high speed. Confirm that your filterpaper discs 
are white. If not this protocol might not yield the best quality of DNA. This is 
usually a result of bad storage conditions. Commercial kits might offer a better 
solution.  
14. Transfer 200uL of the now reddish saponin to a new plate coded. This plate can 
either be transferred to the ELISA room for direct processing or can be stored in 
a freezer at -20/-80°C for subsequent use. 
15. Aspirate the rest of the saponin from the wells using a vacuum system. Try to 
avoid touching the filter paper discs. Preferably change tip after every well, 
alternatively rinse tip in PBS, if filter paper has been ‘touched’ by default replace 
tip. 
16. Add 1 mL of cooled (+4) PBS to each tube (no saponin), seal the plate and shake 
for 30 minutes, again assuring that punches move freely in the well. Incubate at 
4°C for 30 minutes. 
17. Again shake plates for 10 minutes
18. Ensure that filter discs are properly clean.
19. As above, centrifuge and aspirate as much fluid as possible.
20. Add and adequate amount of 6% Chelex into a fluid tray (for 1 plate ~15mL). 
Transfer 150uL of the solution to each well using a multichannel pipette. Make 
sure that the Chelex is properly distributed after every transfer round. Chelex 
settles quickly, this step ensures that not just water is being transferred. 
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21. Extract the parasite DNA by incubating tubes for 3x10 minutes (a minimum of 
10 minutes) in a >95°C heat-block or water bad. Every 10 minutes, spin down the 
plates to make sure the filter papers are still in touch with the chelex solution. 
To release pressure build up under the lids, either punch holes in the lid, or use 
tight sealing aluminum foil (Axygen). 
22. After incubation, centrifuge the plates at maximum speed for 5 minutes. Prepare 
a new plate for storage of the DNA. 
23. Transfer 120uL of the eluted DNA solution from the spun plates Make sure that 
the Chelex pellet is not disturbed. 
24. Spin plates for 10 minutes at high speed and store at -20 or lower degrees 
Celsius until downstream use.
General notes
• Check the amount of saponin solution you have to add to reach the required 
antibody dilution
• It’s of essence that Chelex beads are restricted from the final PCR mixture. Since 
Chelex binds magnesium and other polar elements it will inhibit enzyme activity, 
including Taq polymerase. 
• One way of doing this is by centrifuging the Chelex to a compact pellet, but this 
is only possible if a high speed centrifuge is present on site. Make sure that the 
filter was pressed to the bottom after centrifuging, so you can yield the maximum 
amount of clean supernatant. 
• Before removing template from the final DNA plates make sure they are 
centrifuged.
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Standard Operating Procedure
High Throughput PCR  detection of Plasmodium falciparum
Effective Date: 12/10/11
Purpose / introduction
This SOP describes the detailed process of detection of Plasmodium falciparum 
based on the detection of specific mitochondrial Cytochome B and Ribosomal 18S 
sequences. All assays consist of a nested PCR and conventional visualization on a 
agarose gel. The Cytochrome B assays are more sensitive than the more conventional 
Snounou 18S based PCR, and can detect parasite densities down to 1 parasite/µL. 
optionally a digestion reaction can be performed on the amplified product to make 
a distinction between Plasmodium sub species. 
Short summary of procedure
As indicated the PCR methods are fairly conventional consisting of two identical PCR 
reactions in which only the primers for the first and second reaction differ within 
the mastermix. Detection of amplified fragments takes place on a 1% agarose gel. 
For fragments sizes PCR conditions and primer sequences see supplement file 1. 
We measure product from both the Nested 1 and nested 2 reactions by pipetting 
product together before we visualize it on gel. The whole process takes place within 
a 96 well format reducing the need for additional pipetting steps and reducing the 
amount of error within the total assay. Because of in parallel DNA/Ab extraction DNA 
plates come filled up with 80 samples. For the PCR two controls are added. 
Equipment & consumables
• Thermal cyclers
• Gel Tanks
• Gel Trays
• Gel Casters
• 2.0mL Eppendorf tubes
• 96 well PCR plates (biorad MLP9601)
• Clean room (for the mixture of the Mastermix)
• DNA cabinet (for the addition of DNA)
• 1-10uL Multichannel/Single channel, for the addition of DNA+controls
• Pipettes 1-10/1-100/1-200/100-1000 for Mixing the Mastermix
• 5-50 12channel pipette for adding samples to gel
• Filtertips
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Reagents
• Promega Taq Kit (u1510), contains MgCl2, green buffer, and 500units of Taq 
(100uL) 
• Primers: GCDW2&4 for N1 Plas1 &2 for N2 à Cytochrome B as described by 
Steenkeste et al. 
• rPLU5&6 for N1 rFal 1 & 2 for N2 à 18S as described by Snounou et al. 
• CytB_1&CytB_N2 Plas1 & Plas2à Modified Cytochrome B 
• DNA ladder properly diluted (10x)
• Positive control (pre tested, make sure that both the N1&N2 fragment are visible 
5uL per plate)
• TBE buffer 0.5x
• Ethidium Bromide
Preparing Mastermixes
• Print labels 2*15 containing mastermix 1 or 2. Date and which primers the mix 
includes. 
• Defrost all the components, make 15 tubes of MM1 and MM2
• Label tubes on top with MM1 & MM2 while components are defrosting
• Sterilize tubes, pipettes and tray in the UV-linker
• 15 tubes of PCR buffer (green)
• 8 tubes of MgCl2 (properly mix)
• Defrost according amount of primer
• Defrost dNTP stocks and make a total stock of 25mm (each dNTP is 100mM)
• When tubes are defrosted spin them all down
• For 82 samples (incl. 3% error margin) per tube 
• Make mastermix according to supplement 1 in 50mL tubes
• Distribute over single tubes
• Close tubes and attach labels
• Spin down
• Freeze at -20°C in the clean room freezer
When used: 
• Defrost
• Vortex lightly
• Add polymerase
• Shake gently, spin down and add to PCR plate using a multistep 1mL pipette
• Add 20uL per well (in 82 wells) using the multistep pipette (1mL)
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Setting up PCR
• Defrost  DNA plates. Make sure that it is completely defrosted. Spin down for 5 
minutes at high speed and store in fridge. Spinning down is done to make sure 
chelex is contained in the bottom of the well. 
• Work in clean room from now on. 
• Defrost  mastermix tubes for a N1 reaction. Defrost and briefly spin down
• Add according amount of Taq (see supplement file 1) of Taq polymerase to every 
tube
• Invert tube. Briefly spin
• Use multistep pipette with 1mL tip to discard 20uL of mastermix to every well. 
• Fill rows A-H, 1-10 and A11 (negative control) and B11 (positive control)
• Move to ‘dirty’ room
• Add 5uL of DNA to every according well. A1 DNA goes to A1 PCR etc. 
• Make sure that you don’t mix DNA because of chelex contamination, also gently 
pipette up and down. 
• Seal plate with Microseal B film. 
• Spin down plates for 10 seconds. 
• Start PCR reaction (for PCR cycling condition see supplement file 1). 
• For the N2 reaction fill out N2 plates. Same as the N1 procedure except now you 
use N2 mastermix tubes. 
• Transfer 1.5uL of DNA from the PCR plate N1 to newly made PCR plate 2. 
• Spin down plates briefly (20seconds) while keeping them at 4 degrees in the 
meantime. 
• Start N2 reaction. 
• Finished N2 reaction can be stored for a few days in the fridge or freezer. We 
recommend to visualize it straight away or store at -20°C
Running a gel and visualizing DNA product
• Make a 0.8% Gel out of 0.5x TBE solution. Use 4, 26 well combs per gel. We have 2 
gel tanks which can run simultaneously. (see TBE SOP 20x stock solution)
• Mix 2.4 grams of agarose with 300mL of 0.5x TBE. 
• Heat in the microwave, and shake intermediately, careful since flask will be hot 
• Cool down contents of flask under a stream of flowing cold water. 
• Wait till flash is ‘handwarm’
• Add 6uL of EtBR. Take caution, ethidium bromide is carcinogenic. Use only specific 
dedicated tips and pipettes for this task and discard tips accordingly. 
• Poor gel, avoiding air bubbles. 
• Let the gel become solid. 
• Move gel into gel tank and remove combs with caution. 
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• Place contrast sheets under the wells. 
• Load gel with samples according to instruction. 
• Add lids to gel tanks. Make sure that the poles are correctly connected to the gel 
power pack. Switch it on and run gel @ 180V for 45 minutes. 
• Turn off gel power pack. 
• Put gels on a tray and visualize product with an UV imager. 
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Abstract
Background
Malaria transmission is highly heterogeneous in most settings, resulting in the 
formation of recognizable malaria hotspots. Targeting these hotspots might 
represent a highly efficacious way of controlling or eliminating malaria if the 
hotspots fuel malaria transmission to the wider community.
Methods/design
Hotspots of malaria will be determined based on spatial patterns in age-adjusted 
prevalence and density of antibodies against malaria antigens apical membrane 
antigen-1 and merozoite surface protein-1. The community effect of interventions 
targeted at these hotspots will be determined. The intervention will comprise 
larviciding, focal screening and treatment of the human population, distribution of 
long-lasting insecticide-treated nets and indoor residual spraying. The impact of the 
intervention will be determined inside and up to 500 m outside the targeted hotspots 
by PCR-based parasite prevalence in cross-sectional surveys, malaria morbidity by 
passive case detection in selected facilities and entomological monitoring of larval 
and adult Anopheles populations.
Discussion
This study aims to provide direct evidence for a community effect of hotspot-targeted 
interventions. The trial is powered to detect large effects on malaria transmission in 
the context of ongoing malaria interventions. Follow-up studies will be needed to 
determine the effect of individual components of the interventions and the cost-
effectiveness of a hotspot-targeted approach, where savings made by reducing the 
number of compounds that need to receive interventions should outweigh the costs 
of hotspot-detection.
Trial registration
NCT01575613. The protocol was registered online on 20 March 2012; the first 
community was randomized on 26 March 2012.
Keywords
Anopheles, elimination, epidemiology, eradication, falciparum, heterogeneity, 
immunology, malaria, molecular, transmission
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Background
The transmission of infectious agents is highly heteroge- neous in space and time. 
For many infectious diseases, a small number of human hosts are most frequently 
or most heavily infected while the majority of a local popu- lation is much less 
affected [1-4]. In malaria, this hetero- geneity of disease transmission often results 
in variation in malaria incidence within small areas [5-10]. In some settings the 
non-random distribution of malaria inci- dence between households appears to 
conform to the ‘20/80 rule’ [2], whereby approximately 20% of a host population 
contributes 80% of the cases of an infectious or- ganism [5,9]. The factors underlying 
the micro-epidemiology of malaria are not fully understood but include variation in 
distance from the nearest mosquito breeding site [5-9,11], wind direction[12], house 
construction features [6,8,9,13,14], human behavioural [7,8,13] and genetic factors 
[7,8,15].
Heterogeneity in malaria transmission has implications for malaria control. 
Individuals who are bitten most often are most likely to be infected and can amplify 
transmission by infecting a large number of mosquitoes with malaria parasites. 
Estimates of the basic reproduct- ive number (R0), a central concept in infectious 
disease epidemiology defined as the average number of second- ary cases arising 
in a susceptible population as a result of a single human case over the course of 
their infection, are sensitive to assumptions of heterogeneous mosquito exposure. 
R0 may be four times higher when heteroge- neous mosquito exposure, as opposed 
to homogeneous exposure, is considered [2,4,16].
The large influence of heterogeneous exposure on malaria transmission also 
suggests that interventions tar- geting areas of comparatively high exposure can be 
highly effective. Woolhouse and colleagues suggested that, depending on the costs 
of identifying hotspots of transmission, treating the core 20% might be preferable to 
non-targeted interventions on economic grounds [2]. If hotspots fuel transmission 
to a wider geographical re- gion, community protection may be achieved by target- 
ing those individuals that are most important for disease transmission. This hotspot-
targeted approach will be most (cost) effective if the assumption that hotspots fuel 
transmission in surrounding areas is correct – and then only if such hotspots can be 
reliably detected [4]. Several approaches to identify hotspots of malaria transmission 
have been proposed in recent years. Annual incidence of clinical malaria is a 
frequently used indicator of hotspots of malaria transmission [8-10] but is affected 
by a differ- ential acquisition of protective immune responses inside and outside 
hotspots [17,18]. Geographical clustering of asymptomatic parasite carriage may be 
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a more stable in- dicator of hotspots of transmission [10] and in areas of moderate or 
low endemicity hotspots might be most readily detected using serological markers 
of malaria exposure [9,10,19-22]. In an area of moderate endem- icity in Tanzania, 
serological data have been used to identify clinically and entomologically confirmed 
hot- spots of malaria transmission with 96% sensitivity and 82% specificity [9].
This manuscript describes a methodological approach to identifying hotspots 
of malaria transmission and a protocol for the evaluation of a hotspot-targeted 
inter- vention. The aim of this intervention study is to deter- mine whether the 
simultaneous roll-out of interventions in hotspots of malaria transmission has a 
community- wide effect that extends beyond the hotspot boundaries and results in 
local reduction and possibly elimination of malaria.
Methods/design
Study area
The study will be conducted in highland fringe localities (1400 m to 1600 m altitude) 
in Rachuonyo South District, Western Kenya (34.75 to 34.95°E, 0.41 to 0.52°S). The 
predominant ethnicity in Rachuonyo is Luo. Local residents depend upon farming, 
cattle and goat herding for subsistence [23]. Compounds comprise an average of two 
houses (25th to 75th percentile 1 to 3) and are distrib- uted broadly across a rolling 
landscape intersected with small streams and rivers. The main malaria vectors in the 
area are Anopheles gambiae s.s., An. arabiensis, and An. funestus. Malaria transmission 
is seasonal, with two peaks in malaria cases reflecting the bimodal rainfall pattern; 
a peak corresponding to the heaviest rainfall typically occurs between March and 
June and there is a smaller peak be- tween October and November each year. Most 
malaria is caused by Plasmodium falciparum [23]. Community cross-sectional surveys 
conducted in 2010 indicated para- site prevalence averaging 14.8% in the general 
population but varying between localities from 0% and 51.5%. School surveys carried 
out in primary schools in the same year indicated an average parasite prevalence of 
25.8% in 7 to
18 year olds (minimum and maximum for individual schools 0 to 71.4%). Insecticide-
treated nets (ITNs) have been promoted by the Ministry of Public Health and 
Sani- tation for many years and distribution campaigns have taken place through 
antenatal and child health clinics, reaching net ownership for under 5s of 82.7%, 
as deter- mined in surveys in 2010 (unpublished data). In addition, community-
wide mass distribution of ITNs was under- taken by the Division of Malaria Control 
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(DOMC) in 2011. Indoor residual spraying (IRS) with a pyrethroid was first carried out 
in Rachuonyo South in mid 2008 with financial support of the US President’s Malaria 
Initia- tive. Reported house coverage with IRS in Rachuonyo South was estimated at 
70.3% in 2009 and 74.3% in 2010.
Sampling strategy to identify hotspots of transmission
We will select a 5 × 20 km (100 km2) area within which results from recent community 
and school malaria surveys suggest highly heterogeneous malaria exposure. The 
study area will be divided into 400 cells of 500 × 500 m that will be further subdivided 
into four sub-cells of 250 × 250 m.
All structures in the area have been geo-located using contemporaneous high-
resolution satellite data (Quick- bird; DigitalGlobe Services, Inc., Denver, CO, USA), 
which were acquired and processed using standard digital image processing 
techniques (ENVI 4.8, Exelis Visual Information Solutions, McLean, VA, USA). Pan- 
sharpened colour images were then imported into a geo- graphic information 
system (ArcGIS 9.2; Environmental Systems Research Institute, Redlands, CA, USA) 
and all structures digitized manually, giving a total of 8,632 structures with a median 
of 45 (25th to 75th percentile, 35 to 52) per 500 × 500 m cell. We aim to obtain 
mea- surements from ≥50 individuals per 500 × 500 m cell, since estimates of sero-
conversion rates from fewer than 50 observations from all age groups combined 
are likely to be unreliable [9]. To maximize the discriminative power of serological 
markers of exposure, we will sample indivi- duals in predefined age strata (≤5 years; 
6 to 10 years; 11 to 15 years; 16 to 25 years and >25 years). For logistical reasons, our 
unit of sampling will be the compound.
To limit the chances of two selected structures belong- ing to the same compound, 
an iterative sampling ap- proach will be used that involves randomly selecting a 
‘seed’ structure and then removing all closely neighbouring structures (within 50 
m) from the sample universe before proceeding to select a second structure. This 
process will be repeated until all possible ‘non-neighbouring’ struc- tures have been 
selected. From the resulting list of eligible structures a sample of 16 structures will 
be chosen from each 500 × 500 m cell. To ensure maximum geographical coverage, 
at least one compound will be selected from each 250 × 250 m sub-cell, while the 
number of com- pounds selected from each of the sub-cells will be weighted by the 
structure density in these sub-cells.
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All other structures in which people sleep and which are associated with each 
selected compound will be included. The target number of 50 observations per 500 
× 500 m cell is chosen irrespective of the population density of the cells.
Data collection and measurements to identify hotspots of 
transmission
Enumeration
For planning purposes, the field area will be subdivided into 20 blocks of 5 × 4 
cells (that is, a block is 2.5 × 2 km in size). Teams will be provided with a printed 
over- view map of the block they are working in (Figure 1), as well as detailed high-
resolution maps incorporating the QuickBird satellite data for each 500 × 500 m cell. 
Each team will also be provided with a handheld global posi- tioning system (GPS) 
receiver (Garmin 62S; Garmin International, Inc., Olathe, KS, USA) that has been pre- 
loaded with the selected compound positions and cell boundaries. An enumeration 
team, comprising one field worker, a reporter and a local guide, will visit selected 
compounds to explain the study procedures, enumerate inhabitants, collect 
information on house characteristics and inform residents that the survey team 
will visit later that day. In situations where none of the structures within a selected 
compound corresponds with a residen- tial building, the selected compound will 
be replaced with the nearest visible inhabited compound. The loca- tion of this 
replacement compound will be recorded on the satellite images, mapped using the 
GPS and recorded on the enumeration forms.
All compounds where at least one adult (>20 years) and one child (<15 years) are 
permanent residents (defined as sleeping regularly in the structure) qualify for 
enrolment. For compounds with fewer residents, repla- cements will be made, as 
described. If the head of the compound agrees to participate, the geographical 
coor- dinates of the main house of the compound will be recorded and compound 
and individual house codes will be written on the doors of all sleeping structures 
with a permanent marker. The names and ages of all com- pound members will be 
recorded on study forms and in- formation on compound and house characteristics, 
including structure type, ITN coverage, and IRS history, will be collected using a 
precoded questionnaire (Pro- grammed in Visual Basic, Visual CE v11.0) on a personal 
digital assistant (HP Ipaq 210, Windows Mobile 6.1). A personal study identification 
(ID) card will be issued to each individual, which has to be shown to the sampling 
team when they visit later that same day.
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Figure 1: Overview map of one block in the study area comprising 20 cells. A map of a 2 × 2.5 km 
section of the study area that comprises 20 500 × 500 m cells and 80 sub-cells. Cell numbers are given in 
black bold letters; grey crosses indicate structures; green circles with black crosses indicate selected and 
numbered households. Rivers and roads are indicated in the map as given in the legend.
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The field workers will carry a checklist to record the cumulative number of selected 
individuals for each age category. The order in which compounds are visited will 
be randomly selected based on a computer-generated list. After completing a 
compound, the enumeration team continues to the next compound until at least 
ten compounds have been enumerated. If the checklist indi- cates that age targets 
are not met at this point, they will continue visiting compounds according to the list 
until each age target is met.
Sampling
After enumeration, participating compounds will be vis- ited by a sampling team 
consisting of two fieldworkers trained in consenting, interviewing and sampling 
techni- ques. Sampling teams will be provided with relevant maps, compound 
lists, enumeration forms and ID cards in advance. Compounds will be located using 
the names of the compound heads and by codes marked on doors at the point of 
enumeration; compound occupants will be asked to present their ID card for formal 
confirm- ation. Informed consenting will be conducted and the name, sex, age, 
residency and travel history, ITN use and sleeping times of each compound member 
will be recorded. The axillary temperature of each compound member will be 
measured by digital thermometer (Etos, Zaandam, the Netherlands). For all febrile 
individuals (>37.2°C axillary temperature), a rapid diagnostic test (RDT; ParacheckW, 
Orchid Biomedical Systems, Goa, India) to detect P. falciparum-specific histidine rich 
protein-2 will be performed. For all individuals surveyed, a single finger prick sample 
will be taken for haemoglo- bin (Hb) measurement using a HemoCue photometer 
(HemoCue 201+, Angelholm, Sweden) and three dro- plets of blood transferred onto 
a filter paper (3MM Whatman, Maidstone, UK) for serum and DNA collec- tion. After 
transfer to a field laboratory, filter papers will be dried overnight and stored in plastic 
bags with silica gel. Once a week, samples will be transported to the Kenya Medical 
Research Institute (KEMRI) CDC labora- tory in Kisumu and stored at −20°C until 
further proces- sing. All individuals with an Hb ≤11 g/dl will be given hematinics; 
individuals with an Hb ≤6 g/dl will be ac- companied to a nearby health centre for 
further care. Fe- brile individuals who are found to be parasitaemic by RDT will be 
given artemether-lumefantrine (AL, Coar- temW, Novartis, Switzerland); women of 
childbearing age who are RDT positive will be assessed for pregnancy and offered a 
pregnancy test if deemed appropriate. Febrile children below 6 months of age and 
women who are suspected or found to be pregnant or are unwilling to be tested 
will be transported to the nearest health facility for a full assessment and treatment.
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Malaria parasite prevalence
A combined extraction of DNA and elution of anti- bodies will be performed on the 
samples collected. Two discs with a diameter of 2.5 mm will be cut from the centre of 
a single filter paper bloodspot using a hole- puncher and will be eluted in deep well 
plates with addition of 1120 μl of a 0.5% saponin/phosphate buffered saline solution 
(Sigma Aldrich, Gillingham, UK). DNA will be extracted using the protocol described 
by Plowe et al. [24]; parasites will be detected by nested PCR [25,26].
Serological markers of malaria exposure
Total immunoglobulin G (IgG) antibodies against P. falcip- arum apical membrane 
antigen (AMA-1) and merozoite surface protein 1 (MSP-119) will be detected by ELISA 
using standard methodology [27,28]. Three serological outcome measures will be 
used to determine spatial pat- terns in malaria exposure: (i) the combined antibody 
prevalence, that is, seropositivity for AMA-1 and MSP-119 or for either of the antigens 
alone; (ii) the age-adjusted log10-transformed optical density (OD) [21,29]; (iii) the 
age-dependent sero-conversion rate (SCR) for combined AMA-1, MSP-119 antibody 
prevalence [21,27].
Definition of hotspots
SaTScan software [30] will be used for the detection of spatial clustering in antibody 
prevalence (Bernouilli model) and log10-transformed age-adjusted OD values 
(normal probability model). Circular and elliptic win- dows [30,31] will be used to 
systematically scan the study area as a whole and segments of the study area using a 
2 × 4 km rolling window. Hotspots will be allowed to be <1 km in radius and include 
<25% of the population of each window scanned. Segments of the study area will 
be scanned to improve the sensitivity of the scan to detect local hotspots. Local 
hotspots may not be detected when scanning the area as a whole, since altitude 
differences in the study area result in variations in average levels of transmission 
intensity. A hotspot will be defined as an area for which there is strong evidence (P 
< 0.05) that the observed prevalence or density of combined AMA-1 and MSP-119 
antimalarial antibodies is higher than expected values. Expected values are based 
on average values for the area as a whole and for the 2 × 4 km rolling window.
Since malaria antibodies are relatively long-lived and may indicate current as well 
as past malaria exposure, parasite prevalence inside and outside hotspots of mal- 
aria exposure will be determined by PCR to confirm on- going transmission in 
serologically defined hotspots.
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Selection of hotspots and evaluation areas
Since habitation in the study area is fairly evenly distribu- ted, with every 500 × 500 
m cell having six or more resi- dential structures, clusters are unlikely to be isolated 
geographically. To minimize the influence of neighbouring hotspots on malaria 
transmission in selected intervention or control hotspots, we will select hotspots for 
which there are no other hotspots detected within 1 km in any direction from the 
hotspot boundary. The hotspot- targeted intervention will be evaluated in the area 
sur- rounding the hotspot (evaluation zones). The evaluation zone will comprise 
the area surrounding the hotspot up to 500 m from the hotspot boundary in each 
direction.
Design of the intervention
Intervention clusters
Four interventions will be rolled out in the period pre- ceding the long rainy season: 
larviciding, focal screening and treatment (FSAT), long-lasting insecticide-treated 
nets (LLIN) distribution and IRS. The details of inter- ventions, and their timing, have 
been agreed upon in collaboration with the DOMC of the Kenyan Ministry of Public 
Health and Sanitation (MOPHS). Ten per cent of households will be visited 1 to 2 
weeks after the inter- vention to assess any short-term side effects of the FSAT, LLINs 
and IRS. This sampling strategy was not based on sample size calculations but on 
logistical feasibility; few side effects were expected.
Larviciding
All permanent aquatic mosquito habitats in intervention hotspots will be mapped 
using handheld GPS receivers during the dry season. In the period preceding the 
long rainy season (April), and throughout the long rainy sea- son (until September) 
all stagnant water bodies (perman- ent and temporary) inside these hotspots will 
be treated on a weekly basis with water-dispersible granule formu- lations of the 
commercial strains of Bacillus thuringien- sis var. israelensis (Bti), VectoBacW, which 
will be provided by Valent BioSciences Corp., Libertyville, IL. Larviciding will be 
carried out using previously pub- lished protocols [32]; the entire hotspot area will 
be examined for water bodies on a weekly basis, all of which will be included in the 
intervention. Spot-checks for surviving Anopheline larvae and pupae will be made 
on a weekly basis.
Focal screen and treatment (FSAT)
All compounds in hotspots will be visited and the temperature of each individual will 
be determined. All individuals aged 6 months to 15 years regardless of temperature 
and all older individuals who are febrile (tym- panic temperature ≥37.5°C) will be 
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tested for malaria parasites using HRP-2 and pLDH based RDT (First ResponseW, 
Premier Medical Corporation Ltd., Kachigam, India). If one or more individuals are 
found to be RDT positive the entire compound will receive a curative dose of AL with 
the exception of pregnant women and children below 6 months of age. Because 
of the different times at which treatment is initiated, one treatment dose for three 
consecutive days will be supervised by the field worker (day 1) or community health 
workers (days 2 and 3). Each observed dose will be given with fatty food (>1.5 g fat) to 
facilitate absorption. The second daily dose will be taken without direct supervision 
but advice on taking the treat- ment with food will be given. Information on any 
immedi- ate side effects of the AL will be recorded by the community health workers 
at each visit; all empty blister packs will be collected by community health workers 
after treatment has been completed to monitor adherence.
Long-lasting insecticide-treated nets
All compounds in hotspots will receive one LLIN per two house members according 
to MOPHS guidelines. LLINs (PermanetW 3.0) were donated by Vestergaard Frandsen 
(Hanoi, Vietnam). House members will be given leaflets on proper use and 
maintenance of nets and study personnel will assist in hanging and demon- strate 
correct use of the LLINs within houses. Usage and retention of study nets will be 
assessed by questionnaire six weeks after distribution and any missing or badly torn 
nets will be replaced within two months after distribution.
Indoor residual spraying
Routine annual IRS with lambda cyhalothrin (ICON) will be undertaken in all 
structures where people are sleeping. The IRS campaigns are jointly funded by the 
Government of Kenya and the US President’s Malaria Initiative, and implemented 
by the Research Triangle In- stitute (RTI) with the MOPHS, DOMC and District Health 
Management Teams. For this study IRS will fol- low MOPHS protocols with more 
intense mobilization, repeated visits and implementation prior to the start of the 
malaria transmission season (March to April) in intervention hotspots.
Control clusters
Control clusters will receive the routine malaria control measures, which for 2012 
will be the annual IRS programme as detailed and continued case management at 
health facilities. The IRS is scheduled to take place in April to May 2012. No LLIN 
distribution campaigns are planned for 2012.
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Design of the randomized evaluation
Sensitization and recruitment
Prior to the implementation of the interventions, meet- ings with district 
administrative and health representa- tives in the selected areas will be organized. 
Community meetings will be held with local chiefs, community elders and opinion 
leaders, school representatives and church leaders. All compounds in the selected 
interven- tion areas will be visited prior to the intervention; the procedures of 
the interventions and evaluation proce- dures will be explained to all compound 
members present. Identification cards will be distributed that will be used for 
identification purposes during compound visits and for identification of compound 
members who visit health facilities in the area.
Randomization
Hotspots with their surrounding evaluation areas will be randomly assigned to 
the intervention or control arm. This will be done by simple randomization; no 
stratification by parasite prevalence or altitude will be undertaken. Clusters will 
be ordered according to their geographical location, from northwest to southeast. 
Clusters will be entered in Microsoft Excel 2010 in this geographical order; the same 
programme will be used to generate random numbers for each of the clusters. Fifty 
percent of the clusters with the lowest random numbers will be assigned to the 
interven- tion arm; 50% with the highest random numbers to the control arm.
Hypotheses and outcomes
Hypotheses
1. Hotspot-targeted interventions combining larviciding, LLINs, IRS and FSAT will 
reduce malaria transmission inside and outside hotspots of malaria transmission.
2. The community effect of hotspot-targeted interventions, defined as the impact 
on parasite prevalence in the evaluation zone surrounding the hotspot, is a 
function of distance from the hotspot boundary.
Primary and secondary outcome measures
The primary outcome measure is parasite prevalence by PCR in the evaluation zone 
surrounding malaria hot- spots in intervention and control clusters.
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Secondary outcome measures are:
1. Parasite prevalence by PCR in the evaluation zone surrounding malaria hotspots 
in relation to distance to the boundary of hotspots in intervention and control 
clusters.
2. Indoor and outdoor Anopheles mosquito densities inside and outside hotspots of 
malaria transmission in intervention and control clusters.
3. The presence of Anopheles larvae in mosquito breeding sites in malaria hotspots 
in intervention and control clusters.
4. The number of malaria cases reporting at health facilities, coming from 
intervention and control clusters.
5. Reported side effects and coverage of FSAT, LLINs and IRS.
Evaluation
Cross-sectional surveys
Three cross-sectional surveys will be conducted: at base- line prior to the 
interventions, during the peak transmis- sion season, and at the end of the peak 
transmission season. For each cross-sectional survey, 25 compounds that are located 
inside hotspots, 25 compounds that are located <250 m from the hotspot boundary 
and 25 compounds that are located 250 to 500 m from the hot- spot boundary will 
be randomly selected. This strategy is expected to give ≥100 individual observations 
from each of these three areas. To minimize confounding by neigh- bouring hotspots, 
an exclusion buffer will be incorporated in the selection of compounds, ensuring a 
minimum dis- tance of ≥500 m from neighbouring hotspots.
Study teams will visit selected compounds and, subject to obtaining informed 
consent, collect information from inhabitants of all houses that belong to that 
compound using personal digital assistants (PDAs). For individuals older than 6 
months, tympanic temperature will be mea- sured and a finger prick blood sample 
(~300 μl) will be col- lected for assessment of haemoglobin concentration using 
Copack colour scales (COPACK GmbH, Oststeinbek, Germany) and for collection of 
nucleic acids and serum on Whatman 3MM filter paper (Maidstone, UK). Whole blood 
will be collected in BD K2EDTA microcontainers (BD Becton, Dickinson and Company, 
Oxford, UK) in selected clusters for more detailed molecular analyses. A RDT will be 
used to determine malaria infection for all fe- brile individuals. Those with a positive 
RDT will receive AL or will be referred to a health centre for further care.
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Passive case detection
A passive case detection system will be introduced in government and mission 
health facilities to monitor individuals presenting with malaria. Facilities will be 
selected to cover intervention and control clusters. For this, the catchment areas 
of health facilities in the area have been determined. Individuals from intervention 
and control clusters will be asked to present a household card whenever visiting a 
health facility. This household card will be linked to geo-located compounds. For 
indi- viduals who present without a household card, other in- formation that allows 
geo-location will be collected, such as nearest school. Tympanic temperature will be 
measured, and an RDT used to determine parasite car- riage for each individual with 
measured or reported fever.
Entomological monitoring
In a subset of the control and intervention clusters, larval and adult mosquito 
abundance will be monitored. Within each hotspot, a random selection of 15 water 
bodies along a randomly selected transect will be mapped and the pres- ence or 
absence of early and late stage Anopheline larvae and pupae will be assessed using 
a 250 ml mosquito dipper. Five dips will be made in sites smaller than 5 m2; ten 
dips in sites larger than 5 m2. This will be carried out at two-weekly intervals. Adult 
collections of Anopheline will be carried out at the same time in 36 randomly selected 
houses in each cluster selected in cross-sectional surveys. Twelve of these houses 
will be selected within the hotspots, of which four will be sampled by pyrethrum 
spray catch (PSC), four for indoor light-trap collections and four for outdoor light-
trap collections. Outside the hotspot 24 houses will be randomly selected of which 
eight will be sampled by PSC, eight for indoor and eight for outdoor light traps.
Pyrethrum spray catching will be carried out indoors according to standard WHO 
protocols [33]. CDC mini- ature light traps (Model 512; John W. Hock Company, 
Gainesville, FL, USA) will be used following previously published procedures to 
sample mosquitoes indoors [34] and outdoors [35]. The effective range of CDC light 
traps for outdoor mosquito sampling has been estimated as 5 m [36]. Accordingly, 
outdoor sampling will take place 20 m from selected houses to prevent inhabitants 
acting as unshielded bait. All traps will be set at 1830 hours and collected at 0630 
hours. A collection bottle ro- tator (Model 1512, John W. Hock Company, Gainesville, 
FL, US) will be fitted to eight randomly selected light traps set indoors and outdoors 
within and outside the hotspot; this allows collection cups to rotate every two hours 
to es- timate vector abundance at intervals throughout the night. Vector abundance, 
parity rates and the proportion of Anopheline females unfed, fed, gravid, and infected 
will be determined for each species [37] and compared between the two study arms.
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Statistical considerations
Sample size
All available malaria simulation models indicate that malaria transmission in the 
area surrounding interven- tion hotspots will decrease considerably because malaria 
transmission is effectively interrupted in those com- pounds that seed transmission 
to a larger geographical area [2,16,38]. However, there are no published studies that 
quantify the impact of hotspot-targeted interven- tions. We estimated the predicted 
impact of targeted interventions in our study area using one of the leading individual-
based simulation models [38], using human, entomological and parasitological 
characteristics collected at our sites in Kenya. We modelled three scenarios in situa- 
tions with a pre-intervention parasite prevalence in the human population of 10 
to 20%: (i) no additional interven- tions; (ii) targeted distribution of LLINs, reaching 
90% of the population in hotspots and (iii) targeted LLINs and tar- geted effective IRS 
reaching 90% of the population in hot- spots (Figure 2). The impact of larviciding is 
currently insufficiently described to be included in the model [38].
Figure 2: Simulation of intervention 
outcome. The figure presents a 
simulation of hotspot-targeted 
interventions in areas with a 
baseline parasite prevalence of 10% 
or 20%. ITN coverage is assumed 
to be 41% across all age groups 
(83% in under-fives). Plotted is 
smoothed parasite prevalence in 
the total population as a function 
of time in years since the start of 
the intervention. No interventions 
(solid black line), hotspot-targeted 
increase in LLIN coverage to reach 
90% effective coverage in hotspots 
(dashed grey line) and hotspot-
targeted increase in LLIN coverage 
to reach 90% effective coverage 
in hotspots in combination with 
targeted IRS reaching 90% of 
households in hotspots (dashed 
black line).
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Our simulations show that targeted interventions can interrupt transmission 
completely, both inside and out- side hotspots of malaria transmission, reducing 
overall parasite prevalence to <5%, in a manner that appears sustainable in the 
following years (see Figure 2). These predictions have to be interpreted with caution, 
since (i) of ITNs in Asembo, Western Kenya, indicated that an in- direct beneficial effect 
on malaria transmission is most pronounced within 500 m of the intervention area 
[39]. We used this finding to define our evaluation zone sur- rounding the hotspots. 
Assuming a sample of 200 ran- domly selected individuals in the evaluation zone of 
each cluster, a coefficient of variation of true proportions be- tween clusters within 
each group (k) of 0.4 and mean parasite prevalence of 15% and ≤5% in the control 
and intervention clusters respectively, would require five clus- ters per study arm 
for 80% power and 5% significance level [40]. This power calculation is based on 
a compari- son between arms and the assumption that parasite preva- lence will 
remain unaltered in the control arm.
To estimate the impact of the interventions on the hot- spots themselves a sample 
size of 100 individuals in each of five clusters (hotspots) per study arm, will be required 
to detect a similar difference between intervention and control clusters (≤5% versus 
15% mean prevalence) , as- suming k = 0.5, 80% power and 5% significance.
The entomologic sampling approach was based on previous data from PSC studies 
carried out by the pro- ject where the mean number of female Anophelines caught per 
house was 0.36. To detect an 80% reduction in mean number of female Anophelines 
caught by PSC in intervention houses compared with control houses at 80% power 
and a significance level of 5%, 213 houses would have to be sampled in each arm. 
Data from light- trap studies carried out to date have shown a mean of 1.12 female 
Anophelines caught indoors per trap per night and so to detect an 80% reduction in 
mean num- ber of female Anophelines compared with control houses at 80% power 
and a 5% significance level, 81 traps would have to be set in each arm per month.
the simulation model has not been prospectively tested;
(ii) there is no published evidence that quantifies the im- pact of hotspot-targeted 
interventions on transmission in- tensity in the wider community; and (iii) the 
intensity of transmission will be highly variable between hotspots in our study area. 
There is insufficient evidence on which to base power calculations for a cluster-
randomized trial; however, these simulations can give an indication of the size of 
the effect of the planned interventions. The pri- mary outcome measure is parasite 
prevalence in the evalu- ation zone. A previous study on the community benefits
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Data analysis
Statistical analyses will be performed in Stata version 12 (StataCorp LP, College 
Station, TX, USA). The primary analysis will be based on intention to treat whereby 
all evaluation areas are included in the analysis, regardless of the level of coverage. 
The main outcome measure, parasite prevalence, will be analyzed as binary variable. 
For the primary study outcome, we will compare para- site prevalence in the 
evaluation zones of intervention and control clusters using multilevel mixed-effects 
logis- tic regression to account for clustering per compound and random effects to 
account for differences between study clusters [41]. For secondary study outcomes, 
we will relate parasite prevalence to distance to the hotspot boundary in meters 
and in bins of 100 m; this analysis will be done for each of the clusters separately 
by general- ized estimating equations (GEE), adjusting for correlations between 
observations from the same compound. Indoor and outdoor Anopheles densities 
will be compared between study arms using GEE models and Poisson or negative 
bi- nomial distributions [42]. The proportion of productive breeding sites will be 
compared between intervention and control hotspots by GEE models, adjusting for 
correlations between observations from the same clusters.
Ethics considerations
Ethics approval
The study proposal received ethics approval from the Scientific Steering Committee 
(SSC), the ethical review committee (ERC) of the KEMRI Nairobi (proposal num- bers 
SSC 2163, 2181 and 1589), the London School of Hygiene & Tropical Medicine ethics 
committee (#6111), and from Centers for Disease Control and Prevention (with 
exempt status).
Informed consent
Indoor residual spraying is to be conducted as part of the routine district-wide 
malaria control programme. Consent will be obtained orally at the compound by 
community health workers and spray operators recruited by MOPHS, as is consistent 
with their operating proce- dures. Ahead of targeted distribution of LLINs, informed, 
written consent will be sought at the house level from the head of the household 
or representative in the presence of an independent witness. Larviciding will be 
done after consulting with and receiving approval from the DOMC, the Kenyan 
Pest Control Product Board (PCPB), the dis- trict administrative, fisheries and health 
teams and after community meetings. Oral consent will be sought from owners of 
or persons responsible for any privately owned permanent breeding sites in the 
intervention areas (for ex- ample, fish ponds). Since most mosquito breeding sites are 
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not restricted to particular households, consent at household level is not practical 
and approval from the community, DOMC and PCPB is considered adequate.
Before FSAT and cross-sectional surveys, informed written consent will be sought 
from all individuals and, if appropriate, their parents or guardians. If the signatory 
is not literate, a thumbprint will be obtained and con- firmed by an independent 
witness. Assent forms will be signed by children between the ages of 13 and 17 
years and by their parents or guardians. Each assent form will be accompanied by 
a consent form signed by the parent or guardian. All consent and assent forms will 
be coun- tersigned by the staff member obtaining consent and a copy will be left at 
the household.
Trial oversight
Ethical and safety aspects of the study are overseen by an independent monitor. 
No data safety and monitoring board (DSMB) will be installed. Indoor residual 
spraying and LLINs form part of routine malaria control in Kenya and will be 
undertaken in collaboration with the DOMC and the district public health teams. 
Larviciding with Bti has been undertaken previously in neighbouring districts 
and has previously been shown to pose no health risk [43]. The proposed form of 
FSAT, where household members of parasite carriers are treated regardless of their 
parasite status by microscopy, is not part of the current malaria strategy of the 
Kenyan DOMC, although screening and treatment of asymptomatic parasite car- 
riers is recommended [44]. Our FSAT approach is based on the assumption of a high 
proportion of submicro- scopic infections among asymptomatic individuals [45], 
especially among household members of individuals with patent parasitaemia [46]. 
The drug used throughout the study, AL, is the first line antimalarial treatment in 
most of East Africa, including Kenya.
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Discussion
Targeting interventions to hotspots of malaria transmis- sion is frequently mentioned 
as a cost-effective approach for malaria control and elimination [2,4,5,47], although 
direct evidence for a community effect of hotspot-targeted interventions is currently 
unavailable. The present study aims to determine this effect in a cluster-randomized 
intervention trial.
Valuable information on how to quantify community effects of malaria control 
interventions comes from trials with ITNs [48]. Mortality rates [49], incidence of severe 
malaria [50], incidence of uncomplicated malaria [39,50], anaemia [39] and high-density 
parasitaemia [39] have been shown to be reduced in compounds without ITNs that 
were in close proximity of compounds with ITNs. Hawley and colleagues found that 
individuals living in control villages within 300 m of ITN villages in Kenya experienced 
a level of protection similar to that experi- enced by individuals living in ITN villages 
and that this was plausibly due to area-wide effects on vector densities and sporozoite-
positive mosquitoes [39]. Despite similar- ities, hotspot-targeted interventions may 
differ consider- ably from untargeted ITN campaigns in their community impact. 
Mathematical simulation models suggest that the impact of hotspot-targeted 
interventions may be much larger than that of community-wide ITN distributions 
and may lead to local malaria elimination [4]. In line with this, our trial is powered to 
detect large effects on malaria transmission. However, two of the major assumptions 
underlying the optimistic model outcomes are incom- pletely understood. Firstly, the 
stability of hotspots is cen- tral to ensure sustainable community effects. Hotspots of 
(asymptomatic) parasite carriage are generally assumed to be stable [4,10]. However, 
a report that wind direction in relation to breeding site location may be a key element 
in determining the location of hotspots [12], suggests that local environmental factors 
may also influence the spatial stability of hotspots. We believe that our approach to 
define hotspots serologically may be less susceptible to (short-term) variations in wind 
direction or other eco- logical factors, since it effectively bases hotspot-detection on 
immunological markers of cumulative malaria expos- ure [27]. Secondly, a community 
effect of hotspot-targeted interventions strongly depends on mosquito mixing pat- 
terns. Mosquito mixing patterns are unlikely to be homo- geneous. Reported site-
fidelity where mosquitoes are likely to return to the same compounds [51,52] remains 
to be confirmed but could considerably reduce the com- munity effect of hotspot-
targeted interventions. The most informative measure of mixing patterns may be an 
approach where parasite populations are tracked in human populations, inside and 
outside hotspots of mal- aria transmission.
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Research on the impact of community interventions where ‘herd coverage’ is 
required to ensure effectiveness raises a number of practical issues. Similar to mass 
drug administration campaigns, high community coverage [53,54] is required in our 
study to reduce R0 to values below 1. Our intervention is further challenged by a de- 
pendence on community participation in control measures that are only rolled out in 
a selected proportion of this community. Gaining community trust is essential to the 
study’s success and we expect good participation rates after our lengthy sensitization 
process and strong involvement of community leaders and local workers in all aspects 
of the study preparation, intervention and evaluation.
Even with excellent participation rates, the nature of our intervention will remain 
susceptible to contamination from neighbouring hotspots. An ideal study setting 
would comprise a large number of geographically isolated clus- ters, each being 
an independent focus of malaria transmis- sion, with clearly defined hotspots 
within these clusters [4]. Our real-life setting falls short of this ideal scenario. The 
continuous inhabitation in the area makes it unlikely that clusters are geographically 
isolated. We aim to minimize contamination from non-targeted malaria hot- spots 
by incorporating an exclusion zone in our selection of eligible hotspots and in the 
selection of compounds in the evaluation phase. We nevertheless expect that there 
will be residual contamination that will be reflected in a spatial component in the 
effect of hotspot-targeted inter- ventions: we expect the level of contamination 
to be high- est in areas furthest away from the targeted hotspot and nearest to 
untargeted hotspots. Similarly, the effect of the intervention within the targeted 
hotspots may be largest in those compounds that are most remote from the near- 
est untargeted compound. Mathematical simulation models that incorporate 
heterogeneous malaria exposure [16,23,38] are expected to be valuable as an 
integral part of the evalu- ation of our intervention to assess the plausibility that a 
change in transmission intensity can be attributed to the intervention.
The current study is not designed to determine the ef- fect of individual interventions. 
While simulations sug- gest that targeted interventions with LLINs and IRS will 
be sufficient to eliminate malaria locally [4], we chose a relatively comprehensive 
package of malaria control measures incorporating a wide variety of available inter- 
ventions, targeting both the mosquito vector and the malaria parasite in humans. 
If findings from the current study prove promising, a next step will be to determine 
the optimum package of tools for hotspot-targeted inter- ventions across a range 
of settings. This package will dif- fer between different settings. Larviciding, for 
example, will be most beneficial in settings where breeding sites are discrete and 
well-defined [55-57] while the effects of IRS and ITNs will be affected by insecticide 
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resistance, amongst other factors [48]. Importantly, follow-up stud- ies should 
determine the cost-effectiveness of the hot- spot approach to assess whether 
savings in the number of compounds that need to be targeted for conventional 
vector control in the absence of hotspot treatment out- weigh the costs for hotspot-
detection and coordination of hotspot interventions.
Trial status
The trial was actively recruiting participants at the time that the protocol was 
submitted for publication.
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Abstract
Background
The East African highlands are fringe regions between stable and unstable malaria 
transmission. What factors contribute to the heterogeneity of malaria exposure 
on different spatial scales within larger foci has not been extensively studied. In a 
comprehensive, community-based cross-sectional survey we attempt to identify 
factors that drive the macro- and micro epidemiology of malaria in a fringe region 
using parasitological and serological outcomes. 
Methods
[PLEASE NOTE THAT MALARIA JOURNAL DOES NOT USE FIRST PERSON FORMAT; 
ADJUST ALL SENTENCES ACCORDINGLY] A large cross-sectional survey including 
17,503 individuals was conducted across all age groups in a 100 km2  area in the 
Western Kenyan highlands of Rachuonyo South district. Households were geo-
located and prevalence of malaria parasites and malaria-specific antibodies 
were determined by PCR and ELISA. Household and individual risk-factors were 
recorded. Geographical characteristics of the study area were digitally derived using 
high-resolution satellite images. 
Results
Malaria antibody prevalence strongly related to altitude (1,350-1,600 m, p<0.001). 
A strong negative association with increasing altitude and PCR parasite prevalence 
was found. Parasite carriage was detected at all altitudes and in all age groups; 93.2% 
(2,481/2,663) of malaria infections were apparently asymptomatic. Malaria parasite 
prevalence was associated with age, bed net use, house construction features, 
altitude and topographical wetness index. Antibody prevalence was associated with 
all these factors and distance to the nearest water body. 
Conclusion
Altitude was a major driver of malaria transmission in this study area, even across 
narrow altitude bands. The large proportion of asymptomatic parasite carriers at all 
altitudes and the age-dependent acquisition of malaria antibodies indicate stable 
malaria transmission; the strong correlation between current parasite carriage 
and serological markers of malaria exposure indicate temporal stability of spatially 
heterogeneous transmission. 
Keywords: Malaria, Plasmodium falciparum, hotspots, heterogeneity, transmission, 
elimination, risk-factors, serology, polymerase chain reaction
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Background
Infectious disease transmission often displays heterogeneity of transmission in space 
and time[1]. Malaria forms no exemption to this and in the last decade, considerable 
efforts have been made to improve estimates on the global and local burden of 
malaria transmission [2] [3,4]. At a global scale, Plasmodium falciparum transmission 
is driven by temperature and aridity that limit the distribution and competence of 
Anopheles vectors [5]. However, at a micro-epidemiological scale in endemic areas, 
numerous factors influence malaria transmission dynamics including distance to the 
nearest mosquito breeding site [6–12] and house construction features [6,8,9,13,14]. 
Individual malaria risk may also be associated with human genetic factors [7,8,15] 
or with behavioural factors [6–8,13] including those relating to occupation [16] 
and travel [17]. Variations in these factors over a small area can result in spatially 
heterogeneous transmission, resulting in foci or hotspots of malaria infection [2,18]. 
Targeting hotspots may be a highly efficacious approach for malaria control [1,19]; 
the operational feasibility of such targeted interventions depends on the stability 
of malaria hotspots in space and time [2,20] and the ability to readily detect them. 
In Africa, highland fringe areas have traditionally been associated with unstable 
malaria transmission, epidemics and unpredictable disease patterns [21,22]. Over 
recent decades, however, it appears that this picture has been changing [23] with 
studies describing instances of relatively stable malaria transmission in the Kenyan 
highlands [24,25], characterized by age-dependent acquisition of anti-malarial 
immunity [24,26] and a substantial reservoir of asymptomatic malaria infections 
[27]. These studies were based on passively detected malaria cases [24,25] and 
active surveillance in children [26,27]; a more comprehensive, community-based, 
assessment of parasitological and serological outcomes in all age groups is needed 
to establish the macro- and micro-epidemiology of P. falciparum and to identify 
factors associated with exposure and infection so that more targeted and specific 
interventions can be locally deployed.
Methods
Study site and sampling
This study was conducted in highland fringe localities (1350-1600 m altitude) in 
Rachuonyo South District, western Kenya (Figure 1). The main malaria vectors in 
the area are Anopheles funestus and Anopheles gambiae sensu lato (s.l.) [28]. Malaria 
transmission is seasonal, with two peaks in malaria cases reflecting the bimodal 
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rainfall pattern, with the heaviest rainfall typically occurring between March and 
June and a smaller peak between October and November each year. The study 
procedures have been described in detail elsewhere as part of an online clinical trial 
protocol [29]. Briefly, we selected a 5x20 km (100 km2) area that was divided in to 400 
cells of 500x500 m that were further subdivided in four sub-cells of 250x250 m. All 
structures in the area were geo-located manually in ArcGIS [ArcGIS 9.2; Environmental 
Systems Research Institute, Redlands, CA, USA] using contemporaneous high-
resolution satellite data [Quickbird; DigitalGlobe Services, Inc., Denver, CO, USA]. 
Where possible, a maximum of 16 compounds were chosen from each 500x500 m 
cell. The aim was to obtain measurements from ≥ 50 individuals per 500x500 m and 
sampling of individuals was guided by pre-defined age strata (≤5 years; 6-10 years; 
11-15 years; 16-25 years and >25 years) to maximize the discriminative power of 
serological markers of exposure [30]. To ensure maximum geographical coverage, at 
least one compound was selected from each 250x250 m sub-cell while the number 
of compounds selected from each of the 250x250 m sub-cells was weighted by the 
density of structures in each sub-cell.
The survey was carried out in 2011, during what is considered to be the main malaria 
transmission season, between June and July. After initial consent during enumeration, 
participating compounds were visited and the name, gender, age, residency and 
travel history, use of insecticide-treated nets (ITNs), indoor residual spraying (IRS) in 
the past 12 months and sleeping times of each compound member were recorded. 
All compounds where at least one adult (>20 years) and one child (<15 years) were 
permanent residents (defined as sleeping regularly in the structure) qualified for 
enrolment during the survey. The axillary temperature of each compound member 
was measured by digital thermometer. For all febrile individuals a rapid diagnostic 
test [RDT; Paracheck®, Orchid BiomedicalSystems, Goa, India] detecting P. falciparum-
specific histidine rich protein-2 was performed. A single finger prick sample was 
taken for haemoglobin (Hb) measurement using a HemoCue photometer [HemoCue 
201+, Angelholm, Sweden] and three droplets of blood transferred onto a filter paper 
[3MM Whatman, Maidstone, UK] for serum and DNA [31]. All individuals with an Hb ≤ 
11 g/dL were given haematenics; individuals with an Hb ≤ 6g/dL were accompanied 
to a nearby health centre for further care. Febrile individuals who were parasitaemic 
by RDT were given artemether-lumefantrine [AL, Coartem®, Novartis, Switzerland]; 
women of child bearing age who were RDT positive were assessed for pregnancy and 
offered a pregnancy test if deemed appropriate. Febrile children below six months 
of age and pregnant women with malaria were referred to the nearest health facility 
for full assessment and treatment. 
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Figure 1. The study area in Western Kenya. The study area comprised a 5x20 km rectangle in 
Rachuonyo South District, Nyanza Province.
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PCR and serology
A combined extraction of DNA and elution of antibodies was performed on the 
samples collected, as described elsewhere [31]. Antibodies against P. falciparum 
apical membrane antigen (AMA-1) and merozoite surface protein 1 (MSP-119) were 
measured in all samples by ELISA [32,33]. Parasites were detected by nested PCR 
targeting the 18S rRNA gene [31,34]. For logistical reasons, PCR was performed on a 
subset of all available samples (12,912/16,381).
Geographical information
Altitude data for study compounds were derived from a high-resolution digital 
elevation model (DEM; ASTER GDEM).  These DEM data were also used to derive a 
topographic wetness index (TWI) using the method of Cohen et al. [35]. Aggregated 
TWI estimates were derived for a 500 m circular window around each participating 
compound. Locations of rivers and streams were initially estimated using topographic 
modelling of DEM data and were later refined manually using Quickbird satellite 
data.  The number of digitised structures within a 500 m circular window of each 
compound was used as a proxy for population density.
Statistical analysis
Broad patterns of transmission intensity were described by fitting age-seroprevalence 
curves [32,36] to samples collected from populations residing at different altitude 
bands 1,350-1,449 m, 1,450-1,499 m, 1,500-1,549 m and 1,550-1,641 m and 
quantifying parasite prevalence and antibody prevalence in 10 m altitude bands. For 
quantifying transmission intensity at a finer geographical scale, two individual level 
measures of transmission intensity were used: (i) combined antibody prevalence, 
i.e seropositivity for AMA-1 and/or MSP-119; and (ii) PCR-detected parasite 
prevalence. Correlations between both metrics were determined using a chi-square 
test and hypothesis testing with significance determined where p<0.05 and odds 
ratios (OR) and corresponding 95% confidence intervals were calculated. Potential 
factors associated with antibody prevalence or parasite prevalence were explored 
using multivariate logistic regression models accounting for correlations between 
observations from the same compound. In these models, an equal correlation model 
(exchangeable) was used to specify the within-household correlation structure. All 
univariate analyses were adjusted for clustering of observations from the same 
household and age but no other factors. Adjustment for age was performed because 
this was a very important determinant of both parasite prevalence and antibody 
prevalence. For multivariate models a forward selection method was used, using a 
p-value of 0.05 to retain variables in the model. All analyses were performed using 
Stata (v. 13, StataCorp) 
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Ethical considerations
This study was approved by the ethical committees of the London School of Hygiene 
and Tropical Medicine (LSHTM 5721) and the Kenya Medical Research Institute (SSC 
1802 & SSC2163). Approval was sought from district medical officers, local chiefs 
and communities. Individual informed consent was sought from all participants or 
guardians of those less than 18 years old by signature or a thumbprint accompanied 
with the signature of an independent witness. Assent was also sought from children 
above 13 years of age. As defined in the Kenya national guidelines, participants 
below 18 years of age who were pregnant, married, or a parent were considered 
“mature minors” and consented for themselves.
Results
Characteristics of the study population
In total 17,503 individuals were sampled, coming from 3,213 compounds across 
a 100 km2 study area. The majority of individuals resided within a narrow altitude 
band of 1,400-1,550 m (92.5%; 16,167/17,478). The median number of individuals 
per compound was 5 (interquartile range 3-7, range 1-29). As reported recently, PCR 
detected parasite prevalence was 21.2% (738/3,476) in children ≤5 years of age, 
26.1% (609/2,337) in children aged 6-10 years, 24.8% (462/1403) in children aged 11-
15 years, 19.2% (374/1,574) in individuals aged 16-25 years and 14.6% (480/3,286) in 
individuals aged >25 years [37]. 
Altitude and malaria risk
The proportions of individuals with fever, clinical malaria (a positive RDT in 
combination with temperature ≥37.5°C), parasites detected by PCR, malaria-specific 
antibody responses (Figure 2) and anaemia (Hb<11 g/gL) were all negatively 
associated with increasing altitude (table 1; p<0.001 for all comparisons). The 
median age of individuals diagnosed with clinical malaria was six years (interquartile 
range 3-10 years), although 12.5% (37/295) individuals with clinical malaria were 
>15 years of age (range 0-46 years); 93.2% (2,481/2,663) of PCR-detected malaria 
infections were sub-clinical. The mean age of individuals with clinical malaria was 
not associated with altitude (p=0.40). When altitude was categorized in bins of 
10 m, there was a strong negative association between altitude and PCR parasite 
prevalence (Figure 3A; r=0.92, p<0.0001) and malaria antibody prevalence (r=0.92, 
p<0.0001). Age-seroprevalence curves were fitted for antibody responses to MSP-119 
and/or AMA-1 for the four altitude bands and indicated a clear gradual decline of 
the seroconversion rate with increasing altitude (Figure 3B). There are  no apparent 
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Figure 2. Maps representing altitude, spatial variation of nPCR and antibody prevalence in the study area 
Western Kenyan highlands Rachuonyo South District, Nyanza Province. Figure 2A. Detailed overview of the 
altitude in the study area. Figure 2B. Average nPCR prevalence in 250x250m zones. Figure 2C. Average combined 
seroprevalence (for AMA-1 or MSP-119) in 250x250m zones. 
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observed ‘steps’ in age-seroprevalence curves that can indicate changes in exposure 
due to intervention and/or age-associated behavioral changes patterns such as 
travel to malaria endemic regions outside the area of residence [38]. 
Micro-epidemiological patterns in malaria transmission intensity
There was considerable inter-compound variation in antibody prevalence and 
PCR parasite prevalence. In some compounds no members were antibody positive 
(6.6% of all compounds with ≥3 sampled inhabitants, 178/2,709) or PCR parasite 
positive (49.6%, 1,239/2,496) while for other compounds ≥80% of all compound 
members were antibody (24.1%, 652/2,709) or parasite positive (5.1%, 126/2,496). 
Malaria antibody prevalence and parasite prevalence were strongly correlated at 
an individual level (OR 1.94, 95% confidence interval 1.77-2.13, p<0.001) [37]. This 
association was apparent for all age groups but was strongest for children below 
6-10 years of age (OR 3.16, 95% CI 2.58-3.86, p<0.001) and weakest for adults above 
25 years of age (OR 1.45, 95% CI 1.15-1.83, p=0.002).
Table 1. Characteristics of participants in the cross-sectional survey
1350-1449m 1450-1499m 1500-1549m 1550-1650m Total
Number of participants  
(number of compounds)
5,424 (1,108) 6,363 (1,235) 4,579 (816) 839 (140) 17,503 (3,213)
Age, %(n/N)
<5 years 26.4 (1429/5,424) 27.0 (1,791/6,636) 27.1 (1,239/4,579) 27.7 (232/839) 26.9 (4,701/17,503)
6-10 years 18.9 (1,024/5,424) 18.1 (1,202/6,636) 18.0 (822/4,579) 19.4 (163/839) 18.4 (3,215/17,503)
11-15 years 15.2 (823/5,424) 13.9 (923/6,636) 15.0 (685/4,579) 14.3 (120/839) 14.6 (2,552/17,503)
16-25 years 13.7 (744/5,424) 15.3 (1,018/6,636) 14.8 (677/4,579) 16.5 (138/839) 14.7 (2,579/17,503)
>26 years 25.9 (1,404/5,424) 25.7 (1,702/6,636) 25.3 (1,156/4,579) 22.2 (186/839) 25.5 (4,456/17,503)
Fever, % temperature >37.5°C, 
% (n/N)
4.0 (216/5,423 3.1 (204/6,631) 2.5 (116/4,575) 1.3 (11/839) 3.1 (547/17,468)
Clinical malaria, % (n/N)* 2.3 (126/5,423) 1.8 (120/6,631) 1.1 (48/4,575) 0.12 (1/839) 1.7 (295/17,468)
Parasite prevalence, % PCR 
positive (n/N)
27.2 (1,111/4,083) 19.6 (900/4,599) 16.7 (592/3,548) 8.1 (54/664) 20.6 (2,663/12,912)
Antibody prevalence, % 
positive (n/N)**
62.6 (3,108/4,967) 58.0 (3,623/6,252) 48.3 (2,104/4,361) 31.7 (246/777) 55.5 (9,092/16,381)
Anaemia, % (n/N)
Severe (<6g/dL), % (n/N) 0.6 (30/5,282) 0.7 (46/6,391) 0.4 (19/4,366) 0.2 (2/818) 0.6 (97/16,878)
Moderate (<8g/dL), % (n/N) 3.1 (163/5,282) 3.4 (214/6,391) 2.6 (112/4,336) 2.0 (16/818) 3.0 (505/16,878)
Mild (<11g/dL), % (n/N) 26.0 (1,374/5,282) 23.0 (1,472/6,391) 21.5 (938/4,336) 20.2 (165/818) 23.4 (3,954/16,878)
*clinical malaria is defined as fever with a positive RDT with measured temperature>37.5C
**prevalence of antibodies against P. falciparum MSP-119 and/or AMA-1
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Figure 3. Parasite prevalence and antibody responses in relation to altitude. Figure 3A presents 
parasite prevalence by PCR (open squares) and malaria-specific antibody prevalence (MSP-119 and/
or AMA-1 antibodies detected by ELISA) showed a strong negative association with altitude (r=0.92, 
p<0.0001 for both associations). Figure 3B presents the age-dependent antibody acquisition 
at different altitudes. Lines show the fitted association between age and antibody positivity for 
individuals residing at 1350-1449m (grey line, n=4,967), 1450-1499m (orange line, n=6,252), 1500-
1549m (red line, n=4,361) and 1550 meters and above (black line, n=777). Symbols indicate parasite 
prevalence estimates for children below 5 years of age, 6-10 years, 11-15 years, 16-25 years and >26 
years. Symbols are plotted at the median age for the different categories; for the highest age category 
parasite prevalence is plotted at 35 years. 
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Table 2. Factors associated with malaria parasite prevalence or antibody prevalence
Parasite 
prevalence
Antibody 
prevalence
OR* Adjusted OR 
(95% CI)*
OR* Adjusted OR 
(95% CI)*
Individual characteristics
Age
≤ 5 years 1 (reference) 1 (reference) 1 (reference) 1 (reference)
6-10 years 1.27 (1.13-1.42) 1.26 (1.10-1.46) 1.88 (1.71-2.06) 2.35 (2.10-2.63)
11-15 years 1.22 (1.07-1.39) 1.25 (1.08-1.47) 3.51 (3.17-3.89) 4.70 (4.15-5.33)
16-25 years 0.92 (0.81-1.04) 0.89 (0.76-1.04) 4.57 (4.13-5.07) 6.57 (5.79-7.46)
≥26 years 0.64 (0.57-0.73) 0.61 (0.53-0.71) 4.33 (3.97-4.72) 6.05 (5.43-6.73)
Bed net use 0.79 (0.71-0.88) 0.82 (0.72-0.93) 0.85 (0.79-0.93) 0.89 (0.81-0.98)
House structure
Mud wall 1.46 (1.25-1.71) 1.26 (1.05-1.50) 1.14 (1.03-1.27)
Open eaves 1.25 (1.10-1.41) 1.16 (1.01-1.34) 1.28 (1.17-1.39) 1.33 (1.21-1.46)
Environment
Distance to water
<250m 1 (reference) 1 (reference) 1 (reference)
250-500m 1.04 (0.89-1.22) 0.97 (0.87-1.09) 1.04 (0.92-1.19)
500-999m 0.83 (0.71-0.96) 0.66 (0.59-0.74) 0.91 (0.80-1.03)
1000m+ 0.78 (0.62-0.98) 0.44 (0.38-0.52) 0.81 (0.67-0.97)
Altitude
1350-1449m 1 (reference) 1 (reference) 1 (reference) 1 (reference)
1450-1499m 0.63 (0.55-0.72) 0.84 (0.72-0.98) 0.83 (0.75-0.91) 0.90 (0.81-1.01)
1500-1549m 0.52 (0.45-0.61) 0.68 (0.56-0.81) 0.57 (0.51-0.64) 0.79 (0.69-0.89)
1550-1650m 0.25 (0.17-0.37) 0.43 (0.28-0.66) 0.28 (0.23-0.35) 0.71 (0.56-0.90)
Parasite prevalence 500m radius 1.06 (1.05-1.06) 1.07 (1.06-1.07) 1.03 (1.02-1.03)
Antibody prevalence 500m radius 1.02 (1.02-1.03) 1.04 (1.03-1.04) 1.04 (1.03-1.04)
TWI (minimum) 1.91 (1.70-2.16) 1.23 (1.06-1.41)
TWI (mean) 2.16 (1.94-2.41)
TWI (maximum) 1.03 (1.01-1.05) 0.97 (0.95-1.00) 1.09 (1.07-1.10)
*adjusted for clustering on compound level. The odds ratio and 95% confidence interval of household 
and geographical factors in relation to antibody prevalence, after adjustment for age and clustering 
of observations; TWI is topographical wetness index
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In univariate analysis, individual-level parasite prevalence and antibody prevalence 
was associated with age. When adjusting for age, the following factors were 
associated with parasite prevalence and antibody prevalence: the presence of eaves 
in the sleeping room, reported bed net use, construction of the sleeping room walls 
with mud, distance to water, altitude, the proportion of parasite positive individuals 
within a 500 m radius of the compound and the proportion of malaria antibody 
positive individuals within a 500 m radius of the compound (Table 2). In a multivariate 
model that was constructed using forward selection of variables, nPCR parasite 
prevalence was negatively associated with bed net use, altitude and maximum TWI, 
and positively associated with mud walls, the presence of open eaves (Table 2). 
Similarly, malaria antibody prevalence was negatively associated with bed net use, 
distance to water and altitude, and positively associated with the presence of open 
eaves and minimum TWI (Table 2).  Reported travelling in the previous three months 
was not associated with individual-level malaria risk. At all altitudes, including the 
highest altitude band with the lowest level of infection (8.1% (54/664)), there were 
compounds where ≥80% of inhabitants were parasite positive. The proportion of 
compounds with parasite prevalence ≥80% was 7.6% (68/896) at 1,350-1,449 m, 
5.4% (56/1,041) at 1,450-1,499 m, 4.8% (35/733) at 1,500-1,549 m and 2.3% (3/128) at 
>1,550 m (test for trend, p=0.002). High-risk compounds were characterized by mud 
walls of sleeping structures (OR 1.94, 95% CI 1.00-3.79, p=0.05), a higher PCR parasite 
prevalence in the surrounding community (OR 1.07, 95% CI 1.05-1.09, p<0.001) and 
a higher minimum TWI (OR 2.60, 95% CI 1.37-4.95, p=0.004). 
Discussion
In this study, conducted in the Kenyan highlands, we show ongoing stable malaria 
transmission across an altitudinal range of 1,350-1,600 m, characterized by marked 
spatial heterogeneity. The age-dependent acquisition of malaria antibodies, strong 
correlation antibody prevalence and current parasite prevalence, along with the 
considerable asymptomatic reservoir of P. falciparum infections in all age groups, 
suggests that malaria transmission is relatively stable in the study setting. 
Much of the highlands of East Africa represent fringe regions between stable and 
unstable malaria transmission; seasonal and spatial patterns in malaria transmission 
are affected to some degree by annual variations in rainfall but primarily by ambient 
temperature [39]. The notion that malaria is largely absent in areas higher than 1,500 
m [40] has been challenged by findings of a large asymptomatic reservoir of malaria 
infections at altitudes [27] and an age-dependent acquisition of clinical immunity 
to malaria infections in highland communities [24]. We determined the spatial 
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epidemiology of malaria infections in an area at 1,350-1,600 m above sea level, and 
observed markedly heterogeneous malaria transmission. This is commonly observed 
in areas of low endemicity [2,20,25] and heterogeneity in clinical malaria cases has 
previously been reported in the Kenyan highlands [25]. This study adds detail to 
previous findings by describing the fine-scale spatial distribution of asymptomatic 
parasite carriage and immunological evidence of previous malaria exposure in a 
highland area. PCR-detectable P. falciparum infections were very common in our 
highland setting, apparently asymptomatic and negatively correlated with altitude. 
Parasite prevalence by PCR was 27.2% in the population residing at 1,350-1,449 m, 
19.6% at 1,450-1,499 m, 16.7% at 1,450-1,549 m and 8.1% at 1,550-1,650 m. Using 
an equation model fitted to 86 surveys that determined parasite prevalence by 
microscopy and PCR [41], we were able to estimate the corresponding parasite 
prevalence by microscopy at 9.7% (95% CI 8.3-11.2) at 1,350-1,449 m, 6.1% (95% 
CI 5.1-7.3) at 1,450-1,499 m, 5.0% (95% CI 4.1-6.1) at 1,450-1,549 m and 2.0% (95% 
CI 1.3-3.0%) at 1,550-1,650 m. Only a small fraction of these P. falciparum infections 
resulted in fever at the time of sampling and apparently asymptomatic parasite 
carriage was prevalent at all altitudes [27] and in all age-groups [41]. Recently, a 
manuscript summarized the evidence on the clinical consequences of chronic 
low density infections, arguing that many infections are incorrectly classified as 
asymptomatic and have considerable health consequences in terms of anaemia, 
chronic inflammation, school performance and bacterial infections [42]. Since the 
cross-sectional design of this study does not allow to determine whether the nPCR 
detected infections had clinical implications for the study population, we cannot 
conclude with certainty whether the detected infections were indeed asymptomatic. 
However, concurrent clinical symptoms were reported by a small minority of the 
examined population and infections were probably chronic in nature. Although 
individuals with limited previous exposure may harbor low density infections 
[41], the high prevalence of apparently asymptomatic parasite carriage, absence 
of travelling as obvious risk factor for malaria and the gradual age- and altitude-
dependent acquisition of antibody responses to P. falciparum antigens at different 
altitudes suggests stable local malaria transmission in the area. 
Whilst travel, a known risk factor for malaria in highland areas [43,44], was not 
significantly associated with individual risk of malaria infection or antibodies, 
several household factors such as the presence of open eaves and mud walls [6,9] 
were statistically significant predictors of malaria risk. This suggests that relatively 
simple household improvements may decrease malaria risk [45,46] in a region where 
the perceived and measured indoor exposure to malaria vectors is low [28]. Altitude, 
distance to water and the proportion of antibody or parasite positive individuals in 
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the immediate vicinity of a compound were statistically significant and biologically 
plausible factors associated with malaria risk. The latter could suggest considerable 
between household transmission.
Conclusions
We observed evidence of relatively stable malaria transmission in our site at 1350-
1600 m altitude. Altitude was a major driver of malaria transmission in our study area, 
even across narrow altitude bands. Although malaria risk was spatially heterogeneous, 
the strong correlation between current parasite carriage and serological markers of 
malaria exposure and other established risk factors for malaria indicate temporal 
stability of geographical patterns in malaria exposure. In describing fine scale 
heterogeneity in this setting we provide a likely scenario for more endemic areas with 
active and effective control programmes as they reduce transmission to increasingly 
low levels. A priori knowledge of the factors that influence residual malaria in foci of 
low transmission is likely to further expedite control and elimination attempts.
Competing interests
Authors declare not to have any competing interests.
Authors’ contributions
AB, JS, CD, JC and TB designed the field studies and AB, JS, GS, VO, CO and WO sample 
collection. AB, WS, VO, EM, PC and SS participated in the running of molecular 
and immunoassays. AB, JC, PK and TB worked on the collection of geographical 
information. AB, JS, WO and GS performed database assembly and cleaning. AB, JS, 
SK, CD, JC and TB revised the manuscript. TB, JC and AB conceived the experiments, 
aided their design, and contributed to the drafting and revision of the manuscript. 
All authors read and approved the final manuscript.
Acknowledgements
We thank all the project staff, the community of Kabondo and Kasipul, Rachuonyo 
South, and KEMRI/CDC Kisumu for their support. This manuscript has been approved 
by the Director of the Kenya Medical Research Institute.
Funding
This work was supported by the Bill and Melinda Gates Foundation, under the 
Malaria Transmission Consortium, Grant No.45114 and the Grand Challenge Grant 
No. OPP1024438.
165Factors associated with high heterogeneity of malaria
6
References
1.  Woolhouse ME, Dye C, Etard JF, Smith T, Charlwood JD, Garnett GP, et al. Heterogeneities in the transmission 
of infectious agents: implications for the design of control programs. Proc Natl Acad Sci U S A. 1997;94:338-
42. doi:10.1073/pnas.94.1.338
2.  Bousema T, Griffin JT, Sauerwein RW, Smith DL, Churcher TS, Takken W, et al. Hitting hotspots: Spatial targeting 
of malaria for control and elimination. PLoS Med. 2012;9: e1001165. doi:10.1371/journal.pmed.1001165
3.  Hay SI, Snow RW. The Malaria Atlas Project: Developing global maps of malaria risk. PLoS Med. 2006;3:e473. 
doi:10.1371/journal.pmed.0030473
4.  Hay SI, Guerra C a., Gething PW, Patil AP, Tatem AJ, Noor AM, et al. A world malaria map: Plasmodium 
falciparum endemicity in 2007. PLoS Med. 2009;6:e1000048. doi:10.1371/journal.pmed.1000048
5.  Guerra C a., Gikandi PW, Tatem AJ, Noor AM, Smith DL, Hay SI, et al. The limits and intensity of Plasmodium 
falciparum transmission: Implications for malaria control and elimination worldwide. PLoS Med. 2008;5:e38. 
doi:10.1371/journal.pmed.0050038
6.  Oesterholt MJ, Bousema JT, Mwerinde OK, Harris C, Lushino P, Masokoto A, et al. Spatial and temporal variation 
in malaria transmission in a low endemicity area in northern Tanzania. Malar J. 2006;5:98. doi:10.1186/1475-
2875-5-98
7.  Pruett-jones SG, Pruett-jones MA, Jones HI. Parasites and sexual selection in birds of paradise. Integr Comp 
Biol. 1990;30: 287–98. doi:10.1093/icb/30.2.287
8.  Kreuels B, Kobbe R, Adjei S, Kreuzberg C, von Reden C, Bäter K, et al. Spatial variation of malaria incidence in 
young children from a geographically homogeneous area with high endemicity. J Infect Dis. 2008;197:85–
93. doi:10.1086/524066
9.  Bousema T, Drakeley C, Gesase S, Hashim R, Magesa S, Mosha F, et al. Identification of hot spots of malaria 
transmission for targeted malaria control. J Infect Dis. 2010;201:1764–74. doi:10.1086/652456
10.  Carter R, Mendis KN, Roberts D. Spatial targeting of interventions against malaria. Bull World Health Organ. 
2000;78:1401–11. doi:S0042-96862000001200007 [pii]
11.  Ghebreyesus TA, Haile M, Witten KH, Getachew  A, Yohannes AM, Yohannes M, et al. Incidence of malaria 
among children living near dams in northern Ethiopia: community based incidence survey. BMJ. 1999;319: 
663–666. doi:10.1136/bmj.319.7211.663
12.  Zhou G, Munga S, Minakawa N, Githeko AK, Yan G. Spatial relationship between adult malaria vector 
abundance and environmental factors in western Kenya highlands. Am J Trop Med Hyg. 2007;77:29–35. 
doi:77/1/29 [pii]
13.  Ghebreyesus TA, Haile M, Witten KH, Getachew  A, Yohannes M, Lindsay SW, et al. Household risk factors for 
malaria among children in the Ethiopian highlands. Trans R Soc Trop Med Hyg. 2000;94:17–21. doi:10.1016/
S0035-9203(00)90424-3
14.  Gamage-Mendis  a. C, Carter R, Mendis C, De Zoysa  a. PK, Herath PRJ, Mendis KN. Clustering of malaria 
infections within an endemic population: Risk of malaria associated with the type of housing construction. 
Am J Trop Med Hyg. 1991;45: 77–85. 
15.  Mackinnon MJ, Mwangi TW, Snow RW, Marsh K, Williams TN. Heritability of malaria in Africa. PLoS Med. 
2005/11/02 ed. 2005;2: 1253–1259. doi:10.1371/journal.pmed.0020340
16.  Naidoo S, London L, Burdorf A, Naidoo RN, Kromhout H. Occupational activities associated with a reported 
history of malaria among women working in small-scale agriculture in South Africa. Am J Trop Med Hyg. 
2011/11/04 ed. 2011;85: 805–810. doi:10.4269/ajtmh.2011.11-0092
17.  Shanks GD, Biomndo K, Guyatt HL, Snow RW. Travel as a risk factor for uncomplicated Plasmodium 
falciparum malaria in the highlands of western Kenya. Trans R Soc Trop Med Hyg. 2004/11/20 ed. 2005;99: 
71–74. doi:10.1016/j.trstmh.2004.04.001
18.  Tusting LS, Bousema T, Smith DL, Drakeley C. Measuring changes in plasmodium falciparum transmission. 
Precision, accuracy and costs of metrics. Adv Parasitol. 2014/02/01 ed. 2014;84: 151–208. doi:10.1016/B978-
0-12-800099-1.00003-X
166 |   Chapter 6
19.  Bejon P, Williams TN, Nyundo C, Hay SI, Benz D, Gething PW, et al. A micro-epidemiological analysis of 
febrile malaria in coastal Kenya showing hotspots within hotspots. Elife. 2014/05/21 ed. 2014;2014: 
e02130. doi:10.7554/eLife.02130
20.  Bejon P, Williams TN, Liljander A, Noor AM, Wambua J, Ogada E, et al. Stable and unstable malaria 
hotspots in longitudinal cohort studies in Kenya. PLoS Med. 2010/07/14 ed. 2010;7: e1000304. 
doi:10.1371/journal.pmed.1000304
21.  John CC, Riedesel M a., Magak NG, Lindblade K a., Menge DM, Hodges JS, et al. Possible interruption 
of malaria transmission, highland Kenya, 2007-2008. Emerg Infect Dis. 2009/12/08 ed. 2009;15: 1917–
1924. doi:10.3201/eid1512.090627
22.  Organization WH. Malaria Early Warning Systems: Concepts, Indicators and Partners. A Framework for 
Field Research in Africa [Internet]. Document WHO. CDS/RBM/2001.32. World Health …. Geneva; 2001. 
Available: http://scholar.google.com/scholar?hl=en&btnG=Search&q=intitle:Malaria+Early+Warnin
g+Systems+-+Concepts,+Indicators+and+Partners+-+A+Framework+for+Field+Research+in+Afri
ca#1
23.  Cox J, Hay SI, Abeku T a., Checchi F, Snow RW. The uncertain burden of Plasmodium falciparum 
epidemics in Africa. Trends Parasitol. 2007;23: 142–148. doi:10.1016/j.pt.2007.02.002
24.  Hay SI, Noor AM, Simba M, Busolo M, Guyatt HL, Ochola S a., et al. Clinical epidemiology of malaria 
in the highlands of Western Kenya. Emerg Infect Dis. 2002/05/25 ed. 2002;8: 543–548. doi:10.3201/
eid0806.010309
25.  Ernst KC, Adoka SO, Kowuor DO, Wilson ML, John CC. Malaria hotspot areas in a highland Kenya site 
are consistent in epidemic and non-epidemic years and are associated with ecological factors. Malar J. 
2006/09/15 ed. 2006;5: 78. doi:10.1186/1475-2875-5-78
26.  Rolfes M a., McCarra M, Magak NG, Ernst KC, Dent AE, Lindblade K a., et al. Development of clinical 
immunity to malaria in highland areas of low and unstable transmission. Am J Trop Med Hyg. 
2012/09/19 ed. 2012;87: 806–812. doi:10.4269/ajtmh.2012.11-0530
27.  Baliraine FN, Afrane Y a, Amenya D a, Bonizzoni M, Menge DM, Zhou G, et al. High prevalence of 
asymptomatic plasmodium falciparum infections in a highland area of western Kenya: a cohort study. 
J Infect Dis. 2009;200: 66–74. doi:10.1086/599317
28.  Stevenson J, St. Laurent B, Lobo NF, Cooke MK, Kahindi SC, Oriango RM, et al. Novel vectors of malaria 
parasites in the western highlands of Kenya. Emerg Infect Dis. 2012/08/31 ed. 2012;18: 1547–1549. 
doi:org/10.3201/eid1809.120283
29.  Bousema T, Stevenson J, Baidjoe A, Stresman G, Griffin JT, Kleinschmidt I, et al. The impact of hotspot-
targeted interventions on malaria transmission: study protocol for a cluster-randomized controlled 
trial. Trials. 2013/02/05 ed. 2013;14: 36. doi:10.1186/1745-6215-14-36
30.  Corran P, Coleman P, Riley E, Drakeley C. Serology: a robust indicator of malaria transmission intensity? 
Trends Parasitol. 2007;23: 575–582. doi:10.1016/j.pt.2007.08.023
31.  Baidjoe  a, Stone W, Ploemen I, Shagari S, Grignard L, Osoti V, et al. Combined DNA extraction 
and antibody elution from filter papers for the assessment of malaria transmission intensity in 
epidemiological studies. MalarJ. 2013;12: 272. doi:10.1186/1475-2875-12-272
32.  Drakeley CJ, Corran PH, Coleman PG, Tongren JE, McDonald SLR, Carneiro I, et al. Estimating medium- 
and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc 
Natl Acad Sci U S A. 2005;102: 5108–5113. doi:10.1073/pnas.0408725102
33.  Brown BL, Slaughter  a. D, Schreiber ME. Controls on roxarsone transport in agricultural watersheds. 
Appl Geochemistry. 2005;20: 123–133. doi:10.1016/j.apgeochem.2004.06.001
34.  Snounou G, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, Do Rosario VE, et al. High sensitivity of detection 
of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol. 
1993/10/01 ed. 1993;61: 315–320. doi:10.1016/0166-6851(93)90077-B
35.  Cohen JM, Ernst KC, Lindblade K a, Vulule JM, John CC, Wilson ML. Local topographic wetness indices 
predict household malaria risk better than land-use and land-cover in the western Kenya highlands. 
Malar J. 2010/11/18 ed. 2010;9: 328. doi:10.1186/1475-2875-9-328
167Factors associated with high heterogeneity of malaria
6
36.  Cook J, Kleinschmidt I, Schwabe C, Nseng G, Bousema T, Corran PH, et al. Serological markers suggest 
heterogeneity of effectiveness of malaria control interventions on Bioko Island, Equatorial Guinea. PLoS 
One. 2011;6. doi:10.1371/journal.pone.0025137
37.  Teun Bousema, Gillian Stresman, Amrish Baidjoe, John Bradley, Philip Knight, William Stone, Victor 
Osoti, Euniah Makori, Chrispin Owaga, Wycliffe Odongo, Pauline China, Shehu Shagari, Ogobara 
Doumbo, Robert Sauwerwein, Simon Kariuki, Chris Drakeley, Jenni JC. The impact of hotspot targeted 
interventions on malaria transmission in Rachuonyo South district in the western Kenyan Highlands: a 
cluster-randomized controlled trial. PLoS Med Submitt. 2016; 
38.  Cook J, Speybroeck N, Sochantha T, Somony H, Sokny M, Claes F, et al. Sero-epidemiological evaluation 
of changes in Plasmodium falciparum and Plasmodium vivax transmission patterns over the rainy 
season in Cambodia. Malar J. 2012/03/27 ed. 2012;11: 86. doi:10.1186/1475-2875-11-86
39.  Shanks GD, Hay SI, Omumbo J a., Snow RW. Malaria in Kenya’s western highlands. Emerg Infect Dis. 
2005/10/19 ed. 2005;11: 1425–1432. doi:10.3201/eid1109.041131
40.  Lindsay SW, Martens WJM. Malaria in the African highlands: Past, present and future. Bull World Health 
Organ. 1998/06/06 ed. 1998;76: 33–45. Available: http://www.ncbi.nlm.nih.gov/pubmed/9615495
41.  Okell LC, Bousema T, Griffin JT, Ouédraogo AL, Ghani AC, Drakeley CJ. Factors determining the occurrence 
of submicroscopic malaria infections and their relevance for control. Nat Commun. 2012/12/06 ed. 
2012;3: 1237. doi:10.1038/ncomms2241
42.  Chen I, Clarke SE, Gosling R, Hamainza B, Killeen G, Magill A, et al. “Asymptomatic” Malaria: A Chronic and 
Debilitating Infection That Should Be Treated. PLoS Med. Public Library of Science; 2016;13: e1001942. 
Available: http://dx.doi.org/10.1371%2Fjournal.pmed.1001942
43.  Buckee CO, Wesolowski A, Eagle NN, Hansen E, Snow RW. Mobile phones and malaria: Modeling 
human and parasite travel. Travel Med Infect Dis. 2013/03/13 ed. 2013;11: 15–22. doi:10.1016/j.
tmaid.2012.12.003
44.  Wesolowski  a., Eagle N, Tatem  a. J, Smith DL, Noor  a. M, Snow RW, et al. Quantifying the Impact of Human 
Mobility on Malaria. Science (80- ). 2012/10/16 ed. 2012;338: 267–270. doi:10.1126/science.1223467
45.  Kirby MJ, Ameh D, Bottomley C, Green C, Jawara M, Milligan PJ, et al. Effect of two different house 
screening interventions on exposure to malaria vectors and on anaemia in children in The Gambia: 
a randomised controlled trial. Lancet. 2009/09/08 ed. 2009;374: 998–1009. doi:10.1016/S0140-
6736(09)60871-0
46.  Kirby MJ, West P, Green C, Jasseh M, Lindsay SW. Risk factors for house-entry by culicine mosquitoes in a 
rural town and satellite villages in The Gambia. Parasit Vectors. 2008;1: 41. doi:10.1186/1756-3305-1-41

7Focal screening to identify 
the subpatent parasite 
reservoir in an area of low and 
heterogeneous transmission 
in the Kenya highlands
 
Gillian H. Stresman1*, Amrish Y. Baidjoe2*, Jennifer Stevenson3,4, Lynn Grignard1, 
Wycliffe Odongo5, Chrispin Owaga5, Victor Osoti5, Euniah Makori5, Shehu Shagari5, 
Elisabeth Marube5, Jonathan Cox3, Chris Drakeley1, Teun Bousema1,2
* Authors Contributed Equally
1   Department of Immunology & Infection; Faculty of Infectious and Tropical Diseases, London 
School of Hygiene and Tropical Medicine, London, United Kingdom
2   Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands
3   Department of Disease Control; Faculty of Infectious and Tropical Diseases, London School of 
Hygiene and Tropical Medicine, London, United Kingdom
4   The Johns Hopkins Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, 
615 North Wolfe Street, Baltimore, MD 21205, US
5   Kenya Medical Research Institute, Centre for Global Health Research, Kisumu, Kenya 
Chapter 7
published in The Journal of Infectious Diseases, 2015: https://doi.org/10.1093/infdis/jiv302
170 |   Chapter 7
ABSTRACT
Background: Malaria infections are commonly asymptomatic and of low parasite density. Mass 
screening and treatment currently fails to identify a considerable fraction of these infections 
while mass treatment campaigns without prior screening disadvantageously exposes many 
uninfected individuals to antimalarial drugs. Here we test a hybrid approach to screen a 
sentinel population to identify clusters of subpatent infections in the Kenya highlands with 
low, heterogeneous malaria transmission.
Methods: 2082 inhabitants from five selected localities were screened for parasitaemia by 
nested polymerase chaing reaction (nPCR) prior to the start of the high malaria transmission 
season. Children below the age of 15 and febrile adults were also tested for malaria using a 
rapid diagnostic test (RDT) and served as a sentinel members of households to identify the 
presence of subpatent infections within the household. All parasitaemic individuals were 
assessed for multiplicity of infections (MOI) by nPCR and gametocyte carriage by nucleic acid 
sequence based amplification (NASBA). 
Results: Individuals living in a household with an RDT-positive individual in the sentinel 
population were significantly more likely to be nPCR parasite positive (OR: 1.71, 95% CI: 1.60-
1.84). Screening all individuals ≤ 15 years of age and febrile adults detected 64.5% (locality 
range: 31.6 – 81.2%) of all nPCR-positive households and 77.3% (locality range: 24.2-91.0%) 
of nPCR-positive individuals. The sensitivity of the sentinel screening approach was positively 
associated with locality transmission intensity (p=0.037).
Conclusion: In this low endemic area, a focal screening approach with RDTs was able to identify 
the majority of the subpatent parasite reservoirs. 
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BACKGROUND
Heterogeneity of infectious agents, including malaria is apparent at all spatial 
scales and levels of transmission intensity although it is most pronounced where 
transmission is low. [1, 2] Across all levels of transmission intensity, a substantial 
proportion of malaria infections are asymptomatic and often present at densities 
below the threshold for detection by microscopy or rapid diagnostic tests (RDT) [3-6]
[Cook]. Whilst not associated with (acute) clinical symptoms, a proportion of these 
infections may progress to clinical disease [7] and can also produce gametocytes 
and thereby contribute to onward malaria transmission. [2, 8, 9] It has been argued 
that for programs to sustainably reduce or eliminate malaria transmission, the 
asymptomatic and subpatent reservoir must be detected and targeted. [8, 10, 11]
[Cook] The detectability of malaria infections in malaria endemic countries is related 
to malaria parasite density that is associated with acquired malaria immunity. [12-
14] Consequently, infections are most likely to be detected by microscopy or RDT in 
children and in symptomatic infections, whilst asymptomatic adults are more likely 
to carry infections at subpatent densities. [4, 14, 15]
There are two commonly advocated approaches to include asymptomatic malaria-
infected individuals in treatment campaigns: mass screening and treatment (MSAT) 
and mass drug administration (MDA). MSAT campaigns typically test all individuals, 
using either RDT or microscopy, and treat individuals that test positive. [16] The success 
of MSAT campaigns is greatly influenced by the sensitivity of the diagnostic. In low 
transmission settings in particular, a considerable proportion of infections is missed 
during MSAT campaigns because many infections are present at densities below the 
detection limit of the diagnostic methods commonly used. [9, 17, 18] Onward malaria 
transmission from these subpatent infections was considered the most plausible 
explanation for a recent failure of RDT-based MSAT campaigns to sustainably reduce 
malaria transmission in the pre-elimination setting of Zanzibar [Cook].
Community-based mass drug administration (MDA) campaigns avoid the problem 
of imperfect diagnostics by treating without prior diagnosis. However, MDA in low 
endemic settings would administer medication to individuals whom are not infected 
with malaria nor will have any benefits of the prophylactic effect of drugs due to 
the low exposure. [19, 20] Based on the limited success of MDA approaches under 
research conditions and the risk of increasing drug pressure that is associated with 
the spread of drug resistant strains of parasites,[19, 21] the use of MDA in malaria has 
received limited support. [1, 20] Alternative strategies are required that are capable 
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of targeting the entirety of the parasite population while being operationally 
feasible in malaria endemic communities. 
Malaria infections are known to cluster at the household level and it has been shown 
that asymptomatic parasite carriers are more likely to reside in households when a 
symptomatic case occurs in the same household. [16, 22-24] For example, in Zambia, 
it was found that prevalence of malaria in households with a symptomatic case was 
8.0% compared to <1.0% in households without a symptomatic case. [24] Similarly 
in Senegal, it was found the risk of being parasite positive was more than three times 
higher when residing in a household with a symptomatic case. [23] This suggests 
that a hybrid approach in which focal mass drug administration is guided by the 
occurrence of positive (index) cases detected by screening of a sentinel population 
may represent an efficient method of maximizing the number of infections treated 
whilst limiting the total number of antimalarials distributed and thereby drug 
pressure. [11, 16, 21] We aimed to determine the potential of this approach and 
identify the most appropriate definition of a sentinel population that balances the 
number of individuals screened against the proportion of the parasite reservoir 
identified and to ascertain factors associated with its sensitivity. 
METHODS 
Study area
This study was undertaken in a previously described study site in Rachuonyo South 
District, western Kenyan highlands [34.75 to 34.95°E, 0.41 to 0.52°S] with elevation 
between 1400-1600 m. The landscape is intersected with rivers and rolling hills and 
is characterised by marked variations in elevation within a small area. [25] Malaria 
transmission intensity is generally low but is highly heterogeneous. [26] Plasmodium 
falciparum is the predominant malaria parasite and transmission follows a bimodal 
pattern associated with the peaks in rainfall. Five areas within this 100 km2 area with 
evidence of on going malaria transmission [25] were selected for the current study 
(figure 1). 
Ethical Review and Approval
The study was approved by the ethical committees of the London School of Hygiene 
& Tropical Medicine (Ref: LSHTM 5956) and the Kenya Medical Research Institute 
(Ref: SSC 2163 & SSC 2495). Individual informed consent was sought from all eligible 
participants. Consent for children under the age of 18 was provided by a parent/
guardian and children between 14 and 17 years also provided written assent. 
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Participants below 18 years of age who were pregnant, married, or a parent were 
considered “mature minors” and consented for themselves. [27] 
Data Collection
All residents were enumerated and households were assigned spatial coordinates 
with handheld global positioning system receivers (Garmin 62S; Garmin 
International, Inc., Olathe, KS, USA). In March 2012, prior to the main malaria 
transmission season [25], all households were visited and information obtained 
on standard malaria indicators and socio-economic factors. Tympanic temperature 
was measured (Braun Thermoscan, Braun, USA); those with a temperature >37.5 °C 
were considered febrile. All individuals between 6 months and 15 years as well as 
febrile adults were tested for malaria infections using a RDT (First Response, Premier 
Medical Corporation Ltd., Kachigam, India). This definition of the sentinel population 
was based on previous evidence that these groups have the highest proportion of 
infections with detectable parasite densities.[4, 14, 28] All RDT-positive cases were 
provided treatment according to national guidelines. Blood spotted on filter paper 
(Whatmann 3MM, Maidstone, UK) was collected from all consenting participants ≥ 
6 month of age and stored at room temperature. For gametocyte detection, 100 
μl of whole blood in nucleic acid stabilizer (Angora buffer, Avantor Performance 
materials, Deventer, the Netherlands) was collected from all individuals in three of 
the five localities and stored for up to one week at -20 ˚C and subsequently at -80˚C. 
Laboratory Analysis
Filter paper samples were analysed for malaria infection using nested polymerase 
chain reaction (nPCR) targeting the P. falciparum 18S rRNA gene [29, 30] after Chelex-
Saponin extraction. [29] All nPCR-positive samples were tested for the presence of 
multiple clonal infections based on the Merozoite Surface Protein-2 (MSP2) genetic 
variant using capillary electrophoresis; [31] samples were analysed with Peak Scanner 
(Applied Biosystems, CA, USA, version 1.0) and unique clones were determined to 
be any discrete peaks greater the background noise for each plate. For the three 
localities where whole blood samples were collected, total nucleic acids were 
extracted for all nPCR-positive samples using the MagNA Pure LC Total Nucleic Acid 
Isolation Kit (Roche, Switzerland) on an automated extractor (MagnaNA Pure LC 2.0). 
The presence of gametocytes was determined by detection of gametocyte specific 
PfS25 mRNA by Nucleic Acid Sequence-Based Amplification (NASBA). [32] 
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Statistical Analyses
The sensitivity and specificity of different sentinel definitions was determined at the 
household level (i.e. the proportion of all households with nPCR detected infections 
that was correctly identified) and the individual level (i.e. the proportion of all 
individuals with nPCR detected infections that was correctly identified). Five sentinel 
populations for RDT screening were defined: i) all household occupants ≤5 years; ii) 
all occupants ≤15 years; iii) all occupants ≤5 years and any febrile individual in other 
age groups; iv) all occupants ≤15 years and any febrile individual in other age groups; 
v) only febrile individuals. If at least one individual in this sentinel population was 
found to be parasitaemic by RDT, all household members were considered ‘infection 
positive’ (and therefore eligible for treatment). In addition, the sensitivity of a sixth 
approach was determined in which RDTs were not used but all household members 
were considered infection positive if there was ≥ 1 febrile household member. 
Analysis was conducted using STATA (v12.0, STATA Corps, Texas USA) and R (v. 3.0.2, 
The R Foundation, Boston, USA). Principal component analysis was used to determine 
socio-economic status for each household and resulting scores were divided into 
quintiles.[33] Buffer zones of 50, 100, and 250 m around each household were 
calculated using ArcGIS (version 10.2, ESRI, California USA). The mean number of 
allelic types present in each infected individual was determined and corresponding 
95% CI were calculated assuming a zero-truncated poison distribution. Logistic 
regression was used to assess associations with RDT positivity in the nPCR positive 
sentinel population adjusting for clustering within localities. A finite population 
correction factor was applied to the standard error for all statistics and the corrected 
95% confidence intervals (CI) were calculated. 
RESULTS
In total, 2082 individuals were sampled in 401 households (locality range [range]: 
233-635), representing 94.2% (range: 90.8-100.0%) of all households (table 1). There 
was no significant difference in age, proportion of females, or reported recent travel 
between the localities. Bednet use the previous night was reported by 71.5% of 
participants (range: 53.4-77.4%). Overall, 1203 individuals were screened for malaria 
by RDT based on their age (≤ 15 years, n=1158) or febrile status (n=45) and 24.9% 
(95% CI: 24.3-25.5%; range: 6.7-48.6%) were RDT-positive. 
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Of all participants, 23.5% (95% CI: 23.1-24.0, range: 11.7-38.9) were parasitaemic by 
nPCR, the mean number of allelic forms per infection (MOI) was 2.22 (95% CI: 2.18-
2.25, range 1.61-2.61) and 65.0% (n=249; Range: 64.0-84.6%) of the 383 nPCR-positive 
individuals tested harboured gametocytes. Parasite prevalence (35.6%, 95% CI: 34.8-
36.4 vs. 12.3%; 95% CI: 11.7-12.9%; p<0.001) and MOI (2.33, 95% CI: 2.28-2.38 vs. 1.95, 
95% CI: 1.86-2.04; p<0.001) were significantly higher in the 5-15 year old population 
compared to those 16 years of age and older, respectively. Parasite prevalence in 
5-15 year olds was also significantly higher compared to those <5 years (17.3%, 95% 
CI: 16.3-18.2%; p<0.001) but MOI was not significantly different (2.24, 95% CI: 2.21-
2.34; p=0.105). For individuals tested by RDT, MOI was significantly greater in patent 
infections (2.48, 95% CI: 2.42-2.53) compared to subpatent infections (1.95, 95% 
CI: 1.87-2.02; p<0.001). Of all nPCR-positive children ≤15 years old, 29.9% (95% 
CI: 28.7-31.1%) had subpatent infections.
Identifying parasite positive households through sentinel 
populations
Overall, 42.4% of the 401 households surveyed had no infections and there were 8 
households (2.0%) where all members were nPCR-positive (supplementary figure 1A). 
Individuals who were RDT-negative or not screened by RDT were significantly more 
likely to be nPCR-positive if there was a RDT-positive individual in their household 
(OR: 1.71, 95% CI: 1.60-1.84); the odds of being nPCR-positive increased with the 
number of RDT-positive individuals within a household (supplementary table 1). Of 
the six definitions of sentinel population, testing those ≤15 years or febrile adults 
achieved the highest sensitivity and specificity for detecting the parasite reservoir 
(table 2): at the household level, sensitivity was 64.5% (range: 31.6-81.2) with a 
specificity of 90.6% (range: 82.3-94.9); at the individual level sensitivity was 77.3% 
(range: 24.2-91.0) and specificity was 55.7% (range: 31.3-85.1) (table 2). 
Correctly and incorrectly classified households appeared evenly distributed 
throughout the area with little variation between the best (locality 1) (figure 2A) 
and worst performing locality (locality 5) (figure 2B). Because 82 households with 
244 nPCR-parasite positive individuals were not identified as infection positive, we 
determined the impact of extending the focal treatment response to include buffer 
areas around RDT-positive sentinel cases on sensitivity and specificity. Based on the 
94.2% of eligible compounds sampled, the median distance for households that were 
incorrectly classified as parasite-free (parasite positive individuals by nPCR but not 
by RDT in the sentinel population) from the closest household with an RDT-positive 
sentinel case was 85.1 m (IQR: 56.9 – 147.3 m). The addition of buffer zones around 
targeted households improved the sensitivity, but the specificity was greatly reduced 
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Definition 
of Sentinel 
Population
RDT test ≤5 
years 
RDT test ≤15 
years 
RDT test ≤5 
years and any 
febrile cases
RDT test ≤15 
years and any 
febrile cases
RDT test febrile 
cases 
No RDT, febrile 
cases
% Range % Range % Range % Range % Range % Range
Household Level
Sensitivity 26.0 10.5-36.5 64.1 31.6-80.0 28.1 10.5-41.2 64.5 31.6-81.2 6.5 0-10.6 13.8 5.3-15.0
Specificity 95.3 93.9-97.4 90.6 82.3-97.4 95.3 93.9-97.4 90.6 82.3-94.9 99.4 97.4-100.0 91.8 87.2-95.8
Individual Level
Sensitivity 39.1 9.1-51.3 76.9 24.2-90.1 41.7 9.1-56.3 77.3 24.2-91.0 10.4 0-13.9 18.0 12.1-20.5
Specificity 81.3 71.3-93.9 55.8 31.6-85.1 81.8 71.4-93.9 55.7 31.3-85.1 95.1 91.9-98.3 86.0 81.1-90.7
Table 2: The sensitivity and specificity of sentinel populations to detect the parasitaemic 
reservoir. The sensitivity and specificity of different sentinel populations at the household level 
(i.e. the proportion of all households with nPCR detected infections that was correctly identified) 
and at the individual level (i.e. the proportion of all individuals with nPCR detected infections that 
was correctly identified). All household occupants in the sentinel population were screened and all 
household members were considered infection positive if one individual in the sentinel population 
recorded a positive result (either RDT or fever). The approach with the highest sensitivity is indicated 
in bold.
Table 1: Population Demographics. Demographics of the study population including the number of 
people sampled overall, the range of values per locality and for parasite metrics, the 95% confidence 
interval. 
Mean Locality Range
Population Characteristics
Households Sampled (%) 94.2 90.8 - 100.0
N Sampled 2082 233 - 635
Sex (% Male) 45.3 43.1 - 47.3
Reported Net Use 71.5 53.4 - 77.4
Parasite  Metric
nPCR prevalence 23.5 11.7 - 38.9
<5 17.3 9.8 - 32.1
5-15 35.3 14.0 - 59.5
>15 16.4 8.2 - 25.5
MSP2 – MOI* 2.22 1.61 - 2.61
<5 2.24 1.33 - 2.60
5-15 2.34 1.54 - 2.81
>15 1.95 1.72 - 2.23
* N=489 nPCR-positive
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beyond 50 m and the addition of a 150 m buffer resulted in the inclusion of nearly 
every household as infection positive; thereby resulting in an approach similar to MDA 
if this definition was used to target antimalarial drugs (supplementary figure 2).
Factors associated with parasite carriers being correctly identified vs. 
missed
The number of RDT-positive individuals in the sentinel population ranged between 
1 and 12 per household and larger households were more likely to have RDT-positive 
cases (p<0.001). In the 165 households with RDT-positive individuals, 52.1% had one 
and 31.5% had two RDT-positive individuals. The majority of RDT-positive individuals 
were under 15 years old (96.7%), but the age ranged from 6 months to 82 years 
(supplementary figure 1B). Of the households with a single index case, the median 
age of the RDT-positive individual was 13 (range: 6 months to 82 years). Overall, 
PCR prevalence (35.0%, 95% CI: 34.3-35.6% vs. 11.1%, 95% CI: 10.7-11.6%; p<0.001) 
and MOI (2.35, 95% CI: 2.31-2.40 vs. 1.76, 95% CI: 1.71-1.81; p<0.001) was higher in 
correctly identified compared to missed households, respectively. Sensitivity was 
associated with the average nPCR parasite prevalence in the locality and with the 
proportion of infections in the sentinel population that were subpatent (table 3). 
In the households where parasite carriers were missed due to no RDT-positive test 
result, 43.5% (95% CI: 47.5-51.7% range: 25.0-73.3) of nPCR-positive individuals were 
≤ 15 years of age (figure 3), indicating subpatent parasite carriage in the sentinel 
population. The odds of individuals in the sentinel population being correctly 
identified increased if they reported fever in the past 24 hours (Adjusted Odds Ratio 
[AOR] 1.56, 95% CI: 1.25-1.95); had higher temperature (AOR 1.81 [per °C], 95 CI: 
1.58-2.07) and; had a greater number of parasite clones (AOR 1.26 [per clone], 95% 
CI: 1.16-1.37) (table 4). Whereas, females (AOR 0.73, 95% CI: 0.57-0.92) and those 
reporting having taken antimalarial drugs in the two weeks prior to the survey (AOR: 
0.69, 95% CI: 0.53-0.90) were more likely to have a subpatent infection and therefore 
be missed. 
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Figure 2: Maps of FSAT Sensitivity. Locality with the A) highest and B) lowest proportion of the 
parasite reservoir identified using the FSAT approach. Dots represent each household screened as 
part of this study including those households that had nPCR-positive individuals but were missed 
by the best definition of sentinel population (black circle), those that were correctly identified 
as infection positive (grey triangle) and those that were correctly classified as infection negative 
(black cross). 
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Locality 1 2 3 4 5 p-value
N Households 109 120 73 42 57 -
N Individuals 571 635 365 233 278 -
Sensitivity - nPCR 
Household 81.2 66.1 55.0 44.0 31.6 -
Individual 91.0 76.2 69.9 61.5 24.2 -
Parasite Metrics
nPCR prevalence (95% CI) 38.9 
(38.0-39.9)
19.4
(18.6-20.1)
20.0
(19.1-21.0)
16.8
(15.6-18.0)
11.7
(10.8-12.6)
0.037
Estimated microscopy parasite prevalence 
[4] (95% CI)*
16.5 
(13.6-20.0)
6.1
(4.6-7.9)
6.3
(4.6-8.7)
5.0
(3.3-7.5)
3.2
(2.0-5.0)
-
Subpatent infections** in sentinel 
population (%)
39.2 
(37.6-40.7)
48.4 
(46.2-50.5
65.7
(63.1-68.4)
59.0
(55.2-62.7)
81.8
(78.6-85.0)
0.037
MOI (95% CI) 2.61 
(2.55-2.67)
1.89 
(1.83-1.96)
1.88
(1.79-1.96)
2.32
(2.20-2.45)
1.61
(1.51-1.72)
0.188
Demographic Indicators
Mean altitude (range) 1449.0 
(1417-1478)
1422.8 
(1396-1443)
1495.9 
(1458-1518)
1465.1 
(1447-1477)
1535.2 
(1512-1560)
0.104
Economic status, % in lowest SES quintile 19.1 12.6 14.7 18.2 23.5 0.505
Age, % ≤15y 54.5 57.7 54.2 57.9 53.5 0.391
Fever, % febrile individuals 2.6 2.4 2.5 1.7 2.5 0.492
* Microscopy parasite prevalence was estimated based on nPCR data based on a published mathematical 
model to illustrate transmission intensity in the different localities; statistical testing was not performed 
since this was a derived variable.
** nPCR positive infections that were RDT negative
Table 4: Individual factors with RDT-positivity in nPCR-positive individuals. Results of logistic 
regression to identify factors associated with RDT-positivity in nPCR-positive individuals in the 
sentinel population by. 
Univariate Adjusted
OR 95% CI p-value AOR 95% CI p-value
Gender
Male 1.0 - - 1.0 - -
Female 1.06 0.99-1.13 0.095 0.73 0.57-0.92 0.008
Fever in preceding 24 hours 1.66 1.52-1.82 <0.001 1.56 1.25-1.95 <0.001
Bednet use previous night 0.89 0.82-0.96 0.005 2.31 1.86-2.87 <0.001
Open Eaves 1.88 1.62-2.19 <0.001 1.82 1.33-2.49 <0.001
Temperature in °C 1.44 1.36-1.53 <0.001 1.81 1.58-2.07 <0.001
Reported use of antimalarials in  
the preceding 2 weeks
1.11 1.03-1.19 0.003 0.69 0.53-0.90 0.007
Complexity of infection, mean number  
of MSP-2 clones
1.28 1.23-1.34 <0.001 1.26 1.16-1.37 <0.001
Table 3: Locality level factors associated with screening approach sensitivity. Parasite and 
demographic data per locality ordered by the sensitivity at household/individual level for the 
optimum definition of sentinel population (testing those ≤ 15 years and febrile adults). 
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CONCLUSIONS
Including the asymptomatic and subpatent parasite reservoir of infection in control 
measures is predicted to considerably augment efficiency [4][Cook] but sensitive 
and operationally attractive strategies to identify these individuals are needed. 
Here, we determine the value and limitations of a viable operational approach 
in which individuals who are most likely to harbour parasite densities detectable 
by conventional diagnostics (ie. in this setting, children and those with fever), are 
screened by RDT to identify foci of subpatent parasite carriage in residents of the 
same household. 
Focal MDA campaigns have been used in areas of heterogeneous malaria 
transmission [34] but there have not been any attempts to determine the value of 
this approach in guiding household-level treatment where considerable clustering 
of malaria infections is likely. [35] The presence of RDT-positive individuals in the 
Figure 3: Detectability of infections in the sentinel age population. Prevalence of nPCR infection 
by age group in the sentinel population (aged 0.5-15 years and febrile adults). Bars indicate whether 
these infections were detected by RDT (black) or whether these were RDT-negative but present 
in households with RDT-positive individuals (light grey) or RDT-negative without RDT-positive 
household members (dark grey). Error bars indicate the 95% confidence interval for total nPCR 
parasite prevalence by age. 
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sentinel population was highly predictive of nPCR prevalence in individuals who 
were RDT-negative or not screened by RDT, confirming household-level clustering of 
malaria. [16, 36] We showed that the majority of individuals that were nPCR-positive 
for asexual parasites also had concurrent gametocytes; illustrating their potential 
role in onward malaria transmission. [37] 
We showed that in our setting, screening those ≤15 years and febrile adults with 
a conventional RDT identified over 75% of the patent and subpatent parasite 
infections while minimizing the administration of antimalarial drugs to non-infected 
individuals. If we had conducted focal MDA in all identified households, only one-
third of all uninfected individuals would have received treatment. This approach 
would have been considerably more sensitive than strategies used in Zanzibar 
and Burkina Faso where infection was detected at an individual level by RDT and 
no attempt was undertaken to target subpatent parasite carriage in household 
members of RDT positive individuals [Tiono; Cook].By comparison, if a full MDA 
approach had been used in our setting, three quarters of the total population would 
have received treatment despite not having a current infection. There are known 
risks and expenses associated with overtreatment and the use of antimalarial drugs 
should ideally be targeted to those with infection and at risk of infection. [19, 21]
Our approach to screen individuals most likely to have infections at densities 
detectable by RDT [38, 39] did not result in the detection of all parasite positive 
households or individuals. Although RDT screening of all age groups might be 
advocated, recent studies have shown that this approach is unlikely to result in 
complete uptake [18] and will not detect all infections.[40] Furthermore, individuals 
with subpatent infections in the sentinel population were more likely to be younger 
and have less complex infections suggesting that the infections that were missed 
had lower parasite densities. Although the association of subpatent parasite 
carriage with reported drug use suggests that a fraction of RDT- and nPCR-positive 
individuals may be older infections with persisting gametocyte populations [41], 
this is unlikely to have affected our main outcomes and the HRP-2 based RDT is likely 
to have a similar issue with positive results after clearance of asexual infections. The 
risk of missing infections due to fluctuating parasite densities and the single time-
point of sampling was also minimised by use of an HRP-2 based RDT. [42] 
In this study it was striking that there was a high prevalence of subpatent infections 
in the youngest age groups [Cook]; particularly in localities with the lowest average 
parasite prevalence. These findings indicate that even in low endemic settings and 
young age groups, molecular or alternative diagnostics may be required to detect 
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all parasitaemic individuals. [4, 17][Cook] If we had used nPCR to test the sentinel 
population (≤ 15 years and febrile individuals), we would have achieved a sensitivity 
of 89.2% and a specificity of 50.9% to detect all nPCR-positive individuals in our 
study setting. It is currently unknown what coverage of the parasite populations is 
needed to achieve sustainable reductions in transmission. In addition, it is unknown 
to what extent that the impact of our screening approach may have been maximized 
by an iterative approach where repeated screening with RDTs followed by focal MDA 
may progressively reduce the parasite biomass in the population. However, our 
findings indicate that any screening and treatment approaches to reduce malaria 
transmission would benefit from field-deployable molecular diagnostics. 
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Supplementary Figure 1: Parasite prevalence per household (A) and age characteristics of 
index cases (B) A) The frequency distribution of the proportion each sampled household that was 
positive for malaria parasites by nPCR. B) Frequency distribution of the ages of the RDT-positive index 
cases for the entire sentinel population as well as for the households where only one RDT-positive 
individual was found.
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Supplementary Figure 2: Impact of includingFigure all households located within a defined buffer 
distance (numeric labels) around households identified as infection positive. The true and false 
positivity rate for coverage of the parasite populations was estimated at each buffer distance (50 – 
250 m) if positive households were considered those with an RDT- (light grey circle) or nPCR- (dark 
grey diamond) positive case in the sentinel population.
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ABSTRACT
Background
Malaria transmission is highly heterogeneous, generating malaria hotspots that can 
fuel malaria transmission across a wider area. Targeting hotspots may represent an 
efficacious strategy for reducing malaria transmission. We determined the impact 
of interventions targeted to serologically defined malaria hotspots on malaria 
transmission both inside hotspots and in surrounding communities. 
Methods & Findings
Twenty-seven serologically defined malaria hotspots were detected in a survey 
conducted in 2011 that included 17,503 individuals from 3,213 compounds in a 100 
km2 area in Rachuonyo South district, Kenya. In a cluster-randomized trial in 2012, 
we randomly allocated 5 clusters to hotspot-targeted interventions with larviciding, 
distribution of long-lasting insecticide-treated nets, indoor residual spraying and focal 
mass drug administration (total of 1,590 compounds); 5 control clusters received malaria 
control following Kenyan national policy (total of 1,794 compounds). Our primary 
outcome measure was parasite prevalence in evaluation zones up to 500 m outside 
hotspots, determined by nPCR at baseline and 8 and 16 weeks post-intervention. 
Secondary outcome measures were: parasite prevalence inside hotpots, parasite 
prevalence in the evaluation zone as function of distance to the hotspot boundary, 
Anopheles mosquito density, mosquito breeding site productivity, malaria incidence by 
passive case detection and the safety and acceptability of interventions. Intervention 
coverage exceeded 87 % for all interventions. Hotspot-targeted interventions did not 
result in a change in nPCR parasite prevalence outside hotspot boundaries (p≥0.187). 
We observed an average reduction in nPCR parasite prevalence of 10·2% (95% CI -1·3 – 
21·7%) inside hotspots 8 weeks post-intervention that was statistically significant after 
adjustment for covariates (p=0·024), but not after 16 weeks. Our trial was not powered 
to detect subtle effects of hotspot-targeted interventions nor designed for effects of 
interventions over multiple transmission seasons.
Conclusion:
Despite high coverage, the impact of interventions targeting malaria vectors and 
human infections on nPCR parasite prevalence was modest, transient and restricted 
to the targeted hotspot areas. Our findings suggest that transmission may not 
primarily occur from hotspots to the surrounding areas and that areas with highly 
heterogeneous but widespread malaria transmission may currently benefit most 
from an untargeted community-wide approach. Hotspot-targeted approaches may 
have more validity in settings where human settlement is more nuclear.
Trial registration: www.ClinicalTrials.gov NCT01575613
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Introduction
The transmission of many infectious agents, including malaria, is highly heterogeneous 
in space and time. In the last decade, considerable efforts have been made to better 
estimate the global and local burden of malaria. At a micro-epidemiological scale in 
endemic areas, numerous factors influence malaria transmission dynamics including 
distance to the nearest mosquito breeding site [1-4], wind direction [5], vegetation 
[6], house construction features [1,3,4] and human genetic [2,3,7] and behavioural 
factors [1-3,8]. Variations in these factors over a small area can result in spatially 
heterogeneous transmission and can result in malaria hotspots, where transmission 
intensity is higher than in the surrounding areas. These malaria hotspots may be 
present in all malaria endemic areas but are most readily identifiable in areas of low 
transmission intensity where malaria incidence, parasite prevalence and mosquito 
exposure may be elevated inside hotspots [5,6,9]. 
Malaria control efforts targeted to transmission hotspots may have benefits for both 
the targeted area and the wider community. Mosquito densities are highest in hotspots 
and individuals in hotspots may amplify transmission by transmitting malaria parasites 
to a large number of mosquitoes that fuel transmission to wider areas. This amplified 
transmission can lead to 1·5- to 4-fold increases in the basic reproductive number of 
malaria parasites [9-11]. Successful targeting of malaria control efforts to hotspots 
may therefore be a highly efficient method to reduce malaria transmission in a wider 
area and achieve community protection by eliminating transmission in a relatively 
small geographical area [9,11,12]. Such targeted interventions are likely to become 
increasingly important tools in malaria elimination efforts once transmission in an area 
has decreased but is maintained in hotspots of malaria transmission [13]. We identified 
hotspots of malaria transmission in a hypoendemic area in the western Kenyan 
highlands, using a detailed community survey with 17,503 individuals from a 100 km2 
area (approximately one third of the population). We then selected hotspots for random 
allocation to conventional control methods, as conducted by the Kenyan Division of 
Malaria Control, or hotspot-targeted interventions. Our hotspot-targeted interventions 
comprised three vector control methods: distribution of long lasting insecticide treated 
nets (LLINs), indoor residual spraying (IRS) and weekly larviciding of all waterbodies in 
hotspots. In addition, we conducted a single round of focal mass drug administration 
(MDA) with a curative dose of antimalarial drugs in an attempt to clear a large fraction of 
the human parasitaemic reservoir. We hypothesized that these combined interventions 
would drastically reduce malaria transmission not just inside the hotspots themselves 
but also in adjacent areas. Our primary outcome measure was the effect of hotspot-
targeted interventions in evaluation zones surrounding malaria hotspots. 
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Material and Methods
The original protocol for the cluster randomized trial (Protocol S1) and the supporting 
CONSORT checklist (Checklist S1) are provided as supporting information. A detailed 
study protocol was previously published [14].
Ethics Statement
This study was approved by the ethical committees of the London School of 
Hygiene and Tropical Medicine (LSHTM 5721) and the Kenya Medical Research 
Institute (SSC 1802/2163/2495). Consenting procedures are described in detail 
elsewhere [14]. Prior to the community survey (2011) and randomization for the 
cluster randomized trial (2012), community sensitization meetings were organized. 
Informed written consent was sought from all individuals participating in surveys 
or, where appropriate, their parents or guardians. Written assent was obtained from 
all children aged 13-17 years; accompanied by a consent form signed by the parent 
or guardian. Prior to indoor residual spraying (IRS) and the distribution of long-
lasting combination insecticide-treated nets (LLINs), written informed consent was 
obtained from the head of compound. Prior to focal MDA, individual written consent 
and/or assent was obtained. Larviciding commenced after written approval from 
the Division of Malaria Control and Kenyan Pest Control Product Board and with the 
oral approval of the district administrative, fisheries and persons responsible for any 
privately owned permanent water bodies such as fishponds. The trial was registered 
online under NCT01575613.
Study area and population 
A 5 x 20 km study area located at 1400 m to 1650 m above sea level was selected in 
Rachuonyo South District, western Kenya (34.75-34.94 ºE, 0.41-0.53 ºS.) and divided 
into 500 x 500 m cells (Figure 1). Compounds in the study area are distributed 
broadly across a rolling landscape intersected by streams and rivers; compounds 
typically comprised of a median of two houses (25th to 75th percentile (interquartile 
range, IQR) 1 to 3) and 5 inhabitants (IQR 3 to 7). Malaria transmission in the area 
is seasonal and associated with seasonal rains that typically peak between March 
and June and between October and November. Transmission intensity in the study 
area is generally low; mean parasite prevalence in community surveys in 2010 by 
rapid diagnostic test (RDT) was 10% with marked spatial heterogeneity [14,15]. The 
principal malaria vectors are Anopheles gambiae s.s., A. arabiensis and A. funestus [16]. 
The Ministry of Public Health and Sanitation has been involved in the distribution of 
insecticide treated nets (ITN) in the area for many years; ITN ownership in children 
below 5 years of age was 82.7% in 2010 [15]. Since 2009, the Division of Malaria 
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Figure 1. The study area in the highlands of western Kenya. The study area comprised a 5 x 20 km 
rectangle in Rachuonyo South District, Nyanza Province.
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Control (DOMC) has carried out annual indoor residual spraying (IRS) campaigns 
with pyrethroids in structures that serve as sleeping spaces, reaching ≥70% of all 
compounds [14]. 
Study design
Community survey and hotspot detection
Procedures for hotspot detection and the cluster randomized trial are described in 
detail elsewhere [14]. We imported geo-location data of all structures in the study 
collected from high-resolution satellite data (Quickbird; DigitalGlobe Services, Inc., 
Denver, CO, US) into a geographical information system (ArcGIS 9.2; Environmental 
Systems Research Institute, Redlands, CA, US). Manually digitizing structures yielded 
8,632 structures with a median of 45 structures (IQR 35-52) per cell. For hotspot 
identification, we carried out a community survey in 2011 to obtain measurements 
from ≥ 50 individuals per cell; sampling in equal ratios from predefined age strata 
(≤5 years, 6-10 years, 11-15 years, 16-25 years and >25 years). Twenty field teams 
consisting of 1 enumerator, 1 field worker and 1 person trained for blood sample 
collection were equipped with high-resolution maps and a handheld global 
positioning system (GPS) receiver (Garmin 62S; Garmin International, Inc., Olathe, 
KS, US) with preloaded waypoints for 16 randomly selected compounds and cell 
boundaries. Compounds were eligible for sampling if at least one adult and one 
child (<15 years) were permanent residents (defined as sleeping regularly in the 
structure) and written informed consent was obtained. If compounds did not satisfy 
these criteria the nearest non-selected inhabited compound was selected as a 
replacement. Participating individuals in the community survey were screened by 
axillary thermometer for fever and those with fever tested by rapid diagnostic test 
[RDT; HRP-2, Paracheck®, Orchid Biomedical Systems, Goa, India] for on-site malaria 
diagnosis and treatment with Artemether-Lumefantrine (AL, Coartem, Novartis, 
Switzerland) if RDT positive. Febrile individuals who were RDT negative, pregnant or 
below 6 months of age were accompanied to a local health facility for a full clinical 
assessment and treatment.
Finger prick blood was collected from all participants on filter papers [3MM Whatman, 
Maidstone, UK]. Filter papers were stored with dessicant at -20 °C until used to detect 
antibodies against P. falciparum apical membrane antigen-1 (AMA-1) and merozoite 
surface protein-1 (MSP-119) using established ELISA methodologies [17,18] and to 
detect parasite prevalence by nested polymerase chain reaction (nPCR) targeting 
the 18S rRNA gene [18]. All molecular and serological assays for the 2011 community 
survey were conducted at the KEMRI-CDC laboratories in Kisian, Kenya. Because of 
the labour intensiveness, resource intensiveness and necessity to obtain results on 
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nPCR parasite prevalence prior to hotspot selection, nPCR was only performed on a 
random selection of samples (12,912/16,381). Data on demography, travel behaviour, 
sleeping times, history of malaria treatment and use of protective measures were 
collected on a personal digital assistant (HP Ipaq 210, Windows Mobile 6.1) with a 
pre-coded questionnaire programmed in Visual Basic (Visual CE v11.0). 
Spatial scanning for hotspot detection
Using data from this community survey, we screened for local clustering of 
seroreactivity using SaTScan software [19]. Spatial scans were based on the 
prevalence of antibodies to either AMA-1 and/or MSP-119 (Bernouilli model) and 
log10-transformed optical density values AMA-1 and MSP-119, where the highest age-
adjusted optical density value for either antigen was used in a normal probability 
model. Circular and elliptic windows were used to systematically scan segments of 
the study area using a 2 x 4 km rolling window, allowing for a hotspot size <1 km 
radius and <25% of the population of each window scanned. This rolling window 
was chosen since malaria transmission was expected to show considerable variation 
with altitude, as well as micro-epidemiological variation within altitude bands. We 
thus scanned sections of the study area for variations in antibody prevalence and 
density compared to local average values. A hotspot was defined as an area for 
which there was strong evidence (p<0·05) that the observed prevalence and density 
of combined AMA-1 and MSP-119 antibodies was higher than expected values as 
calculated from the prevalence within the rolling window [14]. nPCR data were not 
used for screening for local clustering or hotspot detection but were used to detect 
current infections in serologically defined hotspots and thereby confirm ongoing 
malaria transmission in these localities.
Cluster randomized trial on the effect of hotspot-targeted 
interventions
Sample size
In the absence of published studies that quantified the impact of hotspot-
targeted interventions, we estimated the predicted impact of our interventions 
using an individual-based simulation model [20]. Simulations on hotspot-targeted 
LLIN distribution and IRS implementation indicated the possible interruption of 
transmission, both inside and outside malaria hotspots, reducing overall parasite 
prevalence to <5%, in a manner that is apparent in the first season and sustainable 
in the following years [14]. A previous study on the community benefits of ITNs 
indicated that the indirect beneficial effect on malaria transmission is most 
pronounced within 500 m of the intervention area [21]. We used these findings 
to design our trial and define evaluation zones that were dichotomized into two 
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categories based on distance to the hotspot boundary (1-249 m and 250- 500 m). 
Assuming a sample of 200 randomly selected individuals in the evaluation zone of 
each cluster, a coefficient of variation of true proportions between clusters within 
each group (k) of 0·4 and mean nPCR parasite prevalence of 15% and 5% in the 
control and intervention clusters respectively, would require five clusters per study 
arm for 80% power at the 5% significance level. 
Randomization
Clusters were serologically defined hotspots with a surrounding 500 m evaluation 
zone. Hotspots were eligible for the intervention trial if no other hotspots were 
detected within 1·0 km of the border of the evaluation zone. Ten selected clusters 
were allocated to the intervention or control arm by a trial statistician using computer 
generated random tables. 
Intervention
In the intervention arm four interventions were concurrently rolled out inside 
hotspots, starting in March 2012 before the long rainy season. 
i) All stagnant water bodies (permanent and temporary) were treated on a weekly 
basis with water-dispersible granule formulations of the commercial strains of 
Bacillus thuringiensis var. israelensis (Bti; VectoBacW, Valent BioSciences Corp., 
Libertyville, IL) [22] by a team that was permanently present in the hotspot with 1 
supervisor per cluster. Larviciding continued from March to August 2012. 
ii) One long-lasting combination insecticide-treated net (LLIN, PermanetW 3·0; 
Vestergaard Frandsen, Hanoi, Vietnam) was provided per two compound members 
by a team of 2 field workers per cluster. Leaflets with instructions in local dialect 
about correct usage and verbal explanations were provided. The use of LLINs was 
confirmed in a follow-up visit 6 to 8 weeks after initial distribution during which 
the presence and quality of study LLINs were observed and replacement LLINs 
issued if required. Any adverse events following net use were recorded by the 
study team and care given as needed.
iii) IRS with the pyrethroid insecticide lambda- cyhalothrin (ICON™, Syngenta®) was 
performed by district teams in all eligible compound structures and supervised by 
2 study staff per intervention cluster. Sensitization visits were undertaken prior to 
the visits of IRS teams to maximize the presence of compound members on the 
days of spraying and to maximize participation. Adverse events associated with the 
insecticides used in intervention compounds were reported to the study team.
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iV) All compounds were visited to determine whether they were eligible for focal 
MDA as described in detail elsewhere [23] andasA sentinel population of all 
febrile individuals (tympanic temperature >37·5 °C) and all individuals aged 6m-
15 years was screened for malaria infection by RDT (HRP-2 and pLDH based First 
Response W, Premier Medical Corporation Ltd., Kachigam, India). If ≥1 compound 
member was RDT positive, all compound members received a curative dose of AL 
[14]. Half of the doses (doses 1, 3 and 5, from a total of 6) were directly observed 
and given with fatty food (>1·5g fat); the other doses were taken without 
supervision. AL blister packs were collected for adherence monitoring. Coverage 
was defined as the proportion of compounds participating in screening of the 
sentinel population, the proportion of compounds eligible for MDA based on ≥1 
RDT positive inhabitant and the proportion of inhabitants of eligible compounds 
who received all 6 doses of AL. Adverse effects monitoring was conducted in 
conjunction with the daily drug supervision visits. Any symptoms reported on 
the final day of treatment were recorded and followed up clinically. 
Control clusters received malaria control following Kenyan national policy: annual 
IRS (ICON- lambda-cyhalothrin), which began in late April 2012 and was completed 
in June/July, routine case management at health facilities (i.e. all suspected cases of 
malaria were treated with AL after confirmation of infection by microscopy or RDT) 
and distribution of LLINs at antenatal clinics. No community distribution of LLINs 
was carried out in control clusters during the study period. 
Primary and Secondary outcome measures
The primary outcome measure was parasite prevalence in the evaluation zone 
surrounding malaria hotspots, measured by nPCR. Secondary outcome measures 
were: i) parasite prevalence inside hotspots; ii) parasite prevalence in the evaluation 
zone as function of distance to the hotspot boundary; iii) Anopheles mosquito 
density; iv) mosquito breeding site productivity; v) the number of malaria cases 
reporting at health facilities by passive case detection; vi) safety and acceptability 
of interventions. As exploratory endpoint, we determined the complexity of malaria 
infections inside and outside targeted hotspots.
Follow-up
Cross-sectional surveys were conducted in 2012 prior to the intervention (March-
April) and then at 8 weeks (June, corresponding to the peak of the rainy season) 
and 16 weeks after the intervention (August, corresponding to the end of the rainy 
season). In each survey, 25 compounds were randomly selected from each setting: 
inside hotspots; 1-249 m from the hotspot boundary; and 250-500 m from the 
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hotspot boundary. All occupants in selected compounds older than 6 months of 
age were sampled. Follow-up surveys were conducted by a total of 15 teams that 
each comprised of 2 fieldworkers, 1 local guide and 1 supervisor who was shared 
between 2 teams. Teams were equipped with high-resolution maps and GPS 
receivers with preloaded waypoints, as described above. In intervention hotspots 
data were available for all compounds at baseline (prior to the intervention) and 
were therefore included in the analysis. 
Laboratory Methods 
All finger prick blood samples collected at baseline (n=3,808), 8 weeks (n=3,817) or 
16 weeks after the intervention (n=3,955), were tested for P. falciparum parasitaemia 
by nPCR targeting the 18S rRNA gene [18]. All nPCR positive samples were tested 
for the presence of multiple allelic forms using the polymorphic Merozoite Surface 
Protein-2 gene [24]. 
Passive Surveillance for Malaria Clinical Incidence
All study participants from intervention and control clusters (hotspots and 
surrounding evaluation zones) received compound identification cards that were 
distributed during the pre-intervention survey in 2012 [14]. Passive case detection 
(PCD) was carried out in government and mission health facilities that covered 
intervention and control clusters. All facilities with a working laboratory and full 
time laboratory technician were eligible for inclusion, resulting in the inclusion of 3 
facilities in the PCD and exclusion of 9 facilities without a functioning laboratories. 
PCD took place between February and September 2012 for a total of 27 weeks [25] 
and relied on RDT-based diagnosis to ensure comparable sensitivity and specificity 
of malaria diagnosis at the participating facilities [26]. Any patient suspected of 
malaria who attended one of the 3 PCD facilities was asked for their compound 
identification card and examined for fever and symptoms of malaria. If an individual 
was febrile (temperature >37.5°C) an RDT was administered. Clinic attendance, the 
number of clinical malaria cases, defined as fever in combination with a positive RDT 
and compound number information were recorded. Spot checks took place on a 
fortnightly basis to assess completeness of records. 
Entomological surveys
Mosquito exposure was monitored in 3 intervention and 3 control clusters; in each 
of the clusters 4 compounds within hotspot boundaries and 8 compounds located 
in the evaluation zone were randomly selected for this purpose. Standard CDC light 
traps with a 6.3 V incandescent light bulb [John W. Hock Company, Florida, US] 
were set indoors from 6 pm – 6 am at 1.5 m above the ground at the foot end of 
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occupied bednets [27]. Adult female anopheline densities were recorded. Mosquito 
breeding site productivity was abandoned as secondary outcome because of labour 
intensiveness of larviciding performed by the same teams. Instead, the presence 
or absence of anopheline larvae and pupae was determined in 15 permanent 
waterbodies in intervention hotspots, using 250 mL dippers and aiming for 5 and 10 
dips in water bodies smaller than 5 m2 and larger than 5 m2, respectively. 
Data analysis
Statistical analyses were performed using Stata (v. 13, StataCorp LP, College Station, 
TX, USA). All analyses were based on intention to treat, whereby all clusters were 
included in the analysis, regardless of the level of coverage. The main outcome 
measure was nPCR parasite prevalence in the evaluation zone surrounding 
hotspots. Each cluster was divided into two areas for the analysis: the hotspot, 
and the evaluation zone. To examine parasite prevalence in the evaluation zone 
as function of distance to the hotspot boundary (defined as secondary objective), 
evaluation zones were stratified into compounds located within 1-249 m and 250-
500 m from the hotspot boundary. For each survey, comparisons between control 
and intervention clusters were made between hotspots as well as each strata of the 
evaluation zone. Each comparison was made using a t-test on the cluster level nPCR 
parasite prevalence. Measures of complexity of infection and prevalence were also 
compared separately for each of the strata by a t-test of cluster level means. Allelic 
richness, a metric for allelic diversity [28], was calculated using the FSTAT software (v 
2·9·3·2). Analyses for nPCR parasite prevalence was carried out adjusting for baseline 
prevalence and known malaria risk factors in the area: age group (<5, 5-14, 15-25, 
>25 years), sex, altitude class (<1450, 1450-1500, >1500 m) and living in a house 
with open eaves [15]. A single pre-specified adjusted analysis was carried out which 
controlled for these factors at once; covariate selection was not based on the data 
collected in the current study. This was done by first performing an individual level 
logistic regression with only the factors we wished to adjust for as the predictors 
while excluding the intervention status of the cluster. This regression was then used 
to predict prevalence in each cluster. We then calculated cluster level residuals 
as the difference between the observed and expected prevalence and compared 
residuals of control and intervention clusters using a t-test [29]. Since complexity of 
infection is count data with an extra Poisson variation, negative binomial regression 
was used to estimate cluster level means. To investigate whether the intervention 
effect varied by distance to the hotspot, a linear regression model of the cluster level 
means was used. A model with distance from hotspot (categorised as 0 m, 1-249 
m and 250-500 m) and intervention was compared to a model with an interaction 
between intervention and distance.
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Role of the Funding Source
The funders had no role in the study design, data collection, analysis, interpretation, 
or writing of the manuscript. Authors had full access to all study data and had final 
responsibility for the decision to submit the current manuscript for publication.
Results
Detection of malaria hotspots 
A total of 17,503 individuals were sampled during 6 weeks of sample collection 
in June-July 2011, residing in 3,213 compounds across the 100 km2 study 
area (Figure 2A). nPCR detected parasite prevalence was 20.6% (2,663/12,912 
observations from 2,802 compounds) was negatively associated with age 
(Table 1). The prevalence of antibodies to P. falciparum AMA-1 and/or MSP-119 was 
55.5% (9,092/16,381 observations from 3,099 compounds) and was positively 
associated with age (p<0.0001; Table 1). Analysis of spatial clusters based on 
combined antibody prevalence for AMA-1 and MSP-119 and age-adjusted antibody 
density identified 27 statistically significant hotspots of variable size (0·035-4·5 
km2; Figure 2B). These hotspots covered 34·7% of the total field area and 44·4% 
(7,780/17,503) of all sampled individuals. From the identified 27 hotspots, we 
selected 10 based on the inclusion criteria of the presence of an evaluation zone 
(1-500 m from the hotspot boundary) that was ≥1 km away from neighbouring 
hotspots, as shown in Figure 2C. Malaria antibody prevalence to AMA-1 and/or MSP-
119 was higher in nPCR parasite positive compared to negative individuals (OR 1·94, 
95% confidence interval 1·77-2·13, p<0·001). Antibody prevalence and nPCR parasite 
prevalence also showed similar geographical patterns (Figure 2D), with nPCR 
parasite prevalence being highest in serologically defined hotspots and declining 
with increasing distance from the hotspot boundary (Figure 3). 5·1% (126/2493) of 
compounds with >3 inhabitants had nPCR parasite prevalence ≥80%; 67·5% (85/126) 
of these compounds were located inside serologically defined hotspots. Even at an 
altitude >1500 m, where overall nPCR prevalence was 15·3% (646/4212 individuals 
from 861 compounds), 3·8% (29/773) of compounds with >3 inhabitants had nPCR 
parasite prevalence ≥80% and 55·2% (16/29) of these compounds were located 
inside serologically defined hotspots. 
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Figure 2. Spatial variation in malaria antibody prevalence and nPCR parasite prevalence in the 
study area in Rachuonyo South District during a community survey conducted in June-July 
2011. Panel A shows the distribution of sampled compounds and variations in altitude across the 
study site (contour interval = 25 m). Panel B shows combined seroprevalence (for AMA-1 and/or MSP-
119) for individual 250 x 250 m sub-cells and the location of 27 significant hotspots derived from 
spatial scan analysis of compound-level data. In Panel C the 10 hotspots that were selected for the 
cluster-randomized trail are presented with evaluation zones. In Panel D the 27 serological hotspot 
locations are overlaid on a map of nPCR-detected malaria parasite prevalence for compounds 
consisting of >3 individuals. 
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Table 1. Parasite prevalence and antibody prevalence in relation to age in the cross-sectional 
community survey in Rachuonyo South District in June-July 2011 that was conducted for 
hotspot detection
nPCR parasite prevalence, % (n/N) Antibody prevalence, % (n/N)
≤5 years 21·2% (738/3,476) 33·8% (1,501/4,437)
6-10 years, 26·1% (609/2,337) 49·5% (1,483/2,994)
11-15 years, 24·8% (462/1403) 65·1% (1,559/2,396)
16-25 years 19·2% (374/1,574) 69·5% (1,685/2,424)
>25 years 14·6% (480/3,286) 69·4% (2,864/4,130)
Figure 3. Malaria parasite prevalence by nPCR inside and outside serologically defined hotspots 
in the study area in Rachuonyo South District during a community survey conducted in June-
July 2011. nPCR-based parasite prevalence is plotted for individuals residing inside 27 serologically 
defined hotspots (hotspot, black bars), 1-249 meters from the hotspot boundary (1-249, grey hatched 
bars), 250-499m from the hotspot boundary (250-499, open hatched bars) and 500 or more meters 
from the hotspot boundary (500+, open bars). Parasite prevalence by nPCR is shown per altitude 
band. Error bars indicate the upper limit of the 95% confidence interval, the p-value for the trend 
test is given, adjusting for correlations between observations from individuals living in the same 
compound. The number of individuals for whom samples were available for nPCR inside hotspot 
boundaries was 2,222 individuals (1350-1449 m); 2,494 (1450-1499 m); 1,348 (1500-1549 m) and 118 
(1550-1650m). The number of individuals for 1-249 m from hotspot boundaries was 698 (1350-1449 
m); 1,248 (1450-1499 m); 1,113 (1500-1549 m) and 246 (1550-1650m). The number of individuals for 
250-499 m from hotspot boundaries was 544 (1350-1449 m); 681 (1450-1499 m); 661 (1500-1549 
m) and 164 (1550-1650m). The number of individuals for 500+ m from hotspot boundaries was 544 
(1350-1449 m); 176 (1450-1499 m); 405 (1500-1549 m) and 135 (1550-1650m).
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Intervention coverage and side effects
In intervention hotspots 7 of the 432 compounds approached were either unoccupied 
at the time of survey or declined participation and therefore did not participate in 
any of the interventions (Figure 4). Larviciding of all water bodies continued for 16 
weeks after the start of the intervention until the week after the final evaluation 
survey. LLINs, IRS and focal MDA were implemented in a period of 3 weeks in March-
April 2012. The percentage of compounds that received Permanet 3·0 LLINs ranged 
from 96·4% (56/58) to 100 % (118/118) across clusters whilst between 96·3% (52/54) 
and 100% (71/71) of compound received IRS in intervention clusters (Table 2). Of 
those compounds that received IRS under the normal campaign (i.e. control clusters), 
63% (16/26) to 81% (22/27) of compounds reported being sprayed six weeks after 
the deployment of interventions. In the intervention hotspots, 11.8% of compounds 
(cluster range: 9·0% (11/120) - 16·2% (7/42)) required more nets due to missing or 
damaged LLINs. Ten individuals (age range: 2-62 years) residing in 3 compounds 
in the intervention hotspots reported adverse effects to IRS. Reported symptoms 
included mild skin rashes and itching and one report of swollen and reddish mouth. 
All participants were provided treatment at Rachuonyo District Hospital. Of all 
compounds in intervention hotspots, 94·0% (406/432 compounds) participated in 
screening of the sentinel population; on average 42·3% of the screened compounds 
(range 14·0 (8/57 compounds) -66·1 (72/109 compounds)) had ≥1 RDT positive 
member and were eligible for focal MDA. 91·8% (1017/1108) of inhabitants of these 
compounds completed treatment with loss to follow-up accounting for the majority 
of non-compliance. There were no reports of side effects deemed likely to be related 
to treatment. 
Effect of hotspot-targeted interventions on nPCR parasite prevalence 
in evaluation zones 
The primary outcome measure was parasite prevalence in the evaluation zone 
surrounding malaria hotspots, based on nPCR parasite detection in three surveys 
conducted in March-April (pre-intervention), June (8 weeks post intervention) and 
August 2012 (16 weeks post-intervention). Each survey took approximately 2 weeks 
to complete. Mean baseline nPCR parasite prevalence of the intervention hotspots 
was 20·1% (range 8.4% (8/95) -38·4% (73/190)) and 18·6% in control clusters (range 
6·7% (8/119) -30·3% (37/122)) (Table 3); all compounds in the intervention clusters 
were sampled at baseline to facilitate evaluation of the focal treatment campaigns, 
and all were included in the baseline survey [23]. At none of the time-points of 
evaluation did we observe a statistically significant reduction in nPCR parasite 
prevalence in the evaluation zones surrounding targeted hotspots (Table 3; p≥0·19). 
204 |   Chapter 8
5 Hotspots 5 Evaluation Areas
432 compounds 
approached
7 compounds 
refused
425 compounds 
participated
IRS: 28 refused, 12 absent
LLIN: 1 refused, 20 absent
fMDA: 11 refused, 15 absent
11 compounds 
replaced
49 compounds 
replaced
66 compounds 
replaced
27 hotspots identified
10 hotspots randomized
17 not eligible:
≤ 1 km from neighbouring hotspot 
5 Intervention Clusters 5 Control Clusters
Intervention/Baseline
Evaluation
5 Hotspots 5 Evaluation Areas
All compounds per 
hotspot eligible for 
intervention
compounds per hotspot  
selected for evaluation
0 compounds 
replaced
2082 participants 
in 402 compounds
1291 participants in 
245 compounds
640 participants in 134
compounds
1159 participants in 
237 compounds
50 compounds per 
area  selected for 
evaluation
25 compounds per 
hotspot  selected for 
evaluation
W
eek 8 Post 
Intervention
W
eek 16 Post 
Intervention
29 compounds 
replaced
1262  participants in 
240 compounds
42 compounds 
replaced
1334 participants in 
247 compounds
13 compounds 
replaced
706 participants in 
127 compounds
13 compounds 
replaced
687 participants in 
123 compounds
41 compounds 
replaced
710 participants in 135 
compounds
29 compounds 
replaced
692 participants in 
123 compounds
63 compounds 
replaced
1176 participants in 
237 compounds
62 compounds 
replaced
1250 participants 
in 248 compounds
50 compounds per 
area  selected for 
evaluation
Figure 4. Overview of the cluster randomized trial conducted in Rachuonyo South District in March-August 2012. 
Clusters were serologically defined hotspots with a surrounding 500 m evaluation zone and randomly allocated to the 
intervention (n=5) or control arm (n=5). Cross-sectional surveys were conducted in 2012 at baseline (March-April 2012) 
and at 8 weeks (June 2012) and 16 weeks after the intervention (August 2012). In each survey, 25 compounds were 
randomly selected from within hotspots and 50 from the surrounding evaluation zone (25 compounds 1-249 m from 
the hotspot boundary; and 25 compounds 250-500 m from the hotspot boundary). In intervention hotspots data were 
available for all compounds at baseline and were therefore included in the analysis. If compounds selected compounds 
were not inhabited or compound members were absent, the nearest non-selected inhabited compound was selected 
as a replacement. Compounds were not re-visited before replacements were sought. IRS = indoor residual spraying, 
LLIN = long-lasting insecticide treated net, fMDA = focal mass drug administration.
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Hotspot-specific data for nPCR prevalence for each survey are presented in the 
supporting information (Figure S1, Table S1). 
Effect of hotspot-targeted interventions on nPCR parasite prevalence 
in hotspots and parasite complexity of infection
Secondary parasitological outcomes were nPCR parasite prevalence inside hotspots 
and nPCR parasite prevalence in the evaluation zone as function of distance to the 
hotspot boundary. An exploratory parasitological endpoint was the complexity of 
malaria infections inside and outside targeted hotspots. In the first post-intervention 
cross-sectional survey (at 8 weeks), mean nPCR parasite prevalence was 9·2% in 
intervention hotspots (cluster range 5.1% (7/138) to 13.5% (17/126)) compared to 
19·4% in control hotspots (cluster range 9.6% (12/125) to 33.3% (42/126)) (Table 3; 
p=0·024 after adjustment for baseline prevalence and covariates). However, malaria 
transmission inside targeted hotspots was not completely interrupted. Although not 
originally defined as study endpoint, we determined parasite carriage in individuals 
who were repeatedly sampled during the study period and were parasite-free by 
nPCR before the intervention. Of 97 individuals who resided in intervention hotspots, 
and who were parasite negative prior to the intervention and coincidentally 
sampled during the first evaluation survey, 4 (4·1%) became parasite positive. These 
individuals (aged 4, 6, 10 and 34 years) did not report spending any nights outside 
their compound between surveys. Sixteen weeks post-intervention, at the end of 
the transmission season, there was no longer a statistically significant difference in 
nPCR parasite prevalence between intervention and control hotspots (p=0·27). We 
observed no statistically significant trend in the effect of the intervention on nPCR 
parasite prevalence in the evaluation zone in relation to distance to the hotspot 
boundary eight weeks post intervention (p=0.27) or sixteen weeks post intervention 
(p=0.75). nPCR parasite prevalence was not statistically significantly associated with 
reported travel in the preceding 3 months in the survey prior to the intervention 
(p=0.30) or surveys 8 weeks (p=0.24) or 16 weeks (p=0.58) after the intervention. 
Only 1 nPCR positive individual reported traveling to an area that is considered 
to experience higher malaria transmission. MSP-2 typing and fragment sizing was 
successful in 97·2% (1517/1561) of nPCR positive individuals coming from 421 
compounds. We observed no statistically significant reductions in the number of 
detected parasite clones, inside malaria hotspots or in evaluation zones or allelic 
richness following the intervention (Table 3). The average number of parasite clones, 
complexity of infection, and allelic richness in the different surveys is presented per 
hotspot in the supporting information (Table S1).
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Effect of hotspot-targeted interventions on malaria cases reporting at 
health facilities 
The number of malaria cases reporting at health facilities by passive case detection, 
coming from intervention and control clusters was defined as a secondary endpoint. 
During passive case detection there were 561 RDT-confirmed clinical malaria cases in 
1,175 febrile patients. The majority resided outside intervention or control clusters. 
Twenty-two patients with RDT-confirmed clinical malaria could be located to 
intervention clusters (incidence of 0·74 cases per 1,000 people per month based on an 
estimated population size of 4,918) and 14 to control clusters (incidence of 0·64 cases 
per 1,000 people per month based on an estimated population size of 3,660). 
Number of mosquitoes sampled indoors
Anopheles mosquito density and breeding site productivity were defined as 
secondary entomological objectives. We sampled a total of 395 female anophelines 
during 648 trapping nights. In the intervention clusters we caught an average of 
Figure 5. Indoor densities of female anophelines by light trap in intervention and control clusters 
in Rachuonyo South District in March-August 2012. Each symbol represents the number of female 
anophelines caught indoors by CDC light trap inside hotspots (filled circles) and in evaluation zones 
(open circles). Each trap night 4 compounds were randomly selected within the hotspot and 8 were 
selected in the evaluation zone per cluster. Findings are summarized for  trapping rounds prior to roll-
out of interventions in March-April 2012 (1 trap per compound), and post-intervention in May-June 
2012 (3 trapping nights per compound) and July-August 2012 (5 trapping nights per compound). 
Findings are presented for 3 intervention clusters combined and for 3 control clusters combined
intervention (p = 0.27) or 16 wk post-intervention (p = 0.75). nPCR parasite prevalence was
not statistically significantly associated with reported travel in the preceding 3 mo in the survey
prior to the intervention (p = 0.30) or the surveys 8 wk (p = 0.24) and 16 wk (p = 0.58) after the
intervention. Only one nPCR-positive individual reported traveling to an area that is consid-
ered to experience higher malaria transmission. MSP-2 typing and fragment sizing was suc-
cessful in 97.2% (1,517/1,561) of nPCR-positive individuals coming from 421 compounds. We
observed no statistically significant reductions in allelic richness or in the number of detected
parasite clones inside malaria hotspots or in evaluation zones following the intervention
(Table 3). The average number of parasite clones, complexity of infection, and allelic richness
in the different surveys is presented by hotspot in S1 Table.
Effect of Hotspot-Targeted Interventions on Malaria Cases Reporting at
Health Facilities
The number of malaria cases reporting at health facilities coming from intervention and con-
trol clusters was defined as a secondary endpoint. During PCD there were 561 RDT-confirmed
clinical malaria cases in 1,175 febrile patients. The majority resided outside intervention or
control clusters. Twenty-two patients with RDT-confirmed clinical malaria could be located to
Fig 5. Indoor densities of female anophelines by light trap in intervention and control clusters in Rachuonyo South District in March–August 2012.
Each symbol represents the number of female anophelines caught indoors by CDC light trap inside hotspots (filled circles) and in evaluation zones (open
circles). Each trap night, four compounds were randomly selected within the hotspot and eight were selected in the evaluation zone per cluster. Findings are
summarized for trapping rounds prior to roll-out of interventions in 22 March–30 April 2012 (one trapping night per compound) and post-intervention in 1
May–30 June 2012 (three trapping nights per compound) and 1 July–31 August 2012 (five trapping nights per compound). Findings are presented for three
interventio clusters combined and f r three control clusters combined.
doi:10.1371/journal.pmed.1001993.g005
Hotspot-Targeted Interventions and Malaria Transmission
PLOSMedicine | DOI:10.1371/journal.pmed.1001993 April 12, 2016 16 / 25
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1.14 female anophelines inside hotspots and 0.47 in evaluation areas; in control 
clusters we caught an average of 0.90 female anophelines inside hotspots and 0.50 
in evaluation areas. We observed no apparent difference between intervention 
and control clusters (Figure 5) and considerable variation within and between 
clusters (Figure S2). Mosquito breeding site productivity was assessed in 15 sites 
per intervention hotspot (n=75 in total). Of the sites sampled prior to larviciding, 
45% (34/75) were positive of which 12 had late stage larvae and/or pupae. After 
larviciding, the number of positive sites varied between 5.3% (4/75) to 28.0% (21/75) 
and no late stage larvae or pupae were detected
Discussion
In this highland fringe setting in western Kenya we identified numerous hotspots 
with serological and parasitological evidence of elevated levels of malaria 
transmission relative to surrounding areas. Targeting these hotspots with a 
combination of 4 interventions, acting against the human parasitaemic reservoir 
and vector populations, had no measureable impact on nPCR parasite prevalence 
in evaluation zones surrounding hotspots and had only a short-lived effect on nPCR 
parasite prevalence within hotspots. 
Hotspot targeted interventions have been hypothesized to form a highly 
efficacious approach to reduce the burden of malaria in areas of heterogeneous 
malaria transmission [9,12]. Operationally feasible approaches to detect stable 
hotspots form a prerequisite for targeted interventions. Our detailed community 
survey, conducted in preparation of the intervention, revealed a large number of 
serologically defined hotspots of malaria transmission. These serological hotspots, 
indicative of longer-term exposure [17], showed a strong association with current 
parasite carriage at both the individual and geographical level: malaria antibody 
positive individuals were significantly more likely to be parasite positive and nPCR 
parasite prevalence decreased with distance from the centre of serologically defined 
hotspots. This suggests temporal stability of spatially heterogeneous transmission 
[6,9], and suitability for targeting of interventions at a fine spatial scale. We selected 
10 hotspots for a cluster-randomized trial on the impact of hotspot-targeted 
interventions with IRS, LLINs, weekly larviciding [30], and focal MDA to minimize 
the parasite reservoir in humans at the start of the transmission season. Despite 
achieving high coverage with all interventions, we observed no measurable impact 
on our primary endpoint: the proportion of nPCR parasite-positive individuals in 
the evaluation zone surrounding targeted hotspots. nPCR parasite prevalence was 
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only transiently reduced inside targeted hotspots and there was no impact on the 
complexity of malaria infections inside or outside hotspots. Whilst heterogeneous 
malaria transmission may influence the acquisition of malaria immunity and clinical 
manifestations [6,31], we hypothesized that our intervention would reduce not 
only the prevalence of asymptomatic infections but also the incidence of clinical 
malaria episodes in intervention compared to control clusters. Passive case 
detection at health facilities identified 36 RDT-confirmed clinical malaria episodes 
in individuals who resided in intervention or control clusters, and no evidence that 
the intervention reduced the clinical burden of malaria. Our decision to monitor 
the incidence of malaria cases passively was based on the low efficiency of active 
monitoring of infections in low endemic settings [32] although we acknowledge 
that passive case detection will lead to a considerable loss in power compared to 
active case detection [33]. As a consequence, our approach will have resulted in an 
unknown number of malaria episodes that were missed due to health care seeking 
behavior or other factors [33,34]. It is also conceivable that we missed further 
malaria cases because health facility attendees failed to present with compound 
identification cards, although we would expect this bias to be non-differential 
between control and intervention arms. These are shortcomings of our passive case 
detection system. As a result, we cannot exclude an impact of our interventions on 
the incidence of clinical malaria episodes but can conclude that parasitologically 
confirmed clinical malaria episodes were passively reported from both intervention 
and control clusters at a similar rate.
Our intervention failed to sustainably reduce malaria transmission inside targeted 
hotspots. Approximately 4% of individuals became parasite positive within 8 weeks 
of the intervention. This infection incidence is remarkable considering the low 
level of transmission intensity in the area; the baseline nPCR parasite prevalence 
of 18·6-23·5% translates to an estimated microscopy parasite prevalence of 5·7-
7·9% [35] and indicates hypoendemic transmission [36]. There are several possible 
reasons for the apparent failure to completely eliminate malaria transmission inside 
hotspots and the undetectable impact in the evaluation zones surrounding targeted 
hotspots. Firstly, it is possible that our interventions did not clear vector populations 
or prevent human-vector contact inside hotspots to the extent that is required to 
interrupt local transmission. Insecticide resistance is a key consideration for any 
vector-based malaria intervention. Resistance to deltamethrin and permethrin 
has been detected in the study area for A. gambiae s.l. and A. funestus [37,38] but 
has not reached saturation as observed in other African settings [39,40] and there 
is currently no evidence that insecticide resistance affects control efforts in the 
region [39-41]. We purposefully selected interventions that have potency in areas 
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of insecticide resistance: LLINs that include piperonyl butoxide as syngergist to 
enhance the efficacy of deltamethrin in resistant vectors [42] and larviciding with 
Bti to which there is no reported vector resistance in the region [22] and which is 
effective against both indoor and outdoor feeding mosquitoes. Activity against 
outdoor feeding mosquitoes is of relevance with increased outdoor biting rates 
following the scaling up of IRS and LLIN coverage [43,44] and the presence of a 
previously unidentified malaria vector in the study area that exhibits a preference 
for outdoor biting [16]. Despite our intensive vector control efforts, we detected 
ongoing breeding site productivity and mosquito exposure in targeted hotspots. 
Secondly, there may have been residual transmission from parasite carriers that were 
unidentified and untargeted by our treatment campaign. Undetected low-density 
parasite carriage may have been responsible for sustained transmission following 
recent mass screening-and treatment campaigns in Zanzibar [45]. We estimate that 
our approach identified approximately 77% of all nPCR positive individuals in the 
area [23]. It is currently unknown whether the untargeted fraction of infections, 
which are mostly of low parasite density, is sufficient to sustain transmission; 
however, infectiousness from low-density infections has been demonstrated [46]. 
A third potential explanation is the importation of parasites by individuals traveling 
to areas of higher endemicity such as the nearby Asembo Bay area [47]. We failed to 
detect an association between reported travel and nPCR parasite prevalence during 
any of the surveys. Analysis of data from earlier surveys in this area indicate that 
most trips that involve an overnight stay occur within families or represent travel 
to urban areas where malaria risk is low [48]. In our surveys only one nPCR positive 
individual reported traveling to an area of known intense malaria transmission. A 
fourth possible explanation is the influx of infected mosquitoes from untargeted 
hotspots. We selected hotspots and evaluation zones for the intervention trial 
that were in relative isolation from neighboring hotspots, assuming that vector 
dispersion in a densely populated area would primarily occur over <1 km distances 
[49]. Importation of infected mosquitoes into the intervention hotspots is possible 
and most likely from areas that surrounded hotspots but were themselves not 
detected as transmission hotspots. The points above may all contribute to varying 
degrees and combine for the fifth possible explanation, which is that our hypothesis 
of how hotspots seed malaria transmission does not apply to transmission dynamics 
in our study setting. Understanding host and mosquito movement in relation to 
fine-scale patterns of mixing parasite populations is of key importance to rationally 
deploy targeted interventions [50]. Our findings suggest that transmission may 
not primarily occur from hotspots to the surrounding areas. Our hotspot definition 
encapsulated 34·7% of the total area and 44·4% of all inhabitants but 32·5% (41/126) 
of all compounds with ≥80% nPCR parasite prevalence were located outside 
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statistically significant malaria hotspots. These high parasite prevalence compounds 
may have fuelled transmission outside and into our serologically defined hotspots. 
The existence of isolated high parasite prevalence compounds has been described 
before [12,23] and suggests that our hypoendemic study area has not yet reached 
the phase where parasite carriage is confined to malaria hotspots or primarily occurs 
from hotspots to surrounding areas. 
There are several limitations to this study. Our study was conducted in the presence 
of other ongoing interventions that may have made it difficult to attribute any 
specific, small changes in nPCR parasite prevalence to our intervention. The absence 
of detailed meteorological data further makes it impossible to relate the impact 
of our interventions to their exact timing in terms of local changes in rainfall and 
temperature that determine malaria transmission dynamics. Our trial included a 
total of 10 clusters during a single season and was therefore not powered to detect 
subtle effects of hotspot-targeted interventions nor designed to detect effects 
that become apparent after interventions over multiple transmission seasons. 
Furthermore, we saw a higher than expected level of inter cluster variation. Sample 
size calculations were based on an assumed coefficient of variation of 0.4. In fact 
the baseline data indicate a coefficient of variation of 0.5, which would have 
also reduced the power of the trial to detect subtle effects of hotspot-targeted 
interventions. The limited number of clusters is a major limitation of the current 
study. Our sample size of 5 intervention and 5 control clusters was based on the 
assumption that our combination of 4 malaria interventions would (temporarily) 
eliminate malaria transmission inside targeted hotspots [9] and would result in near-
elimination of malaria from the surrounding community. Neither hypothesis was 
confirmed. It is unclear to what extent the results from our trial can be extrapolated 
to other settings. Our study was conducted in a highland fringe setting with low and 
heterogeneous malaria transmission. Whilst markedly different from nearby lowland 
areas of intense malaria transmission, we believe our study setting is representative 
of many other East African settings with continuous habitation and low intensity 
malaria transmission that is spatially heterogeneous as a consequence of large 
and small-scale determinants of malaria transmission [9,12]. Our observation that 
individual compounds with high levels of asymptomatic parasite carriage exist 
within areas where parasite carriage is generally much lower, has also been reported 
in coastal Kenya [12]. We consider this existence of such single-compound hotspots 
an important hurdle for hotspot-targeted interventions since these compounds are 
logistically very challenging to identify and may require very intensive community 
surveys. In coastal Kenya, hotspots that are unstable in space and time [6] may 
further affect the operational attractiveness of hotspot-targeted interventions. 
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Conclusion
Approximately one-third of our study area fell within identified hotspots of malaria 
transmission. Hotspot targeting failed to influence malaria transmission dynamics 
outside the targeted area and resulted in a modest and transient reduction in 
nPCR parasite prevalence inside targeted hotspots. Whilst our study may have 
been underpowered to detect subtle effects on malaria transmission, we consider 
it unlikely that hotspot-targeted interventions are cost-effective in our setting. The 
considerable resources required for hotspot detection at the local scale are unlikely 
to be offset by savings from a more rational deployment of interventions in the 
study area. As a result, areas like our study site in Rachuonyo South with highly 
heterogeneous but widespread malaria transmission may currently benefit most 
from an untargeted community-wide approach that reaches all malaria-infected and 
malaria exposed individuals. The hotspot-targeted approach may have validity and 
should be tested further in settings where human settlement is more nuclear. 
Acknowledgements
This project was supported by the Bill and Melinda Gates Foundation, under the 
Malaria Transmission Consortium, Grant No.45114 and the Grand Challenge Grant 
No. OPP1024438. We thank project staff, the community of Kabondo and Kasipul, 
Rachuonyo South, and KEMRI/CDC Kisumu. We also thank the project scientific 
advisory board consisting of Sodiomon Sirima (Centre National de Recherche et de 
Formation sur le Paludisme, Ouagadougou, Burkina Faso), Umberto d’Alessandro 
(Medical Research Council Laboratories, Fajara, The Gambia) and Philip Bejon (Kenya 
Medical Research Institute, Wellcome Trust Research Programme, Kilifi, Kenya). 
This manuscript has been approved by the Director of the Kenya Medical Research 
Institute. We acknowledge the donation of Permanet® 3.0 LLINs by Vestergaard 
Frandsen (Hanoi, Vietnam) and Bti Vectobac® by Valent BioSciences Corp (Libertyville, 
IL, US). This manuscript has been approved by the Director of the Kenya Medical 
Research Institute.
214 |   Chapter 8
References
1.  Oesterholt MJ, Bousema JT, Mwerinde OK, Harris C, Lushino P, et al. (2006) Spatial and temporal 
variation in malaria transmission in a low endemicity area in northern Tanzania. MalarJ 5: 98.
2.  Clark TD, Greenhouse B, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, et al. (2008) Factors 
determining the heterogeneity of malaria incidence in children in Kampala, Uganda. J Infect Dis 198: 
393-400.
3.  Kreuels B, Kobbe R, Adjei S, Kreuzberg C, von Reden C, et al. (2008) Spatial variation of malaria 
incidence in young children from a geographically homogeneous area with high endemicity. J Infect 
Dis 197: 85-93.
4.  Bousema T, Drakeley C, Gesase S, Hashim R, Magesa S, et al. (2010) Identification of hot spots of malaria 
transmission for targeted malaria control. J Infect Dis 201: 1764-1774.
5.  Midega JT, Smith DL, Olotu A, Mwangangi JM, Nzovu JG, et al. (2012) Wind direction and proximity to 
larval sites determines malaria risk in Kilifi District in Kenya. Nat Commun 3: 674.
6.  Bejon P, Williams TN, Liljander A, Noor AM, Wambua J, et al. (2010) Stable and unstable malaria hotspots 
in longitudinal cohort studies in Kenya. PLoS Med 7: e1000304.
7.  Mackinnon MJ, Mwangi TW, Snow RW, Marsh K, Williams TN (2005) Heritability of malaria in Africa. 
PLoS Med 2: e340.
8.  Shanks GD, Biomndo K, Guyatt HL, Snow RW (2005) Travel as a risk factor for uncomplicated 
Plasmodium falciparum malaria in the highlands of western Kenya. Trans R Soc Trop Med Hyg 99: 71-
74.
9.  Bousema T, Griffin JT, Sauerwein RW, Smith DL, Churcher TS, et al. (2012) Hitting hotspots: spatial 
targeting of malaria for control and elimination. PLoS Med 9: e1001165.
10.  Woolhouse ME, Dye C, Etard JF, Smith T, Charlwood JD, et al. (1997) Heterogeneities in the transmission 
of infectious agents: implications for the design of control programs. Proc Natl Acad Sci U S A 94: 338-
342.
11.  Smith DL, McKenzie FE, Snow RW, Hay SI (2007) Revisiting the basic reproductive number for malaria 
and its implications for malaria control. PLoS Biol 5: e42.
12.  Bejon P, Williams TN, Nyundo C, Hay SI, Benz D, et al. (2014) A micro-epidemiological analysis of febrile 
malaria in Coastal Kenya showing hotspots within hotspots. Elife 3: e02130.
13.  World Health Organization (2010) Global malaria control and elimination: report of a technical review.
14.  Bousema T, Stevenson J, Baidjoe A, Stresman G, Griffin JT, et al. (2013) The impact of hotspot-targeted 
interventions on malaria transmission: study protocol for a cluster-randomized controlled trial. Trials 
14: 36.
15.  Stevenson JC, Stresman GH, Baidjoe A, Okoth A, Oriango R, et al. (2015) Use of different transmission 
metrics to describe malaria epidemiology in the highlands of western Kenya. Malar J 14: 418.
16.  Stevenson J, St Laurent B, Lobo NF, Cooke MK, Kahindi SC, et al. (2012) Novel vectors of malaria 
parasites in the western highlands of Kenya. Emerg Infect Dis 18: 1547-1549.
17.  Drakeley CJ, Corran PH, Coleman PG, Tongren JE, McDonald SL, et al. (2005) Estimating medium- 
and long-term trends in malaria transmission by using serological markers of malaria exposure. 
ProcNatlAcadSciUSA 102: 5108-5113.
18.  Baidjoe A, Stone W, Ploemen I, Shagari S, Grignard L, et al. (2013) Combined DNA extraction 
and antibody elution from filter papers for the assessment of malaria transmission intensity in 
epidemiological studies. Malar J 12: 272.
19.  SatScan T http://www.satscan.org/.
20.  Griffin JT, Hollingsworth TD, Okell LC, Churcher TS, White M, et al. (2010) Reducing Plasmodium 
falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies. PLoS 
Med 7.
21.  Hawley WA, Phillips-Howard PA, ter Kuile FO, Terlouw DJ, Vulule JM, et al. (2003) Community-wide 
215The impact of hotspot targeted interventions on malaria transmission   | 
8
effects of permethrin-treated bed nets on child mortality and malaria morbidity in western Kenya. Am 
J Trop Med Hyg 68: 121-127.
22.  Fillinger U, Kannady K, William G, Vanek MJ, Dongus S, et al. (2008) A tool box for operational mosquito 
larval control: preliminary results and early lessons from the Urban Malaria Control Programme in Dar 
es Salaam, Tanzania. Malar J 7: 20.
23.  Stresman GH, Baidjoe AY, Stevenson J, Grignard L, Odongo W, et al. (2015) Focal screening to identify 
the subpatent parasite reservoir in an area of low and heterogeneous transmission in the Kenya 
highlands. J Infect Dis in press.
24.  Mueller I, Schoepflin S, Smith TA, Benton KL, Bretscher MT, et al. (2012) Force of infection is key to 
understanding the epidemiology of Plasmodium falciparum malaria in Papua New Guinean children. 
Proc Natl Acad Sci U S A 109: 10030-10035.
25.  Afrane YA, Zhou G, Githeko AK, Yan G (2013) Utility of health facility-based malaria data for malaria 
surveillance. PLoS One 8: e54305.
26.  Zurovac D, Githinji S, Memusi D, Kigen S, Machini B, et al. (2014) Major improvements in the quality of 
malaria case-management under the “test and treat” policy in Kenya. PLoS One 9: e92782.
27.  Mboera LE, Kihonda J, Braks MA, Knols BG (1998) Short report: Influence of centers for disease control 
light trap position, relative to a human-baited bed net, on catches of Anopheles gambiae and Culex 
quinquefasciatus in Tanzania. Am J Trop Med Hyg 59: 595-596.
28.  Barry AE, Schultz L, Senn N, Nale J, Kiniboro B, et al. (2013) High levels of genetic diversity of 
Plasmodium falciparum populations in Papua New Guinea despite variable infection prevalence. Am 
J Trop Med Hyg 88: 718-725.
29.  Hayes RJ, Moulton LH (2009) Cluster randomized trials: Chapman and Hall/CRC.
30.  Tusting LS, Thwing J, Sinclair D, Fillinger U, Gimnig J, et al. (2013) Mosquito larval source management 
for controlling malaria. Cochrane Database Syst Rev 8: CD008923.
31. Mosha JF, Sturrock HJ, Greenhouse B, Greenwood B, Sutherland CJ, et al. (2013) Epidemiology of 
subpatent Plasmodium falciparum infection: implications for detection of hotspots with imperfect 
diagnostics. Malar J 12: 221.
32.  Tusting LS, Bousema T, Smith DL, Drakeley C (2014) Measuring changes in Plasmodium falciparum 
transmission: precision, accuracy and costs of metrics. Adv Parasitol 84: 151-208.
33.  Tiono AB, Kangoye DT, Rehman AM, Kargougou DG, Kabore Y, et al. (2014) Malaria incidence in children 
in South-West Burkina Faso: comparison of active and passive case detection methods. PLoS One 9: 
e86936.
34.  Olotu A, Fegan G, Williams TN, Sasi P, Ogada E, et al. (2010) Defining clinical malaria: the specificity and 
incidence of endpoints from active and passive surveillance of children in rural Kenya. PLoS One 5: 
e15569.
35.  Okell LC, Bousema T, Griffin JT, Ouedraogo AL, Ghani AC, et al. (2012) Factors determining the 
occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun 3: 1237.
36.  Hay SI, Smith DL, Snow RW (2008) Measuring malaria endemicity from intense to interrupted 
transmission. Lancet Infect Dis 8: 369-378.
37.  Mulamba C, Riveron JM, Ibrahim SS, Irving H, Barnes KG, et al. (2014) Widespread pyrethroid and 
DDT resistance in the major malaria vector Anopheles funestus in East Africa is driven by metabolic 
resistance mechanisms. PLoS One 9: e110058.
38. Ochomo E, Bayoh NM, Kamau L, Atieli F, Vulule J, et al. (2014) Pyrethroid susceptibility of malaria 
vectors in four Districts of western Kenya. Parasit Vectors 7: 310.
39.  Strode C, Donegan S, Garner P, Enayati AA, Hemingway J (2014) The impact of pyrethroid resistance on 
the efficacy of insecticide-treated bed nets against African anopheline mosquitoes: systematic review 
and meta-analysis. PLoS Med 11: e1001619.
40.  Mathias DK, Ochomo E, Atieli F, Ombok M, Bayoh MN, et al. (2011) Spatial and temporal variation in the 
kdr allele L1014S in Anopheles gambiae s.s. and phenotypic variability in susceptibility to insecticides 
in Western Kenya. Malar J 10: 10.
216 |   Chapter 8
41.  Lindblade KA, Mwandama D, Mzilahowa T, Steinhardt L, Gimnig J, et al. (2015) A cohort study of the 
effectiveness of insecticide-treated bed nets to prevent malaria in an area of moderate pyrethroid 
resistance, Malawi. Malar J 14: 31.
42.  World Health Organization (2009) Report of the twelfth WHOPES working group meeting. WHO/HTM/
NTD/WHOPES/20091 Geneva, WHOWHO_Pesticide_Evaluation_Scheme 2009, 1-120.
43.  Russell TL, Govella NJ, Azizi S, Drakeley CJ, Kachur SP, et al. (2011) Increased proportions of outdoor 
feeding among residual malaria vector populations following increased use of insecticide-treated 
nets in rural Tanzania. Malar J 10: 80.
44.  Olanga EA, Okombo L, Irungu LW, Mukabana WR (2015) Parasites and vectors of malaria on Rusinga 
Island, Western Kenya. Parasit Vectors 8: 250.
45.  Cook J, Xu W, Msellem M, Vonk M, Bergstrom B, et al. (2015) Mass Screening and Treatment on the 
Basis of Results of a Plasmodium falciparum-Specific Rapid Diagnostic Test Did Not Reduce Malaria 
Incidence in Zanzibar. J Infect Dis 211: 1476-1483.
46.  Ouedraogo AL, Goncalves BP, Gneme A, Wenger EA, Guelbeogo MW, et al. (2015) Dynamics of the 
Human Infectious Reservoir for Malaria Determined by Mosquito Feeding Assays and Ultrasensitive 
Malaria Diagnosis in Burkina Faso. J Infect Dis.
47.  Desai M, Buff AM, Khagayi S, Byass P, Amek N, et al. (2014) Age-specific malaria mortality rates in the 
KEMRI/CDC health and demographic surveillance system in western Kenya, 2003-2010. PLoS One 9: 
e106197.
48.  Wesolowski A, Stresman G, Eagle N, Stevenson J, Owaga C, et al. (2014) Quantifying travel behavior for 
infectious disease research: a comparison of data from surveys and mobile phones. Sci Rep 4: 5678.
49.  Midega JT, Mbogo CM, Mwnambi H, Wilson MD, Ojwang G, et al. (2007) Estimating dispersal and 
survival of Anopheles gambiae and Anopheles funestus along the Kenyan coast by using mark-
release-recapture methods. J Med Entomol 44: 923-929.
50.  Perkins TA, Scott TW, Le Menach A, Smith DL (2013) Heterogeneity, mixing, and the spatial scales of 
mosquito-borne pathogen transmission. PLoS Comput Biol 9: e1003327.
217The impact of hotspot targeted interventions on malaria transmission   | 
8
Study data
Data underlying this manuscript has been deposited in a digital repository: 
http://datadryad.org/review?doi=doi:10.5061/dryad.nr8d8
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Supporting Figure S1 Parasite prevalence following before and after hotspot-targeted interventions 
in Rachuonyo South District in March-August 2012. nPCR prevalence (%) in hotspots selected for the 
cluster randomized trial; measured in July 2011 (community survey for hotspot detection), March-April 
2012 (pre-intervention) and post intervention June 2012, August 2012. Measured inside hotspot, 1-249 
from hotspot border and 250-500m from hotspot border. Error bars indicate the upper limit of the 95% 
confidence interval.
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Supporting Figure S2. Indoor densities of female anophelines by light trap in intervention and 
control clusters in Rachuonyo South District in March-August 2012, presented for individual 
clusters. Each symbol represents the number of female anophelines caught indoors by CDC light trap 
inside hotspots (filled circles) and in evaluation zones (open circles). Each trap night 4 compounds 
were randomly selected within the hotspot and 8 were selected in the evaluation zone per cluster. 
Findings are summarized for  trapping rounds prior to roll-out of interventions in March-April (1 trap 
per compound), and post-intervention in May-June (3 trapping nights per compound) and July-
August (5 trapping nights per compound).
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Synopsis
Since 2000 the world has witnessed an unprecedented decline of morbidity and 
mortality caused by Plasmodium falciparum malaria, this has coincided with strong 
financial commitments leading to wider availability of interventions such as 
insecticide treated nets (ITNs). Household ownership in Africa of least one ITN per 
household increased from 50% in 2010 to 80% in 2015 [1]. This scale-up in vector 
control efforts has concurred with increased access to diagnosis and treatment 
of malaria and resulted in an estimated 20% reduction in the incidence of clinical 
cases between 2010 and 2016 in the World Health Organisation African Region[1]. 
With these reductions in malaria burden, spatial heterogeneity of P.falciparum 
transmission has become more evident. This spatial heterogeneity exists at all spatial 
levels and can limit the impact of general broad scale malaria control efforts, and 
simultaneously highlights the potential for more accurately targeted interventions 
in hotspots of malaria [2]. 
Initially, community-wide campaigns can be aimed at entire foci that experience 
widely distributed malaria transmission. As these campaigns progress and 
transmission intensity in the overall area declines if interventions are executed 
adequately, these campaigns can be geographically downscaled and adapted to 
target remaining (smaller) hotspots, which can potentially re-seed transmission 
if general intervention efforts were to be scaled back. Ultimately this can result 
in interventions aimed at single households or even individuals who sustain 
transmission. With a combination of data derived from modern geographical 
information systems (GIS) [3,4], the usage of molecular and serological tools, 
an integrated method was proposed in this thesis to allow reliable detection of 
geographic and demographic variation in malaria transmission at both macro and 
micro-epidemiological scales in areas where limited resources are available. 
In addition, this combination of tools and methods may provide a better 
understanding of how to support current intervention efforts in a changed malaria 
landscape and offer a perspective into new operationally targeted methodologies in 
the effort to augment malaria elimination efforts.
Mathematical modelling studies have suggested that targeting these geographically 
confined hotspots with indoor residual spraying (IRS) and long lasting insecticide 
treated nets (LLINs) would lead to a significant decline of transmission over time 
when compared to non-targeted interventions [5]. Until the studies presented in 
this thesis, this approach was never trialled in the field. 
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Operationalising sensitive laboratory tools to detect 
foci of malaria
The presence of low density infections in all malaria endemic regions [6] and in 
particular in low endemic settings [7], highlights the value of molecular parasite 
detection tools for epidemiological studies and monitoring of interventions as well 
as possibly more routine surveillance efforts. 
A large proportion of malaria infections are of low parasite density [6], especially 
in low-endemic settings [7]. It was estimated that sub-microscopic, PCR detectable 
infections roughly constitute 20% of all malaria infections in high-transmission 
areas, in low transmission areas this estimate reaches up to 70% [7]. The detection of 
these low-density infections could be of importance in settings where it is deemed 
feasible to move forward towards elimination [8].  
Molecular diagnostics for pathogens detection were developed with the use of 
whole blood samples in mind [9] but the requirements for a cold chain and often 
venous sampling hinders the wide-scale use of molecular diagnostics in settings 
deprived of more modern laboratories and cold-storage facilities. This is one of the 
reasons why molecular diagnostics are not routinely used in community surveys. To 
adapt to challenges imposed by sampling in field settings, paper matrices to store 
blood samples have been used for the detection of different tropical pathogens 
[10]. Filter paper samples or dried blood spots (DBS) have been used for decades 
in clinical malaria trials to allow genotyping of infections to determine resistance 
markers [11] or distinguish between recrudescent infections and new infections 
during follow-up investigations [12]. These approaches are highly successful but 
differ in two important aspects from the surveys needed in community settings 
of low malaria endemicity: sampling commonly occurs in health facility settings 
and malaria parasite densities in clinical malaria cases are typically in the range of 
several thousand parasites per microliter. By contrast, community surveys typically 
encounter individuals with lower parasites densities in circulation [13] and such 
surveys are conducted in more logistically challenging working environments. This 
outlines another key advantage of the use of DBS, they allow detailed molecular 
and serological analyses within population surveys and make sample collection and 
storage logistically easier [13].
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Sample collection in field settings
During the field studies described in this thesis, filter paper was used as a storage 
matrix for whole blood samples. In total close to 30,000 samples were collected in 
all studies described. On all these samples a dual extraction methodology described 
in chapter 4 was used to recover nucleic acids and antibody containing serum [14]. 
The baseline samples of June 2011 counted well over 17,500 samples which were 
collected within a narrow timeframe of 28 days. In addition, to assessment of current 
infection by the detection of parasite DNA, this set of samples was also screened for 
antibody levels against parasite antigens Apical Membrane Antigen 1 (AMA-1) and 
Merozoite surface protein 1 (MSP-119); these antibodies served as a biomarker for 
history of infection. 
For the purpose of collection, a specific set of operational procedures were applied 
as described by Corran et al [15], with modifications to facilitate the collection of 
large numbers of samples and the detection of DNA. Blood was directly collected 
on filter papers, these were dried in the absence of light for twenty minutes (to 
avoid exposure to UV) in the field before they were added to a mobile storage box 
which was filled with desiccant for the purpose of decreasing internal humidity of 
the mobile storage boxes. Within three days samples were transported to a facility 
where they were stored at -20°C until they could be extracted and analysed. Storage 
is preferably done at sub-zero temperatures for to retain optimal antibody recovery 
[16]. The studies in Chapter 3 showed that nucleic acid remains stable for up to 
two year if samples are stored at room temperature, after that significant drops in 
sensitivity can be measured [17]. This specific way of collecting and storing samples 
allows for a rapid, low cost alternative to whole blood tube collection while making 
limited concessions on sample quality and the limit of detection (LOD). The dual 
extraction approach described in chapter 4 yielded results comparable in terms of 
antibody optical density and prevalence to classical extraction approaches while 
bypassing the challenges associated with the limited logistic facilities in the field, 
like the immediate availability of appropriate cold storage at the time of sampling. 
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Factors that influence sample quality and successful 
detection of parasites  
When collecting field samples directly on filter paper, the total quantity of blood is 
in general lower and less well standardized. Average bloodspots contain up to 50µL 
of blood but typically only a fraction of these spots is used for extraction. Based 
on the use of Whatmann no. 3 filter paper, it is estimated that the volume of fresh 
blood is 1µL/3.5mm2, this relationship between surface area and blood volume is 
linear [15].. Using in vitro cultured parasites spotted on filter papers, we observed 
that the proportion of infections with a density 1 parasite/µL is detected in 100% of 
the instances when stored at -20°C while this proportion declines to 0% when stored 
at ambient temperature for 2.5 years (Chapter 3) [17].
Different extraction methods also impact the yield and possibly quality of DNA from 
filter papers. The two most widely used approaches are the commercial Qiagen kit 
which is based on spin column extraction and a more lower cost extraction approach 
based on saponin incubation and the subsequent boiling of filter paper spots 
samples in chelex resin. In standardized laboratory conditions tests this yielded 
a LOD of around 1 parasite/µL when amplifying the P. falciparum small ribosomal 
subunit gene (18S); a similar LOD was achieved when targeting the mitochondrial 
cytochrome B gene [14]. 
The number of filter paper punches (2.5mm diameter, each) made a difference in 
terms of sensitivity as well, something which is unsurprising since this theoretically 
results in an increased quantity of nucleic template material. Whilst unsurprising, 
our results demonstrate that the quantity of punches can have consequences for the 
interpretation of field data and that this did lead to some additional samples being 
positive. In a random sub-selection of samples from the study described in chapter 
6 the estimated parasite prevalence increased by 3.8% when two filter papers spots 
(diameter 2.5 millimetres , each) were used instead of a single filterpaper punch [10]. 
This contrasts with a large meta-analysis of Okell and colleagues where no influence 
was found of the amount of material used for DNA extraction and parasite prevalence 
[7]. In this meta-analysis, the plausible impact of starting material size may have 
been obscured by inter-laboratory variation in extraction or PCR performance.
Surprisingly the use of commercial kits like the DNA purification spin columns 
from Qiagen did not increase the sensitivity for these specific samples, even 
when optimizing the reaction by the addition of carrier RNA during the extraction 
procedure [17]. This might be due to proper dry, cold-storage of the samples and 
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the short time between collection and extraction. Hwang et al. show that Qiagen 
kits more often recover template material from samples that have been stored for 
over 10 years after initial blood collection and in less favourable conditions [18]. 
Drying of samples seems to be key in successful recovery of nucleic acid; this might 
have a beneficial effect due to the inhibition of enzymatic hydrolyses and therefore 
inhibiting degradation of nucleic acid [19,20]. The detection of Pfs25 mRNA, a target 
utilized to detect the presence of gametocytes in samples has similarly been proven 
to be remarkable successful from filter papers as long as the samples had been 
sufficiently dried and stored at optimal conditions after collection [19]. 
Heterogeneity of genomic parasite material and 
antibodies on filter papers
When it comes to the relative quantification of genomic targets of samples stored on 
filter paper, we observed heterogeneity in the distribution of cellular material within 
the visible spot of blood spotted filter papers. This implies that exact quantitative 
measurements on genetic material derived from filter papers can only be performed 
if one uses material from the complete visible spot during extraction and directly 
measure the quantity of blood applied on the filter paper. One way to circumvent 
the heterogeneity of cellular material on filter paper is to perform a lysis step before 
blotting the blood sample onto the filter paper. Practically, this would involve a pre-
lysis and homogenizing the sample before applying the sample on filter paper. Such 
an approach however would be operationally less attractive in field settings than 
directly spotting blood from finger pricks onto filter papers. Alternatively, genes 
from human white blood cell could be used (such as the human β tubulin gene) 
to normalise qPCR data and allow slightly more accurate quantitative estimates of 
relative parasite density in each individual sample [21]. 
Sensitivity and stochasticity of different nested PCR 
methods
None of the used PCR assays described in chapter 4 achieved 100% sensitivity (for 
sensitivity assessments, true positivity was determined as a sample being positive 
in at least 2/3 of the PCR assay variants) when performed in-duplo, indicating there 
is a stochastic element involved in the detection of parasite DNA in samples [14]. 
Theoretically a single present gene copy within a reaction should be sufficient 
to allow amplification. However, as parasite densities become lower, chances of 
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potentially pipetting a genome fragment into the PCR reaction also decline. The 
stochastic element in PCR is also important when comparing diagnostic performance. 
Results derived from molecular assays such as PCR are often interpreted as the 
true positives based on the assumption it obtains the most sensitive and specific 
results for malaria diagnosis. In cases where a sample might be deemed positive by 
microscopy or RDT but shows negative in a screen with PCR it is often interpreted as 
a false-positive by microscopy or RDT. However, this may oversimplify matters. Our 
data demonstrates that false-negative PCR results are not uncommon and need to 
be incorporated in the interpretation of epidemiological surveys that use multiple 
diagnostic approaches. 
The specific genetic targets that can be used for detection of malaria parasites also 
vary in stability and copy number. In malaria parasites mitochondrial targets seem 
to result in a higher sensitivity [14,17,18]. This is probably attributed to the larger 
abundance of mitochondria and the more robust encapsulation of the genetic 
material within the mitochondria, rendering the genetic material more resistant to 
degradation [17,22]. 
Combining molecular and serological methods
The optimization of the collection of whole blood on filter paper, the assessment of 
storage conditions and extraction methods [17] in addition to the described dual 
extraction assay, offer a more affordable, high throughput tool to assess transmission 
intensity and the detection of hotspots of malaria transmission [14].
The combination of both current (DNA) and historical malaria exposure (antibodies 
against AMA-1/MSP-119 ) gives a more accurate estimate of areas that experience 
more intense malaria transmission. As shown in chapter 6 the association between 
serological data and PCR data is strong [14]. Especially in low-endemic settings 
where low-density infections are prevalent, the addition of serological data can be 
utilized to detect hotspots of malaria transmission. Antibody yields from single cut 
filter papers with the dual extraction methods and separate extraction were highly 
similar (R2 = 0.93, p = <0.0001) [14]. The used antigen specific antibodies that are 
measured in serological assays can’t reliably measure gradual or short-term changes 
in P.falciparum exposure either at the population or individual level for example 
to evaluate the impact of the deployed interventions. At present this is one of the 
reasons sampling strategies include age-stratified sampling, to allow the generation 
of age seroprevalence curves and provide information on parasite exposure over 
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different periods, reflected by different age strata. New serological markers might 
offer an attractive alternative here. In a study which screened 856 antigens for 
their utility to more accurately estimate the time post last malaria infection, three 
new antigens were identified which accurately assessed whether individuals 
were infected within stratified periods of 30, 90 or 365 days [23]. Combinations of 
responses against different antigens may provide a more informative signature of 
past or recent exposure compared to single antigens. In addition newly identified 
antigens like Anopheles gambiae salivary antigen (gSG6), could potentially serve as 
a the basis of serological tools to estimate malaria vector exposure as an alternative 
to often resource intensive classical forms of vector surveillance [24], especially in 
areas where malaria vectors bite outdoors. Outdoor biting is a growing problem in 
sites close to our own study area [25] and will require more innovative surveillance 
approaches. 
Another limiting factor in large scale epidemiological surveillance studies is the 
operational cost of sample collection, extraction and sensitive screening methods. 
Filter paper collection (on Whatman 3mm paper), averaged at 0.07USD per sample. In 
comparison costs of whole blood collection in EDTA microtainers (maximum volume 
500 µL) varies between 0.19-0.35USD for self-made EDTA tubes or commercial EDTA 
microtainers respectively. If a nucleic acid stabilizer (mostly required for RNA-
screening) is included, which is often required when collecting liquid whole blood 
in field studies and in absence of direct cold-storage, an additional cost of 0.08-
0.80USD (depending on sample volume 50-500µL) must be taken into consideration. 
Costs ranged from 0.56USD for saponin-chelex to 2.5USD for Qiagen spin column 
extraction. The total cost to augment more accurate estimations of malaria based on 
current infections (nested-PCR) and history of exposure (serological measurements, 
based on AMA-1 and MSP-119 antibody detection) with blood samples collected on 
filter paper range around $2,80 per sample using the methodologies described in 
this thesis. 
A quantitative estimate of parasites densities might have been insightful for this 
study to investigate the relation between parasite densities and history of exposure 
to malaria. The relationship between parasite density and exposure is complex 
and seems be related to endemicity and history of malaria transmission [26,27]. A 
study performed in a moderate transmission setting in Tanzania showed that high 
exposure households in general showed a tendency to have lower density infections 
and in this specific setting over 56% of the infections had densities lower than 100 
parasites/µL, meaning they would very likely be missed if RDTs or microscopy would 
have been used for screening [26,28]. This is in line with the findings of large study 
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done by Okell et al. [7] which indicates that screening by microscopy would have 
shown us a microscopy based prevalence across the different hotspot intervention 
between 5.7 and 7.9% while the actual determined PCR prevalence was between 
18.6 and 23.5%.
More recent developments in molecular detection of malaria parasites increased 
the sensitivity 10-fold, something that the new generation of more sensitive RDTs 
can’t match [29]. The increase in sensitivity by molecular methods is achieved by 
targeting multi-copy sub telomeric sequences, reducing the LOD towards 0.03-0.15 
parasite/µL [30] whilst integrating better quantitative estimates by moving to qPCR 
methodologies [29]. Data derived from a cross-sectional study conducted in Tanzania 
indicated that in practice this resulted in the detection of 16% more infections, 
of which 40% carried gametocytes and were therefore plausibly contributing to 
onward transmission to mosquitos [30]. This indicates that screening individuals for 
the presence of gametocytes is not required to detect the majority of the infectious 
reservoir in some settings. If persons carry parasites, even in low-endemic settings 
like ours, there is a considerable likelihood that they will actively contribute to the 
transmission cycle and should be considered in intervention approaches aiming for 
malaria control and elimination [6,31] despite this the evidence for the contribution 
to onwards transmission is incomplete for submicroscopic subpatent infections [8].
Finding the last parasite: from asymptomatic to 
submicroscopic infections
In support of many other studies [6,13] we observed high proportions of asymptomatic 
individuals in our study. 94% of individuals with PCR confirmed infections in our 
baseline surveys lacked febrile illness at the time of sampling. The occurrence of 
such, ‘asymptomatic’, infections is becoming more evident in areas with medium 
to low transmission and is to be thought widely distributed among different age 
groups [32–34]. In the studies presented in Chapter 7&8 asymptomatic infections 
which were not detected by RDT were found in children below 5 years of age [33]. 
Since these proportions of asymptomatic infections were determined in the scope 
of a cross-sectional study design and individuals were not followed up in time it is 
logical to assume that a fraction of these infections will progress to a more severe 
state and might show clinical illness at some point. Yet there is strong evidence of 
a large proportion of individuals who suffer from more chronic malaria infections 
without obvious symptomatic illness [35]. Such infections have been reported to last 
over 18 months, even spanning between sub-sequent transmission seasons [36,37]. 
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In addition to the carriage of gametocytes and their role in onward transmission (as 
described in Chapter 1 & 2), there are documented consequences for individuals 
suffering from these sub-clinical infections. These symptoms might not be directly 
associated with mortality or acute disease but do have an impact on health and 
development of especially children. In a review written by Chen et al. a plea was made 
to actively consider such sub-clinical cases in intervention programmes for reasons 
other than transmission interruption [38]. Such infections can lead to reoccurring 
episodes of symptomatic malaria. Lower levels of haemoglobin and chronic 
aenamia have also been associated with subclinical infections  as well as placental 
parasitaemia which poses a health risk for both mother and child [39]. More recent 
evidence also shows an impact on cognitive function  and school performance in 
children of school going age [38]. An overall decline of malaria infections has also 
been associated with a decline of all cause hospitalisations in Kilifi, Kenya [40]. What 
is becoming increasingly evident is that ‘asymptomatic’ infections should be actively 
be taken into consideration in intervention programmes both from a transmission 
point of view as well as from the clinical perspective. 
In chapter 7 it was shown that, a large percentage (65%) of asymptomatic infected 
individuals have molecular detectable levels of gametocytes in circulation and 
therefore likely play a significant role in onward transmission [41–43]. Naturally, 
these percentages will vary depending on the historical and prevailing transmission 
intensity [44]. In a study performed in Burkina Faso with high transmission rates 
it was shown that >90% of the mosquito infections were likely due to individuals 
with asymptomatic infections of which >28% would likely be undetectable by RDT 
or microscopy (asymptomatic undetectable) [31]. How to include these individuals 
in intervention programmes remains challenging but utterly relevant if the aim 
is to clear the infectious reservoir and prevent reinfection. To that extend there 
is evidence that microscopically detectable asymptomatic infections should be 
targeted, but the evidence for sub-microscopic infections in less clear [7,8] and may 
be dependant on setting and vector competence.
Factors contributing to heterogeneity in malaria 
exposure on fine spatial scales
An array of factors have been associated with heterogeneity in malaria transmission 
as described in detail in chapter 2 [45]. This includes ecological factors [46], that 
mostly impact the development, competence and survival of both the vector and 
parasite [47], like altitude [48–50], temperature, aridity [47], surrounding vegetation 
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types [48], and wind direction [51]. Other influencing factors are more related to 
individuals like genetic factors [52,53], human behaviour and socio-economic 
constructs associated with occupation, travel and characteristics related to house 
building features [49,54–56], and proximity of humans to mosquito breeding sites 
[51]. The complex variations in these factors can result in foci or hotspots of locally 
higher malaria transmission: a phenomenon that is most apparent in areas of lower 
transmission but is likely to exist at all levels of transmission [5,57]. 
The data presented in this thesis shows that variation occurs on every geographical 
scale. Within large geographical areas but even within designated foci there is 
variation observed between neighbouring households or compounds [33]. 
GIS methodologies including remote sensing allowed us to derive altitude from 
a digital elevation model (DEM; ASTER GDEM), and to gather other geographical 
data including topographic wetness indices (TWI) [58], and proximities of rivers 
and smaller streams which were estimated using the DEM and more accurately 
annotated high resolution satellite images. Using these data we found that the most 
profound factor associated with malaria risk in our area was altitude (range 1350-
1600m); using narrow altitude bands (50m intervals) a negative correlation between 
altitude and PCR confirmed infection was clearly observed (r = 0.92, p < 0.0001) 
[59]. A substantial number of malaria infected individuals was also found at higher 
altitudes, at altitudes above 1500m parasite prevalence reached 15.3%,  a notion 
which was is generally assumed very uncommon [60].  Though we anticipated 
finding broad altitude dependency in the entire study area, we were surprised by 
our observation that the effect of altitude on malaria was significant in smaller 
geographical confinements. In addition to the expected occasional single cases of 
malaria (nPCR/RDT positive) we also found high risk households at altitudes above 
1500m  (3.8%, 29/773). High risk households were classified as households with a 
minimum of 3 residents of which over 80% of the household had malaria determined 
by PCR. Also, at altitudes above 1500m, the clear majority (>90%) of these cases 
did not present any fever at the time of visit. This is an important finding, since the 
existence of such households and asymptomatically infected individuals at these 
altitudes is not generally assumed. The existence of such high burden household 
might be explained by micro-epidemiological factors, like man-made habitats where 
vectors can breed [61]. It was not uncommon to see households at higher altitudes 
with (abandoned) fishponds or borrow pits in the direct vicinity of the households. 
Fishponds both active and abandoned and borrow pits have been linked to increased 
vector densities at higher altitudes [61,62]. In line with other findings [49,63] malaria 
risk decreased with increasing distance to waterbodies. In our study area malaria 
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prevalence was highly heterogeneous at all altitudes (between 1350-1600m), this is 
frequently reported in areas with declining endemicity or lower prevalence [5,48,64]
and has been previously been reported for clinical cases in the Western Kenyan 
highlands [64].  
Although studies have indicated that within house exposure to mosquitos might be 
low in our study area, we found household factors like the presence of closed eaves 
or higher quality walls (mud vs brick/concrete) of sleeping areas lead to a lower 
risk of malaria infection. This indicates that relative small intervention measures 
on household level could greatly reduce malaria risk, something that has been 
demonstrated in other studies as well [65–67]. In a study where data from 21 African 
countries and over 84,000 households was analysed, it was concluded that living in 
more modern housing (metal roofs and brick or concrete walls) reduced the odds of 
malaria between 9-14% [68]. A study from Asia, Cambodia described the importance 
of household level and socio-economic characteristics as factors explaining micro-
epidemiological patterns of asymptomatic malaria, highlighting the importance of 
focussing attention of intervention programmes on house improvements [69].  Many 
studies have found an association between travel and the risk of malaria infection, 
mostly with individuals travelling from and to higher prevalence areas [70]. In this 
study there was no significant correlation found between these factors, although 
other studies conducted in the highland areas of western-Kenya did identify travel 
as a risk factor [71,72]. In our study, travel associated malaria risk might have gone 
unnoticed because other factors that sustained transmission played a larger role in 
individuals getting infected or because transmission was already relatively high in 
our study area. Travel and imported cases should be taken in account and could play 
more of a prominent role when levels of transmission decline further in Rachonyo 
and individuals would travel back from higher endemic areas. [73,74]. 
In chapter 7 we described a method to potentially address this importation of 
malaria cases that could seed local transmission with a novel f(ocal)MDA approach. 
This approach aims to maximize the detection and treatment of the majority of 
the infected individuals within the population while taking in account some of the 
operational challenges. This is achieved utilizing a sentinel population that is more 
likely to be parasite positive, with the assumption that when there are infected 
individuals in a household it is likely that other household members are infected 
as well [33]. In our study the sentinel population (≤15 years and febrile adults) 
was screened by RDT (pLDH/HRP-2 combo test), and if one of this sentinel group 
members was malaria positive the entire household was treated. This approach may 
be more attractive than Mass Screen and Treat (MSAT) and Mass Drug Administration 
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(MDA), both in terms of operational feasibility, impact, and cost-effectiveness. As 
described in Chapter 1, MDA campaigns are based on the administration of curative 
doses of antimalarial drugs to populations within larger geographical confinement 
irrespective of parasite carriage [75]. MDA intervention strategies typically overtreat 
populations which invariably leads to unnecessary drug exposure in areas with low 
parasite prevalence and might accelerate the process of drug resistance development 
and spread [76,77]. MSAT campaigns screen individuals with a diagnostic before 
curative drugs are administered to parasite positive individuals [78]. Although 
current pLDH/HRP-2 based RDTs play an essential role in the diagnosis of clinical 
malaria, their sensitivity is insufficient in areas of low transmission. When used in 
MSAT to detect all infection, RDTs tend to miss a substantial proportion of low-
density infections [6,79]. Covering and treating the whole infected population and 
sustaining a longer term effect for either approach remains challenging without the 
augmentation of vector control efforts[75,80–82].
The fMDA approach we deployed did achieve a relatively high detection rate, by 
screening approximately 50% of the total population living in the screened areas 
77.3% of malaria infected individuals (positive by nPCR) were identified after a single 
round of screening by RDT. If a more sensitive approach like nPCR was applied to 
screen the sentinel population, and treatment was administered to all household 
members if at least one sentinel household member was found nPCR positive, 89% 
of the total of infected individuals would be correctly identified and treated.  
On the other hand, if a full MDA strategy would have been applied in our area, almost 
three quarters of the population would have received treatment without having a 
current infection. Individuals who would have received treatment in the absence of 
ongoing infection would have still benefited of the prophylactic effect of ACT, which 
last around 14 days, depending on the type of combination therapy [83]. Infections 
in the population would have been largely cleared regardless of symptoms whilst 
including those with submicroscopic infections [82]. Such submicroscopic infection, 
would not likely be detected by RDTs of even more recent Ultra-sensitive RDTs [29].
Individuals with submicroscopic infections in our sentinel population were likely to 
be younger and had less complex infections (based on the mean number of different 
MSP-2 clones [84]). Although children often suffer from more severe infections 
associated with higher parasite densities it was remarkable to find such a high 
fraction of submicroscopic infections in the youngest age groups, especially in areas 
with the lowest measures of average parasite prevalence [79]. This enforces the 
recommendation for the use of more sensitive screening methods for surveillance 
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in low endemic areas to properly detect the entire human parasite reservoir [32]. 
Although our identification and treatment of 77.3% of the infected population after 
a single round of RDT screening of the sentinel population is not a disappointing 
result, it remains unknown what coverage would be needed to achieve reduction of 
transmission for sustained periods. In our transmission setting, this level of coverage 
is unlikely to be sufficient to interrupt transmission longer term, to a stage where it 
even could be halted. This seems supported by MDA simulated models conducted 
by Brady et al. in which at 70% coverage a reduction of 61% would be observed in 
Pf. parasite rate [82].
The detection of hotspots and the impact of hotspot 
targeted intervention in an area of heterogeneous 
malaria transmission in the Kenyan highlands
Within the presented study site (5 x 20km), 27 statistically significant hotspots were 
identified based on spatial scans using serological data (seroprevalence and age-
adjusted antibody-densities) against two antigens (AMA-1/MSP-119); identifying 
sections of the study area where anti-body density and prevalence were higher than 
local average values (p<0.05). The hotspots covered 34.7% of the total surface study 
area and harboured 44.4% of all sampled individuals [85] as described in Chapter 
8 . Although nPCR data was not used in our methods of classifying hotspots, 
serological data did correlate well with parasitological and entomological indicators 
[86,87]. This indicated that the selected hotspots were hotspots with active ongoing 
transmission. The strong association between serological and nPCR prevalence 
(on both the individual and geographical level), the occurrence of widespread 
subclinical infections in all age-groups [85] and the strong association of antibody 
and PCR positivity with several environmental and social-economic risk factors [88] 
suggest that the majority detected hotspots is of a more stable nature since their 
existence seems largely dependent on more permanent factors. This was supported 
by the finding that nPCR prevalence declines with an increasing distance from the 
serologically defined hotspots centre. In other studies that looked into the stability 
and detectability of hotspots, it was noted that in some cases hotspots of subclinical 
malaria were more stable over time, but those with febrile malaria seemed more 
unstable or mobile [48]. This could be in part explained because subclinical infections 
are more often observed in malaria endemic areas with stable transmission, which 
may be attributed to high rates of immunity which prevents the progression to 
febrile illness, which leads to more subclinical infections within stable hotspots [48]. 
Hotspots consisting mostly of febrile and symptomatic cases could be unstable due 
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to transient periods of increased malaria infection which arise due to the increase 
of mosquito populations following seasonal rain periods [25,89,90]. In our study 
hotspots mostly consisted of asymptomatic individuals; such hotspots are more 
likely arise from areas with more stable transmission [70].
Determining or even forecasting where hotspots will appear based on remote sensing 
data (like satellite images and environmental data derived from such images) remains 
challenging although it has been attempted on numerous occasions  [91,92]. Such 
methods have remained largely unsuccessful in areas with declining transmission 
where foci of transmission tend to become smaller and factors beyond environmental 
factors play a role in transmission [46,70,91–93]. Where environmental factors play a 
more dominant role these could also be mapped with the use of unmanned aerial 
vehicles like the Medizdroids [94,95], especially in areas that are hard to reach by foot. 
Such vehicles might ultimately be utilized to guide the application of environmental 
interventions such as larvicides by pinpointing the exact location of even the smallest 
water bodies. In future scenarios such vehicles might even be used to simultaneously 
identify and treat waterbodies with larvicides [94].
Out of the 27 hotspots we identified, ten eligible hotspots were randomly selected 
as part of a cluster randomized trial to assess the impact of hotspot targeted 
interventions, five in the intervention and five in the control arms. Previous 
simulations showed that the impact of interventions with universal deployment 
of LLINs and IRS coverage would likely interrupt transmission within and outside 
the intervention area, bringing parasite prevalence down to <5% as well as having 
a sustained effect for years to follow [5,96]. A study that investigated community 
benefits of LLINs in the highlands of western Kenya showed that the impact of 
the intervention was measurable up to 500m from the intervention boundaries 
[97]. These findings were used to designate evaluation zones outside the original 
hotspot border. Two evaluation zones were identified, up to 250m and 500m around 
the hotspot borders. To prevent spill over from adjacent hotspots there was a 
minimum distance imposed of 1km from the evaluation zone border to the nearest 
neighbouring hotspot, assuming this would minimize the risk of vector dispersion 
interfering with the intervention outcomes [98]. The five hotspots in the intervention 
arm received an extensive package consisting of four interventions aiming to reduce 
transmission by targeting the human parasite reservoir and the vector population 
(as described in chapter 8). 
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In our study, the intervention did have an effect inside the intervention hotspots, 
although nPCR results need to be interpreted with caution. During the first 
assessment of the impact, nPCR parasite prevalence declined from 20.1% [range: 
6.3 -33.9%] to 9.2% [range 5.1-13.5%] in the intervention hotspots, while remaining 
relatively constant in the control hotspots. However, the durable impact of hotspot 
targeted interventions in this study context was not very convincing nor did we 
observe an impact in evaluation areas around the designated hotspots (Chapter 
8, table 3). Transmission was never completely interrupted, and sixteen weeks 
post intervention there was no statistically significant difference detected between 
control and intervention hotspots. Noteworthy was that 4.1% of the individuals 
residing in the intervention hotspots who were nPCR negative became nPCR parasite 
positive within 8 weeks, suggesting ongoing transmission during this period. This 
is remarkable considering the intensiveness of the intervention package and the 
measured low-levels of baseline transmission in the area. [99]. It could have been 
possible that these infections were already present but simply not detected to 
stochasticity or fluctuation in detectability at the time of sampling. 
There are several explanations for the somewhat disappointing impact in this 
context. Although spatial resolution was high, and hotspots were defined based 
on a baseline survey that took in account a large number of households and 
individuals, not all parasite positive household members were treated during 
the intervention, despite the high coverage and compliance for all interventions 
(≥84%). More importantly, it is possible that households outside the hotspot with 
parasite positive individuals were located right outside the hotspot border or even 
adjacent to our study area frame. We did find households where a high proportion 
of inhabitants (>80%) were nPCR parasite positive outside hotspot borders. In fact, 
32.5% of these households were located outside the detected hotspots (Chapter 8, 
figure 2D). Hence, the outside border of the actual hotspots might have not been 
that clear cut and our approach might not have been sufficiently conservative in 
placing the hotspot boundaries. Within another study, not presented in this thesis, 
which utilized data from the same study area, it was determined what the effect of 
sampled population size and the use of different metrics like serology or parasite 
detection by nPCR would be on the placement of hotspot boundaries. There was a 
considerable variation in the boundaries of defined hotspots. A considerable loss of 
accuracy in hotspot borders was observed if less than 21% of the total population 
was sampled. This would  lead to an average of 38% (seroprevalence) and 51% (PCR-
prevalence) of the structures in hotspots being misclassified as being outside the 
hotspot boundary [100]. 
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When considering the variable but on average high R0 of malaria under vector 
favourable conditions [2,57,101], reinfection of previously cleared areas might have 
occurred rapidly, especially when taking into account that a long intense rain season 
(with flooding) started directly after initial delivery of the four interventions. These 
extensive rainfalls might especially have affected the effectiveness of larviciding 
granulates in treated water bodies. 
The addition of larvicides (B. thuringiensis var. israelensis) to the intervention package 
was specifically added to address the issue of increased rates of outdoor biting 
behaviour exhibited by malaria vectors in the area which possibly resulted from the 
wide upscaling of the use of IRS and LLINs in the region [102,103]. Despite the intensive 
vector control measures that were deployed, we still found active mosquito breeding 
sites. This highlighted how challenging it is to apply larviciding in each waterbody in 
a particular dynamic landscape. 
Resistance against deltamethrin and permethrin has been reported in the area for both 
A.funestus and A. gambiae but there is no evidence that this has affected the efficacy 
of routine control efforts in the region [104,105]. At the time we chose intervention 
measures which were thought to be most suitable and efficient in the provided study 
context. The LLINs selected for this intervention study included piperonyl butoxide 
which increases the efficacy of deltamethrin in resistant vectors [106]. 
As mentioned, our fMDA campaign managed to identify approximate 77.3% of all nPCR 
parasite positive individuals in the study area (chapter 7), however we don’t know if 
the missed fraction, likely to be low-density infections, would be able to sustain and 
ultimately refuel transmission [8,31,41,44].
Most routine interventions implemented on national or regional levels tend to run for 
multiple malaria seasons to retain effectiveness and bring transmission down to a level 
where it is low enough to be sustained [1,82,107]. The impact of our intervention might 
have benefitted from another round of fMDA within weeks of the first round and would 
have depleted the remaining infectious reservoir to lower levels since a proportion 
of subclinical infections might have progressed to infections with detectable levels 
of parasites by RDTs [44]. Without continued surveillance, and resources to sustain 
vector control in regions where malaria has been reduced, reinfection is likely to occur 
if environmental factors that support an ecological niche for vector establishment 
and transmission remain present [82]. This is what likely occurred after mass screen 
and treat campaigns in Zanzibar [79] and in other settings where interventions were 
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scaled back due to reduced funding or political developments as recently occurred in 
Venezuela [108,109]. 
Considering the practical detection of hotspots in our presented study, we need 
to take in account that our surveys were done with a methodology that resource 
wise is not cost-effective in this specific setting and with this specific impact.  Wide 
scale deployment of our intervention package would by far exceed any annual funds 
available for routine surveillance and malaria control programmes in Kenya or other 
countries in sub-Saharan Africa [110]. However, this study had the primary objective 
to assess if we could reliably identify hotspots and what the impact of hotspot 
targeted interventions could have been in an ideal scenario. The study was the first 
of its kind to assess this on such a large yet densely sampled scale. We do believe that 
our study area was representative of numerous other areas in the East African setting 
with low level spatially heterogenous malaria transmission. In our study area either 
transmission levels were too high or too widely dispersed to allow a large impact of 
a hotspot targeted approach. A blanket, community wide approach with LLINs and 
IRN would have possibly been warranted for a longer period until transmission levels 
would have been more suitable for targeted interventions within more isolated foci. 
Future perspectives
A changing landscape towards finer scale interventions
It’s clear that global efforts towards malaria control and elimination, especially in the 
last 15 years have had a significant positive impact on global mortality and morbidity 
caused by malaria [111]. An increasingly large number of national governments 
and malaria research and funding agencies are shifting their attention from control 
to elimination [1]. With the set goals within the Global Technical Strategy for 
Malaria  milestones for 2020, global partners aim to eliminate malaria in at least 10 
countries that were endemic at the end of 2015. WHO considers a country eligible 
for certification of malaria elimination after it has reported zero indigenous cases 
of malaria for at least 3 consecutive years. Between 2000 and 2016, 18 countries 
managed achieved zero indigenous malaria cases for at least 3 years. Of these 
countries 10 achieved this between 2011 and 2016. As of 2016 (report year 2017), 44 
countries are nearing elimination [1].
While moving towards elimination it is evident that the epidemiological parameters 
of transmission will change. Surveillance and intervention programmes need to 
adapt in accordance with these changes if elimination and ultimately eradication is 
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to be achieved. Within the current global budget allocated for malaria control and 
elimination efforts, it will not be possible to achieve universal coverage of currently 
used interventions. This directly implies available resources must be more rationally 
allocated to the areas where they might have the highest impact. 
In a modelling study presented by Walker et al. [110] it was estimated which 
interventions would be most efficiently allocated to achieve reductions of 
Plasmodium falciparum malaria burden and transmission in Africa. They concluded 
that this heavily depends on the goal either being disease reduction or elimination. 
Classical interventions like LLINs were considered to be generally the most cost-
effective first choice intervention measure, followed by IRS and seasonal malaria 
chemoprophylaxis (depending on patterns of seasonality and vector species). This 
would lead to an estimated reduction to less than one case per 1000 people per 
year in roughly 43.4% (95% C.I. 40.0-49.0) of the population at risk in Africa. Adding 
three rounds of MDA administration to the package would increase the proportion 
to 90.9% (95%C.I. 86.9-94.6). Tailoring malaria interventions based on policies on a 
smaller spatial confinement like the provincial level was estimated to reduce costs 
by 32.1% (95% C.I. 29.6-34.5) in comparison to nationwide policies. The approaches 
presented in this study, if further explored, might offer an approach to better target 
intervention to smaller confinements. 
The relevance of asymptomatic low-density infections for malaria 
control programmes
Declining levels of transmission within foci will initially result in less severe cases  due 
to the reduced force of infection and lower parasite densities. This potentially poses 
challenges for detection of infections with routinely available diagnostics. In our 
specific study area targeting remaining pockets of transmission will initially require 
identification of such pockets or more ideally predicting where such hotspots would 
occur. Ideally, this will require a scale up of more sensitive diagnostic and operational 
attractive assays that can detect infection with low densities of parasites. The current 
generation of ultra-sensitive P.falciparum RDTs offer an operationally attractive 
alternative to molecular diagnostis but when compared to ultrasensitive quantitative 
PCR (with larger blood volumes) they miss a substantial number of gametocyte 
positive (Pfs25) low-density infections [29]. Measuring gametocyte densities in 
circulation might not be the best proxy for the probability of onward transmission 
although gametocyte densities are positively associated with successful mosquito 
infections in mosquito feeding assays [34]. Onward transmission might be more 
dependent on the density and presence of mature gametocytes in subcutaneous 
tissues [112] and more importantly, the majority of infections appear to produce 
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gametocytes at some point during the infection [6]. To what extend malaria control 
programmes can benefit from detecting the whole “iceberg” of infections remains 
unexamined. Current more sensitive molecular tools are not sufficiently adapted 
to be applied in resource limited settings at this time, but such tools are under 
development although cost will remain high for the foreseen future [113–115]. 
The current value and remaining questions around hotspot targeted 
interventions
As with all infectious diseases it is a constant arms race between the transmission 
and adaptation of pathogens and different intervention strategies. Non universal 
coverage, limited adherence, over-use, or poor quality [116] of anti-malarial 
drugs [117,118] and insecticides [119] will ultimately always result in resistance if 
elimination is not achieved before this turning point. Hotspot targeted interventions 
have been used in a regional study looking at the effect of generalised access to early 
diagnosis and treatment of malaria in the Greater Mekong region in south-East Asia 
[107]. A region with widespread artemisinin resistance [120], urging actors to act 
swiftly and develop strategies to interrupt transmission. Within this study hotspots 
were defined as villages with >40% malaria prevalence of which 20% P.falciparum 
detected by an ultra-sensitive quantitative PCR. Each village was provided with 
access to early diagnosis and treatment through community-based malaria posts. 
In addition, each hotspot was covered by rounds of MDA for 3 consecutive months. 
P.falciparum incidence declined between 60-98% in a period of 3 years indicating 
considerable potential of the approach described in this non-randomized study. The 
approach used in the Greater Mekong region was based on assumption similar to 
those underlying our intervention study. 
However, in our study such success was not obtained, raising questions on how to 
define a hotspot and what role it plays in sustaining transmission [70,121] at different 
endemicities.  Hotspot targeted interventions may work, as became evident from 
the study conducted in the Greater Mekong Region. Key to its success will be how 
we can systematically define hotspots based on available metrics collected under 
routine surveillance. General surveillance is improving in many African countries. 
In parts of Kenya a Health and Demographics Surveillance Systems (HDSS) has 
been established as of 2012 [91]. Initially the system in western Kenya was set up 
to monitor the impact of implementation of ITNs but it has far expanded beyond 
the monitoring of the impact of malaria interventions and now covers over 220.000 
individuals from whom blood samples are taken to screen for malaria (RDT, in some 
cases molecular assays and serology),  among other diseases [122]. Such surveillance 
systems have been key in tailoring intervention campaigns within narrower spatial 
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frames and monitoring the impact of such interventions. That said, there is ground 
to gain with the currently available methodologies, but it will likely not be sufficient 
to move towards elimination of malaria in all countries that have been certified as 
moving towards elimination.  
The availability of novel interventions like transmission blocking vaccines could 
inhibit transmission for a longer duration allowing other interventions to clear the 
existing parasite reservoir without the pressure of reinfection. However, as with 
many vaccines the question remains how long they will retain their effectiveness. 
This goes for vaccines like the pre-erythrocytic vaccine RTS,S/AS01 as well [123], 
which shows only short lived efficacy of protection after administration both in 
adults and children even after additional booster dosages [124]. More than novel 
tools though, what will be key is the available means to boost the wide availability 
of current intervention strategies like ITNs and currently available effective curative 
drugs, since these are still effective interventions at this point in time [110].
During the studies presented in this thesis we aimed to identify factors that explain 
heterogeneity and the formation of hotspots and assessed if hotspot targeted 
interventions would be an efficient tool to interrupt transmission in an area of the 
western-Kenyan highlands. Although not successful in completely interrupting 
transmission, the author of this thesis still believes that more tailored targeted 
interventions are a cost-effective way to move forward looking at the limited funding 
available for general malaria control programmes. How to identify such hotspots 
and which tailored package of interventions would be most effective to interrupt 
transmission is likely to be very dependent of the specific characteristics and our 
understanding of such foci and its transmission reservoir within different endemic 
settings [121,125]. 
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Summary
In the last decades tremendous efforts have been made by the global health 
community to reduce malaria related mortality and morbidity. Between 2000 and 
2015 cases of malaria almost halved, mainly due to large scale investments in 
key interventions such as the wide distribution of long lasting insecticide treated 
nets (LLINs), the application of indoor residual spraying (IRS) of households with 
insecticides and making curative drugs (Artemisinin Combination Therapy, ACTs) 
more widely available across malaria endemic countries. Despite these efforts’ 
malaria remains a disease that leaves its devastating mark in many areas of the 
world. With the number of cases declining globally, it is slowly becoming evident 
that malaria risk is not uniformly distributed across countries, provinces, villages or 
even individual households. The factors contributing to this heterogeneity are not 
always well understood however do offer potential for more targeted inventions 
which could potentially assist malaria control and elimination programmes in better 
tailoring interventions according to the local context and save valuable resources. 
The work described in this thesis attempts to address some key questions to assess 
the feasibility of these targeted interventions by putting theory in practice in an area 
in the Western Kenyan highlands that has observed significant declines of malaria 
and is now marked as a pre-elimination setting. In Section I of this thesis we look 
at the theory behind heterogeneity of malaria exposure and risk, and hypothesize 
if hotspots of intensive transmission can be detected and if targeted interventions 
could be effective as a control strategy.
The evaluation of malaria control efforts relies on the generation of knowledge of 
local transmission dynamics. The accuracy of such data for the purpose of scientific 
studies or surveillance is greatly dependant on diagnostic tools that can assess 
current and past infection with malaria in individuals. Especially in low endemic areas 
where many infections will be missed due to the limited sensitivity of diagnostics 
such as microscopy and rapid diagnostics tests (RDTs) the need for more sensitive 
diagnostics becomes evident. To assess the true extend of cases that are infected 
with parasites and get an idea of the history of exposure to malaria we present 
an operationally attractive tools box that allows for convenient sampling in areas 
devoid of cold-storage facilities using dried blood spots  (DBS) and low volumes of 
blood in section II of this thesis. In chapter 3 we determine how stable DNA remains 
within blood samples that have been collected as dried blood spots and investigate 
the effect of different storage temperatures, the duration of storage and different 
methods of extraction on the successful detection of parasite DNA. Samples stored 
for two years or more at ambient temperature showed a significant decline in the 
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successful detection of parasite DNA. Samples stored at ambient temperature for 
10 years or more with higher parasites densities (>1000 parasites/mL) only showed 
a positive result in 10% of the cases. Conversely, DBS and extracted DNA stored at 
−20°C showed no loss of sensitivity with time. Samples with lower parasite densities 
extracted using the cheaper chelex/saponin extraction method as described in 
chapter 4, amplified better compared to the more expensive spin-column-based 
extraction. Both extraction methods yielded DNA that was stable even after 20 
freeze-thaw cycles. These results suggest that DBS should be stored at −20°C or 
extracted immediately, especially if anticipating 2 or more years of storage.
Using DBS for sample collection proved stable and allowed for the detection of 
serological and molecular markers, which have demonstrated great sensitivity in the 
quantification of transmission intensity in low endemic settings where the sensitivity 
of traditional methods is limited. DBS are a commonly used source of both DNA 
and antibodies. Yet, to further enhance the operational utility of these methods for 
use in large scale malaria surveys the utility of near simultaneous extraction of DNA 
and antibodies from a single DBS was assessed in chapter 4. This method yielded 
comparable results to separate extraction processes. Doubling the amount of 
blood samples (by adding an extra DBS snippet) increased PCR sensitivity. We have 
showed that the concentration of cell and antibody material was not homogenously 
distributed throughout blood spots which has possible implications when exact 
quantification of parasite material is required.
In section III of this thesis we moved from theory to practice. In chapter 5 we 
have described detailed study protocol to assess the detection of hotspots and 
subsequently targeting these with intervention to determine the impact of 
focussed intervention strategies. The western-Kenyan highlands are fringe regions 
between stable and unstable malaria transmission. Which factors contribute to 
the heterogeneity of malaria exposure on different spatial scales within larger foci 
has not been extensively studied in that setting. In a comprehensive, community-
based cross-sectional survey including over 17.000 individuals an attempt was 
made to identify factors that drive the macro- and micro epidemiology of malaria 
in a fringe region using parasitological and serological outcomes. Malaria antibody 
prevalence did strongly correlate to altitude. A strong negative association with 
increasing altitude and PCR parasite prevalence was found and parasite carriage was 
detected at all altitudes and in all age groups. Over 93% of the malaria infections 
(detected by molecular tools) were asymptomatic in our setting. Malaria parasite 
prevalence was associated with age, bed net use, house construction features, 
altitude and topographical wetness index. Antibody prevalence was associated 
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with all these factors and distance to the nearest water body. Although altitude was 
a major driver of malaria transmission in this study area, the large proportion of 
asymptomatic parasite carriers at all altitudes and the age-dependent acquisition 
of malaria antibodies did indicate stable malaria transmission. In addition, the 
strong correlation between current parasite carriage and serological markers of 
previous malaria exposure did indicate temporal stability of spatially heterogeneous 
transmission. The findings of a large proportion of asymptomatic malaria cases does 
offer potential for a focal screening and treatment approach which is described in 
chapter 7. To address the limitations of mass screening and treatment approaches 
currently which fail to identify a considerable fraction of low parasite density 
infections and mass treatment exposes many uninfected individuals to antimalarial 
drugs we designed and tested a hybrid focal screen and treat approach to screen a 
sentinel population with the aim to identify clusters of subpatent infections. Within 
this study we did find that households with Rapid Diagnostic Test (RDT) positive 
individuals in the sentinel population were more likely to have nPCR-positive 
individuals in the same household. The sentinel population identiﬁed 64.5% (locality 
range: 31.6%–81.2%) of nPCR-positive households and 77.3% (locality range: 
24.2%–91.0%) of nPCR-positive individuals. This indicates that in low-endemic 
areas utilising a focal screening approach with RDTs prior to high-transmission 
seasons could identify a large proportion of the subpatent reservoirs. In chapter 
8 the field piloted approach of hotspot targeted interventions on serologically 
defined hotspots and assess its impact both inside the hotspots and surrounding 
communities was described. Out of the Twenty-seven serological defined malaria 
hotspots, five were randomly allocated to an intervention arm, which included 
distribution of long-lasting insecticide-treated nets, indoor residual spraying, 
and focal mass drug administration. Five control clusters received malaria control 
following Kenyan national policy on malaria control. Intervention coverage reached 
over 87% for all interventions. Parasite prevalence was determined at the start of 
the study, at eight and respectively 16 weeks post intervention. Anopheles mosquito 
density, mosquito breeding site productivity and malaria incidence by passive case 
detection were measured as well. Hotspot targeted interventions did not achieve a 
significant measurable change outside the hotspot boundaries at 8- and 16-weeks 
post intervention. However, we did observe a 10.2% (95% C.I. 1.3-21.7%) decrease in 
parasite prevalence measured by molecular tools eight weeks after the intervention. 
Unfortunately, this effect was not maintained 16 weeks post intervention. Thirty-
six patients tested positive for malaria detected by passive case detection (using 
RDTs) within health facilities could be traced back to hotspots, however there was no 
difference between the different study arms. There were no significant reductions 
observed in mosquito catches between the study arms. Despite the high coverage 
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of interventions their impact on vector and human infection reduction was modest, 
transient and confined to the areas that were covered by interventions. These findings 
suggest that transmission does not exclusively occur from hotspots to surrounding 
areas and that malaria transmission at the time was more widespread. This indicates 
that our study area would have benefitted from an untargeted community wide 
approach at this stage. Hotspot-targeted approaches may have more potential in 
settings where human settlement and transmission is more focused. 
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Samenvatting
In de laatste decennia is significante progressie geboekt door de globale gemeenschap 
in het reduceren van malaria gerelateerde morbiditeit en mortaliteit. Tussen 2000 
en 2015 zijn de hoeveelheid malaria infecties bijna gehalveerd, hoofdzakelijk door 
de grootschalige investeringen in interventie methodes zoals de wijdverspreide 
distributie van insecticide behandelde bednetten, de applicatie van insecticiden in 
huishoudens en de beschikbaarheid van geneesmiddelen (Artemisinin combinatie 
Therapie). Ondanks deze progressie heeft malaria nog steeds een negatieve impact 
in vele delen van de wereld. Met de afname van het aantal globale malaria gevallen 
wordt het duidelijk dat het risico om malaria op te lopen verschilt tussen landen, 
provincies, dorpen en zelfs individuele huishoudens. De factoren die een rol spleen 
bij deze heterogeniteit zijn niet altijd duidelijk maar dezelfde heterogeniteit kan 
mogelijk bijdragen aan meer gerichte malaria. Dit proefschrift beschrijft wat de 
potentie is van het detecteren van gerichte interventies door de theorie omtrent 
gerichte interventies te testen in een veldstudie in de westelijke Keniaanse 
Hooglanden, De Keniaanse Hooglanden hebben in de laatste jaren een significante 
verlaging heeft gezien van het aantal malaria gevallen en staan nu bekend staat als 
een gebied wat richting malaria eliminatie beweegt. In Sectie I van dit proefschrift 
kijken we naar de theorie van heterogeniteit in het risico om malaria op te lopen 
en gaan we in op de hypothese of zogenaamde hotspots van malaria in kleinere 
gebieden kunnen worden gedetecteerd en gebruikt kunnen worden voor gerichtere 
malaria interventies als een effectieve strategie in de richting van malaria eliminatie. 
De evaluatie van malaria controleprogramma’s hangt sterk af van de kennis en data 
die gegenereerd wordt over de lokale transmissie dynamiek, De nauwkeurigheid van 
deze data is sterk afhankelijk van diagnostische hulpmiddelen die een onderscheid 
kunnen maken tussen een bestaande infectie en een infectie die in het verleden 
heeft plaatsgevonden. Vooral in gebieden met een lagere malaria transmissiegraad 
worden malaria gevallen vaak over het hoofd gezien door de gebrekkige sensitiviteit 
van diagnostiek zoals klassieke microscopie en rapid diagnostic tests (RDTs). De 
noodzaak voor meer sensitieve diagnostiek is cruciaal om een goed overzicht te 
verkrijgen van het ware aantal malaria infecties. Om te identificeren wat de situatie 
is omtrent huidige en eerdere malaria infecties is hebben we een diagnostische 
tool box ontworpen en gevalideerd die goed toepasbaar is in gebieden waar 
bloedmonsters niet koud kunnen worden opgeslagen en waar een groot aantal 
monsters moet worden verzameld. Deze kleine hoeveelheden bloedmonsters 
worden verzamelend op zogenaamd filterpapier. In Sectie II van dit proefschrift 
gaan we in op deze aanpak. In Hoofdstuk 3 bekijken we hoe stabiel DNA blijft als 
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het opgeslagen ligt als gedroogde bloedmonster op filterpapier en bekijken we de 
invloed van verschillende duraties en temperaturen op het succesvol detecteren 
van parasieten DNA. Monsters die langer dan twee jaar opgeslagen liggen op 
kamertemperatuur laten een significante verslechtering zien van detectie van 
parasieten DNA. Bij samples die langer opgeslagen liggen dan 10 jaar (parasiet 
dichtheid 1000 parasieten/ml) laten alleen nog positieve detectie zien in 10% van 
de geteste monsters. Monsters die opgeslagen liggen op −20°C lieten geen verlies in 
detectie zien.  Bloedmonsters met lagere parasieten dichtheden welke geëxtraheerd 
zijn met de chelex/saponine methode zoals omgeschreven in Hoofdstuk 4 lieten 
een betere amplificatie zien dan monsters die met de duurdere spin-kolom extractie 
methode waren geëxtraheerd. Met beide extractie methodes werd DNA verkregen 
dat stabiel bleef na meerdere keren het extract bevroren en ontdooid te hebben. 
Deze resultaten wijzen erop dat gedroogde bloedmonsters op filterpapier het beste 
kunnen worden bewaard bij −20°C of direct moeten worden geëxtraheerd als opslag 
voor langer dan twee jaar wordt geanticipeerd. 
Het gebruik van gedroogde bloedmonsters blijkt betrouwbaar en laat de detectie 
van serologische en moleculaire markers toe. Deze markers laten zich goed 
gebruiken voor de kwantificatie van transmissie intensiteit in laag endemische 
gebieden waar traditionele diagnostische middelen ontoereikend zijn vanwege hun 
lage sensitiviteit. Gedroogde bloedmonsters worden vaak gebruikt voor monster 
opslag, echter om goed in te schatten hoe betrouwbaar dit opslagmedium is, en 
om de toepasbaarheid in grote veldstudies te valideren, hebben we gekeken naar 
de kwaliteit van data van deze samples wanneer we antilichamen en DNA simultaan 
extraheren van deze monsters in Hoofdstuk 4. Deze methode vergaarde resultaten 
die goed vergelijkbaar zijn met een afzonderlijke extractie aanpak. Door de 
hoeveelheid monsters te verhogen, verhoogden we de sensitiviteit van detectie van 
positieve monsters in een PCR (Polymerase Chain Reaction, moleculaire test). Ook 
is aangetoond dat de concentratie van cel en antilichaam materiaal niet homogeen 
over een sample is verdeeld. Dit laat zien dat kwantificatie van een monster 
gedeeltelijk afhankelijk is van de fractie van het gebruikte monster.
In Sectie III van dit proefschrift bewegen we van de theorie naar de praktijk. 
In Hoofdstuk 5 beschrijven we een uitgebreid studieprotocol voor de detectie 
van hotspots en het vervolgens uitrollen van hotspot gerichte interventies. De 
west-Keniaanse hooglanden staan bekend als een tussengebied voor stabiele 
en onstabiele malaria transmissie. Welke factors precies aan deze heterogeniteit 
bijdragen op verschillende geografische niveaus is niet uitgebreid bestudeerd in dit 
gebied. Binnen een community based cross-sectionele studie die meer dan 17.000 
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individuen bevat is gekeken naar verschillende risico factoren die de macro en 
micro-epidemiologie van malaria drijven. Dit is gedaan op basis van serologische 
en moleculaire indicators. De prevalentie van malaria antilichamen heeft een 
sterkte correlatie met de hoogte van het landschap. Een sterke negatieve correlatie 
werd gevonden tussen een toenemende geografische hoogte en malaria PCR-
prevalentie. Personen geïnfecteerd met malariaparasieten werden op alle hoogten 
en in alle leeftijdsgroepen gevonden. In onze studie waren meer dan 93% van de 
malaria infecties asymptomatisch (op basis van PCR). Malariaparasiet prevalentie 
was geassocieerd met leeftijd, gebruik van bednetten, de bouwmaterialen van 
huishoudens en de topografische vochtigheidsindex. Ook antilichaam prevalentie 
was met al deze factoren geassocieerd, net als de afstand tot waterbronnen. Alhoewel 
geografische hoogte een sterke drijver is achter malaria transmissie in dit studiegebied 
lijkt het hoge percentage asymptomatische infecties op alle geografische hoogtes 
en de leeftijd gerelateerde acquisitie van malaria antilichamen erop te wijzen dat 
malaria transmissie vrij stabiel is. De sterke correlatie tussen huidige infecties en 
serologische markers lijken erop te wijzen dat malaria transmissie stabiel is over tijd. 
De hoge hoeveelheid asymptomatische infecties nodigt uit tot nieuwe manieren van 
het screenen van geclusterde cases, waarvoor een nieuwe aanpak gepresenteerd 
wordt in Hoofdstuk 7. De gepresenteerde hybride aanpak kan een oplossing 
bieden indien diagnostische screening en behandeling van de volledige populatie 
ontoereikend is het detecteren van infecties met een lage parasieten dichtheid en 
volledige preventieve behandeling van een populatie tot overbehandeling leidt. 
Deze aanpak test een hybride strategie die gebruik maakt van de hypothese dat 
gevallen van malaria clusteren binnen een huishouden. Door een zogenaamde 
sentinel populatie te screenen met RDTs kunnen we mogelijk een groot deel van 
de malaria patiënten met lage parasiet dichtheden ook behandelen.  Binnen deze 
studie laten we zien dat gevallen van malaria inderdaad vaak clusteren binnen 
huishoudens. Individuen die positief waren bevonden met een RDThadden vaker 
individuen met PCR positieve malaria binnen hetzelfde huishouden. Deze sentinel 
aanpak stelde ons in staat om 64.5% van de PCR-positieve huishoudens en 77.3% van 
de PCR positieve individuen te identificeren. Deze resultaten suggereren dat deze 
aanpak voorafgaand aan een hoog transmissie seizoen een grote proportie van de 
lage parasiet dichtheid infecties zou kunnen detecteren. In hoofdstuk 8 beschrijven 
we de pilotstudie voor de hotspot gerichte interventie op bases van serologische 
gedefinieerde hotspots en evalueren we het effect van deze interventies binnen de 
hotspot en direct daaromheen. Van de zevenentwintig serologisch gedefinieerde 
hotspots werden er vijf gerandomiseerd toegewezen aan een interventie arm en 
vijf voor de controle arm. Binnen de interventie arm werd een intensief pakket aan 
interventies uitgerold, bestaande uit de distributie van bednetten, het sprayen van 
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huishoudens met insecticide, de hybride screen en behandel aanpak (beschreven in 
hoofdstuk 7) en larvicides die werden toegepast op waterlichamen. Binnen de vijf 
controle clusters werden alleen routine interventies uitgerold volgens het Keniaanse 
nationale malaria controleprogramma. De dekkingsgraad van interventies was meer 
dan 87%. Parasiet prevalentie binnen alle clusters werd bepaald aan de start van de 
studie en vervolgens acht weken en zestien weken na de interventies. De dichtheid 
van de Anopheles mug, de productiviteit van broedplaatsen en passieve detectie 
van malaria gevallen werden ook gemeten. De hotspot gerichte interventies hadden 
geen significant effect direct buiten de hotspot grenzen, noch acht weken noch 
zestien weken na het uitrollen van de interventies. Acht weken na de interventies 
werd een effect binnen de hotspots gemeten, maar dit effect was niet blijvend. 36 
patiënten die werden gevonden in lokale klinieken konden worden herleid naar 
hotspots maar er werd geen effect gemeten in de verschillende armen van de 
studie. Er werden geen significante reducties gemeten in de hoeveelheid gevangen 
muggen tussen de verschillende studie armen.  Ondanks de hoge dekkingsgraad 
van interventies was hun effect op de vector populatie en humane infecties zeer 
bescheiden, niet langblijvend en behouden tot de hotspots zelf. Deze resultaten 
laten zien dat transmissie waarschijnlijk niet alleen vanuit hotspots plaatsvindt naar 
omringende gebieden maar dat in het studiegebied transmissie van een wijdere 
omgeving kwam. Dit studiegebied had waarschijnlijk meer baat gehad bij een 
wijdere uitrol van interventies. Hotspot gerichte interventies hebben waarschijnlijk 
een sterker effect in gebieden waar humane settlement en transmissie meer 
gefocust is. 
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bij te zijn.
My international Nijmegen crew; Sarah 1 & Michael (that for the amazing graphics 
for chapter 1, figure 1 and 2), Sarah 2, Minh, Duy, Enrique, Celia, Anna (and the 
few little ones!), it kind of started with a silly karaoke evening, a crazy cocktail 
evening and all of the sudden we became good friends. Really appreciated all the 
evenings of Pub Quizzes, Catan, Cocktails, proper dinners (BBQ!) and movies that 
271Acknowledgements   | 
10
we all shared. Moving out again, to different directions of this pale blue dot but, 
absolutely sure we will keep in touch and meet wherever (preferably at Sarah her 
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dat je een echt vak moet zoeken. 
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teaching me never to give up, to keep your head straight, no matter how many 
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